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Abstract 
In tailed bacteriophages and evolutionarily related herpes viruses, the portal 
protein is a central component of the DNA packaging molecular motor, which 
translocates viral genomic DNA into a preformed procapsid. The motor is the most 
powerful molecular machine discovered in nature, generating forces reaching ~50 
pN and translocating DNA with a speed of several hundred bp/sec using ATP as an 
energy source. The oligomeric portal protein ring is situated at a unique vertex of 
the procapsid forming a conduit for DNA entry and exit. Although the 
three-dimensional structure has already been determined for portal proteins from 
bacteriophages P22, SPP1 and phi29, several important questions about the role of 
individual protein segments in DNA translocation and their interaction with other 
components of the motor remain unanswered. Structural information on portal 
proteins from other bacteriophages, like T4 for which a wealth of biochemical 
information is already available, will help to answer at least some of these 
questions. 
The portal protein of bacteriophage SPP1 (gp6) can form circular oligomers 
containing 12 or 13 subunits. It is found as a 12-subunit oligomer when 
incorporated into the viral capsid and as a 13-subunit assembly in its isolated form. 
The X-ray structure of the SPP1 portal protein is available only for the isolated 
13-subunit assembly of the N365K mutant form. Because this mutation results in a 
reduction in the length of packaged DNA, determining the structure of the wild 
type portal protein would shed light on the mechanism of DNA translocation. 
Elucidation of the mechanism of DNA packaging depends also on the availability of 
accurate structural information on the SPP1 portal protein in its 12-subunit 
biologically active state. Such structural knowledge would be particularly useful in 
future, for designing a stable molecular machine that can function in vitro.  
In this thesis, experiments were designed to promote the formation of the 
dodecameric gp6: viz fusing gp6 with TRAP protein that forms a stable circular 
dodecamer as well as the co-expression of gp6 with the SPP1 scaffolding protein 
gp11. The protein targets were cloned, expressed and purified, and the oligomeric 
state of gp6 was characterised by a combination of biochemical, biophysical and 
structural approaches. The structure of the wild type gp6 was solved at 2.8 Å 
2 
resolution, revealing a 13-fold symmetrical molecule.  The protein’s fold is the 
same as for the N365K mutant, with most significant conformational differences 
observed in the tunnel loop and in segments of the clip and crown domains. 
Comparison with the structure of N365K mutant reveals significant differences in 
subunit-subunit interactions formed by tunnel loops, including different hydrogen 
bonding and van der Waals interactions. It is likely that these differences account 
for the different amount of packaged DNA, indicating involvement of tunnel loops 
in DNA packaging. 
The portal protein of bacteriophage CNPH82, cn3, was also successfully cloned, 
expressed and purified. Promising crystallisation conditions have been identified 
that yield crystals diffracting to 4.2 Å. Further optimisation should lead to 
determination of the X-ray structure of this protein in not too distant future. 
Self-rotation function calculations and SEC-MALLS analysis indicate that the cn3 
protein forms 13-subunit assemblies, in common with the SPP1 portal protein. 
Foundation work has been carried out for the bacteriophage T4 portal protein, 
aimed at identifying suitable production and purification conditions. In addition, 
the full-length bacteriophage SPP1 scaffolding protein gp11 has been cloned, 
purified and crystallised. Degradation was observed in the full length gp11 protein 
and therefore a series of truncations were designed, cloned and purified aiming to 
improve the stability. Further studies on limited proteolysis of the full-length gp11 
should lead to a stable gp11 tuncation that will form crystals with better 
diffraction.  
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1 Introduction 
1.1 The Bacteriophages 
Bacteriophages are viruses that infect and replicate within bacteria, often causing 
bacterial lysis following their replication. Bacteriophages were independently 
discovered by Frederick Twort and Félix d'Hérelle in the 1910s (Twort, 1925). 
However, due to their small size, bacteriophages were not visualised until the 
advent of the electron microscope in the 1940s (Luria et al, 1943). As the most 
abundant organisms in the biosphere, bacteriophages display striking diversity in 
their morphological properties - shape (spherical, helical, rod, polyhedral, etc.), 
size and auxiliary structures such as tails and envelopes (Orlova, 2009). Notably, 
the genetic material in the majority of bacteriophages is double-stranded DNA 
(dsDNA), but bacteriophages containing single-stranded DNA (ssDNA), 
double-stranded RNA (dsRNA) and single-stranded RNA (ssRNA) have also been 
discovered.  The morphology and nucleic acid properties provide the basis for the 
classification of bacteriophages, and nineteen families have now been defined 
(Calendar, 2006). 
Bacteriophages are obligate intracellular parasites of bacteria. Viral protein 
production and genome replication are fulfilled by bacterial machinery. These 
viruses are categorised as lytic bacteriophages or temperate bacteriophages based 
on the ability to cause lytic or lysogenic infection of the host cell (Bertani, 1953). 
Lytic bacteriophages can merely replicate throughout the lytic life cycle and cause 
lysis of the host bacteria, whereas temperate bacteriophages can also integrate 
their genetic materials into the bacteria's genome as a non-infectious “prophage”. 
During lytic infection by DNA bacteriophages, viral DNA replaces the bacterial 
genomic DNA as the template for both replication and transcription in host cells. 
Viral proteins, such as the coat proteins and tail proteins, are synthesised using 
host cell ribosomes, tRNAs and amino acids. The process of DNA replication, 
protein synthesis, and viral assembly is sequentially coordinated in the lytic life 
cycle (Figure 1-1). The first step of infection is adsorption, during which a phage 
recognises a specific receptor on the surface of the bacterial cell and adheres to the 
site, often by means of the tail fibres (Rakhuba et al, 2010). Following adsorption, 
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viral DNA is injected into the host cell. The synthesis of “early proteins” is 
triggered immediately after viral DNA penetration, to produce virus-specific DNA 
polymerases, which exclusively replicate phage DNA. “Late proteins” are 
synthesised after the replication of the bacteriophage genome, subsequently 
followed by the assembly of infectious virion particles. Mature virions are released 
from host cells with the assistance of phage-encoded lytic enzymes, such as 
lysozyme, to break down the peptidoglycan in bacterial cell walls. It takes about 
25-35 minutes for a T-phage to complete a life cycle, during which some 50 to 200 
phage particles may be produced from every infected bacterium (Calendar, 2006). 
 
Figure 1-1 The major steps in the lytic life cycle of a typical tailed bacteriophage.  
This figure was adapted from (Casjens, 2011). 
The potential for using bacteriophages to treat bacterial infections was recognised 
early on, with phages being introduced as antibacterial agents in the 1920s 
(Summers, 2001). The development of phage therapy was stalled because of the 
discovery and wide application of antibiotics. However, with the recent emergence 
of multi-antibiotic resistant bacteria, phage therapy is now considered a promising 
tool to treat bacterial infections that cannot be cured by conventional antibiotics 
(Thiel, 2004). Phage therapy has been successfully applied in the agricultural, 
food-processing and fishery industries (Inal, 2003). As the understanding of 
bacteriophage biology advances, the potential of phage therapy as a means of 
treating or preventing human diseases is likely to become more evident.  
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1.2 The Virus Assembly Process 
Research on the viral assembly process progressed rapidly with the isolation of 
conditional lethal mutants and the characterisation of the structures that 
accumulate in mutant-infected cells (Casjens & King, 1975). The viral assembly 
process, which proceeds along an ordered morphogenetic pathway, has been 
extensively studied. A more detailed understanding of the viral assembly process 
could enable the design of new antiviral agents, and lead to the development of 
new routes for designing nanoparticles (Harvey et al, 2009). 
This thesis is concerned with proteins involved in the assembly of tailed dsDNA 
bacteriophages. It is a tightly regulated and strictly ordered process, which often 
involves shell formation, DNA encapsidation and tail attachment. Bacteriophage 
heads and tails assemble independently and join together to form mature virions 
following the translocation of DNA into heads. The empty protein shell, termed the 
“procapsid”, can form spontaneously providing the capsid proteins are present at 
sufficient concentrations. In most cases, the formation of the procapsid is 
facilitated by other structural proteins, such as the auxiliary scaffolding proteins 
and the oligomeric portal protein. A DNA translocation molecular motor, located in 
one vertex of the procapsid, is responsible for driving the viral genome into the 
procapsid. The assembly process is often completed by the attachment of tail 
proteins. The morphogenic pathway of bacteriophage P22 is shown here (Figure 
1-2) as a typical example of tailed dsDNA bacteriophages (Teschke & Parent, 2010). 
 
Figure 1-2 The assembly pathway of bacteriophage P22.  
This figure was adapted from (Teschke & Parent, 2010). 
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1.3 The DNA Packaging Molecular Motor  
The double-stranded DNA bacteriophages and herpes viruses adopt common 
machinery – a DNA translocating molecular motor - to encapsidate the genomic 
DNA into a preformed procapsid protein shell. The packaging motor is powered by 
ATP hydrolysis, converting chemical energy into mechanical force to pump DNA 
into the procapsid against large internal pressure (Casjens, 2011).  
The DNA translocation process is initiated when the small terminase recognises 
and specifically binds to a recognition site on the concatemeric phage DNA (the 
pac site for phages P22, SPP1, T4 and T7 and the cos site for the λ-like and 
P2/P4-like phages) (Rao & Feiss, 2008). The small terminase also plays a role in 
recruiting the large terminase (Buttner et al, 2011). The large terminase displays 
endonuclease activity and makes an initial cut in the phage DNA at a specific site 
close to the recognition site. Following the initial cut, a small terminase - large 
terminase - DNA complex is formed and then docked to the portal protein, which is 
positioned at one vertex of the procapsid. Powered by ATP hydrolysis, the large 
terminase drives translocation of the viral DNA, via the portal protein, into the 
pre-formed procapsid. Once the capsid is filled, the large terminase is triggered to 
make a second cut in the DNA, thereby releasing the packaged DNA from the 
remainder of the concatemeric DNA (Rao & Feiss, 2008). Precisely one 
genome-length of DNA is packaged into phages in which both cuts are made in a 
sequence specific manner (for example bacteriophage λ). For phages in which the 
second cut is carried out in a sequence independent manner, slightly more than 
one genome length (102-110%) of phage DNA is normally packaged.  
The properties of the DNA packaging molecular motor can be investigated by 
single-molecule experiments, involving the use of optical tweezers (Figure 1-3). In 
this technique, a single active procapsid-motor complex is tethered to a 
microsphere coated with an anti-capsid protein antibody, and the distal end of the 
biotinylated DNA is tethered to another microsphere coated with streptavidin. 
Both microspheres are captured in optical traps (the narrowest point of a focused 
laser beam), and packaging is initiated by moving the packaging motor bead into 
close contact with the fixed DNA bead. The dynamics of the DNA packaging 
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molecular motor such as translocation speed, force and step size can then be 
studied by manipulating the microspheres (Rao & Feiss, 2008; Smith et al, 2001). 
 
Figure 1-3 Single-molecule analysis of DNA packaging using optical tweezers. 
This figure was adapted from (Casjens, 2011). 
The bacteriophage DNA packaging molecular motor is one of the most powerful 
biological motors reported. The dsDNA molecule is as compact as crystalline DNA 
in most mature capsids (Earnshaw & Casjens, 1980). In order to package genomic 
DNA, the motor has to work against a high internal pressure that builds up inside 
the capsid with the filling of DNA, and overcome the extremely unfavourable 
energetic environment resulted from extensive DNA bending and charge repulsion 
of the compacted phosphate backbone. The force generated by the motors of phi29, 
λ, and T4 is approximately 60 pN (Smith et al, 2001). 
An average translocation step size of two base pairs of DNA per molecule of ATP 
hydrolysed was deduced for phages phi29 and T3. The velocity of DNA 
translocation varies in different phages and appears to be correlated with the 
phage’s genome size.  The highest rate recorded to date was approximately 2000 
bp/sec in the case of bacteriophage T4 (Fuller et al, 2007). As packaging proceeds 
and internal pressure increases, the translocation rate decreases and eventually 
falls to zero when approximately 100% of the genome is packaged (Smith et al, 
2001). 
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The mechanism underlying the packaging of viral genomic DNA by the DNA 
packaging molecular motor is a fascinating research topic. A better understanding 
of the packaging motor will provide insights into the assembly of tailed 
bacteriophages, and also shed light on the potential applications of this nanomotor 
in nanotechnology and gene therapy. The structural basis of the motor 
components has been the subject of intensive research over the past two decades, 
and recent findings are reviewed in the following sections. 
1.4 Components of DNA Packaging Motors 
In general, a fully functional packaging motor relies on the co-operation of three 
essential components: the portal protein, the small terminase and the large 
terminase (Figure 1-4) (Casjens, 2011). One exception is the packing motor of 
phage phi29, which lacks the small terminase and instead requires a small 174-nt 
packaging RNA (pRNA), which docks the large terminase to the portal protein 
(Guo, 2002). 
 
Figure 1-4 Schematics of the bacteriophage DNA packaging molecular. 
TerL: Large terminase, TerS: Small terminase. The portal protein is shown as a dodecameric 
ring embedded in the 5-fold symmetrical vertex of an icosahedral bacteriophage capsid. The 
portal protein, large terminase and small terminase form the dsDNA translocating motor. 
The large and small terminase proteins are shown as rings made up of five and eight 
subunits, respectively, but their exact oligomeric states may differ in different 
bacteriophages. All known functional portal proteins are dodecamers (Rixon, 2008). The 
position of the small terminase is speculative. The arrow indicates the position and direction 
of dsDNA movement during translocation. This figure was adapted from (Casjens, 2011). 
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1.4.1 The Central Component - The Portal Protein 
The portal protein assembly is located at a unique vertex of the procapsid shell, 
and forms a passage through which DNA can be translocated. As an essential 
component of the DNA packaging motor, the portal protein plays several 
indispensable roles in the assembly of viral particles. Not only can the portal 
protein initiate procapsid assembly and control the size of the procapsid, but it is 
also a central component of the DNA translocating molecular motor, a headful 
sensor for DNA packaging and a connector for tail attachment (Bazinet & King, 
1988; Casjens et al, 1992; Droege & Tavares, 2005; Tavares et al, 1992).  
The portal proteins from different bacteriophage species are highly diverged 
homologues, and there is no detectable similarity in amino acid sequences. In spite 
of the lack of homology between the amino acid sequences, a close resemblance in 
the overall architecture of bacteriophage portal proteins was revealed by X-ray 
structural and cryo-electron microscopy studies (Guasch et al, 2002; Lebedev et al, 
2007; Leiman et al, 2004; Olia et al, 2011; Orlova et al, 2003; Simpson et al, 2000b). 
Portal proteins have a cone-shaped structure containing a central channel, with 
the wider end situated inside the capsid and the narrower end protruding out of 
the capsid. The channel is lined by 12 α-helices that expose several acidic residues 
which allow efficient passage of negatively charged DNA through the tunnel 
(Figure 1-5A). A single subunit of portal proteins can be subdivided into four 
regions, namely the clip, stem, wing and crown (Lebedev et al, 2007). The core 
domain of the portal protein from different phages demonstrated a strikingly 
similar fold, especially in the region spanning from helix α3 to helix α6 (Figure 
1-5B), which is observed in three-dimensional structures of all portal proteins.  
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Figure 1-5 Conservation of the overall architecture and core domain of portal 
proteins 
(A) Crystal structures of the portal proteins from bacteriophages phi29 gp10 (PDB: 
1FOU), SPP1 gp6 (PDB: 2JES) and P22 gp1 (PDB: 3LJ4) (Lebedev et al, 2007; Olia et 
al, 2011; Simpson et al, 2000a); (B) The core domains of the portal proteins show 
that the four α-helices, helices α3 to α6, are observed in all three structures. Cyan 
arrows correspond to β-strands, red ribbons correspond to α-helices and loop regions 
are coloured in grey. Variability is localised in the wing regions, which differ in both 
conformation and size (Veesler & Cambillau, 2011) .  
SPP1 gp6 
phi29 gp10 
P22 gp1 
A 
B 
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The molecular mass of different portal proteins varies greatly, with the smallest 
one found in phage phi29 (~35 kDa per subunit) and the largest one found in 
phage P22 (~83 kDa per subunit). In phage P22, the portal protein has a 200 Å 
long C-terminal extension, which forms an α-helical barrel and extends into the 
cavity of the capsid (Olia et al, 2011). In comparison with phi29, the extra 
molecular weight of the SPP1 portal gp6 (57.3 kDa per subunit) resides in the 
considerably larger wing and longer C-terminal region (Lebedev et al, 2007; 
Orlova et al, 2003). Given the large differences in size, the length and spatial 
arrangement of the helices in the core domain is surprisingly comparable. This 
conserved core segment accounts for 46% of the phi29 portal protein sequence 
and is likely to be an ancient structural unit with an important role in genome 
packaging (Lebedev et al, 2007). The conservation of the core architecture of 
portal proteins also suggests bacteriophages employ a similar mechanism to 
translocate genomic DNA into procapsids. 
It is believed that the portal proteins exist exclusively as dodecamers in their 
biologically active state (Rao & Feiss, 2008). However, following ectopic 
expression and purification, the oligomeric state of the portal proteins from 
bacteriophages T7, T3, SPP1 and P22 has been found to range from an 11-mer to a 
14-mer in vitro, and heterogeneous populations have also been reported 
(Cingolani et al, 2002; Dube et al, 1993; Kocsis et al, 1995; Trus et al, 2004a; 
Valpuesta et al, 2000). Portal proteins retain a similar overall architecture in 
different oligomeric states with conformational changes occurring in specific 
segments such as helix α6 of the crown region and tunnel loops (Lebedev et al, 
2007). The factors determining the stoichiometry of the portal protein rings have 
not yet been identified conclusively. 
1.4.2 The Large Terminase - the ATPase and Endonuclease of the 
DNA Packaging Molecular Motor 
The genome of most dsDNA viruses is replicated as a concatemer without free 
ends, and a linear chromosome must be generated for packaging. The ter protein, 
from phage λ, was the first protein found to be required for termini formation 
(Mousset & Thomas, 1969). The term “terminase” remains in use because of the 
role of the terminases play in generating new DNA termini from viral genomic 
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concatemers. The nuclease activity actually only resides in the C-terminal domain 
of the large terminase (Bhattacharyya & Rao, 1993; Kuebler & Rao, 1998; Rentas & 
Rao, 2003), whereas the N-terminal domain, with its ATPase activity, fuels the 
motor to pump DNA into the procapsid. Interestingly, co-operation of the ATPase 
domain and the nuclease domain is thought to be crucial for the endonuclease 
activity. Evidence has shown that the nuclease activity of the C-terminal nuclease 
domain is completely lost, or significantly decreased, in the absence of the 
N-terminal domain (Alam et al, 2008; Alam & Rao, 2008; Smits et al, 2009). 
2.1.1.1 The Nuclease Domain of the Large Terminase 
During the packaging process, two events require nuclease activity, namely the 
initiation of DNA packaging and the “headful” termination cuts.  The initial 
cleavage of the concatemer is commonly sequence specific, and occurs near the 
recognition site of the small terminase, after the large terminase has been 
recruited to the small terminase:DNA complex (Gual et al, 2000). The packaging of 
genomic DNA starts from the end generated by this cut. The second cleavage is 
triggered when the virus particle is fully packaged. For λ-like phages the second 
cut is also sequence specific, and precisely one genome-length of DNA is packaged 
accordingly. For phages such as SPP1, T4 and P22, the second cut is 
sequence-independent and triggered by a headful-sensing mechanism when the 
capsid has been filled with DNA (Rao & Feiss, 2008). In this case, slightly more 
than one genome-length of DNA (102 -110%) is packaged (Smits et al, 2009). 
 
Figure 1-6 The headful packaging of genome DNA by tailed dsDNA phages. 
Top: one genome-length of DNA is packaged by λ-like phages with a sequence specific 
second cut; Bottom: “headful filling” packaging with a sequence-independent second 
cut as in phages SPP1, T4 and P22, etc. This figure was adapted from (Rao & Feiss, 
2008). 
Three-dimensional crystal structures of the nuclease domain of the large 
terminase have been determined for bacteriophages P22, SPP1, T4 and T4-like 
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RB49 (Alam et al, 2008; Smits et al, 2009; Sun et al, 2008).  Despite displaying 
low sequence homology, these proteins all share a similar RNase H fold, 
comprising a central β-sheet sandwiched between two clusters of α-helices, and 
conserved catalytic acidic residues (Smits et al, 2009). Notably, a structure-based 
alignment revealed that the large terminases possess several distinct, conserved 
features, for example extension of the central β-sheet and a C-terminal β-hairpin 
(β8 and β9) (Smits et al, 2009). These additional structural elements are not 
shared with other members of the RNase H family, indicating their importance for 
the function of the terminase.  
 
Figure 1-7 The structure of the nuclease domain of the SPP1 large terminase.  
The central β-sheet (blue) is surrounded by a three-helix bundle on the concave face 
(yellow) and two helices on the convex face (orange). The C-terminal β-hairpin (β8 
and β9) is shown in green, as shown in (A). The three conserved acidic residues are 
shown in (B). This figure was adapted from (Smits et al, 2009). 
RNase H family members catalyse the hydrolysis of RNA-DNA hybrids by means of 
a two metal ion-dependent mechanism (Tadokoro & Kanaya, 2009). During 
catalysis, it has been proposed that one metal ion activates a nucleophilic hydroxyl 
group and the other metal ion stabilises the transition state. Conserved acidic 
residues co-ordinate the two metal ions and are required for catalysis. The large 
terminases of some bacteriophages, such as bacteriophage λ and RB49, require 
magnesium ions (Mg2+) for catalysis (Sun et al, 2008; Tomka & Catalano, 1993). In 
contrast, the large terminases of the bacteriophage SPP1 and the evolutionarily 
related HSV-1 depend on manganese ions (Mn2+) (Cornilleau et al, 2013; Nadal et 
al, 2010). Sequence-based and structure-based alignments of large terminase 
A B 
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proteins revealed three highly conserved acidic residues within the catalytic site. 
Mutagenesis analyses showed that these three acidic residues are essential for the 
nuclease activity of the large terminases, (Alam et al, 2008; Smits et al, 2009; Sun 
et al, 2008). 
On the basis of the structures, several mechanisms have been proposed to explain 
the headful nuclease activity of the large terminases that occurs following DNA 
packaging. Due to the conformational changes that occur in the portal protein 
upon maturation (Figure 1-8), it was proposed that expansion of portal protein 
might potentiate the dissociation of the large terminase from the portal protein 
and thus trigger DNA cleavage (Alam et al, 2008; Xiang et al, 2006). After defining 
the unique fold of the C-terminal β-hairpin in the large terminase, a mechanism 
was proposed based on the regulation by the β-hairpin. The β-hairpin is flexible 
and can therefore adopt different conformations which can obstruct or promote 
interactions between large terminase with substrate DNA molecule (Smits et al, 
2009). 
 
Figure 1-8 Conformational changes of the portal protein upon phage maturation. 
(A) Model of the portal protein crystal structure (Cα trace in red) fitted into the 
cryo-EM density of the five-fold averaged reconstruction of the procapsid, prior to 
DNA packaging; (B) The cryoEM density of the asymmetric reconstruction of mature 
viral particles, following removal of the packaged DNA. The narrow end of the portal 
protein would have to increase its radius in order to fit into the density (dark blue) of 
the mature viral particle. This figure was adapted from (Xiang et al, 2006). 
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2.1.1.2 The ATPase domain of the large terminase 
Viral genomic DNA is packaged into the procapsid to near-crystalline density, 
using the energy released from ATP hydrolysis (Sun et al, 2007). The ATPase 
activity resides in the N-terminal domain of the large terminase proteins 
(Kanamaru et al, 2004; Rao & Mitchell, 2001). The N-terminal ATPase catalytic 
centre is strictly conserved in terms of sequence signatures and secondary 
structure motifs among different bacteriophages, which contains the 
adenine-binding motif, catalytic carboxylate, the walker A motif and the walker B 
motif (Feiss & Rao, 2012; Goetzinger & Rao, 2003; Walker et al, 1982).  
The atomic structure of the N-terminal domain of the T4 large terminase gp17 
with the D255E/E256D mutations (Figure 1-9) revealed a flat structure consisting 
of two spatially separate subdomains (Sun et al, 2007). Subdomain I contains the 
nucleotide-binding domain (NBD, Figure 1-9) with the characteristic 
Rossmann-fold motif - a conserved β-sheet core with six parallel β-strands (Rao & 
Feiss, 2008; Rossmann et al, 1974; Sun et al, 2007). The apo- and ADP/ATP-bound 
structures are very similar. The only difference is the conformation of the adenine 
binding loop, which may reflect the state of the ATP binding pocket (Sun et al, 
2007).  Subdomain II contains residues 1–58 from the N-terminus and residues 
314–360 from the C-terminus.  
 
Figure 1-9 The structure of the N-terminal domain of the T4 large terminase. 
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A ribbon diagram shows the structure of the N-terminal domain of the large 
terminase gp17 N360-ED mutant from the bacteriophage T4. The Rossmann-fold 
motif in Subdomain I follows a 324516 topology and the β strands are coloured in 
sequence with red, orange, yellow, green, cyan, and blue. The conformational change 
in the adenine binding loop is shown between the ATP-bound state (purple) and the 
apo state (yellow). This figure was adapted from (Sun et al, 2007). 
1.4.3 The Small Terminase  
The small terminase is the third component of the DNA packaging motor and is 
responsible for recognising the viral DNA for the initiation of packaging (Camacho 
et al, 2003). The small terminase binds to specific sequences in the viral DNA 
(either cos or pac sites) from where packaging is initiated (Lin et al, 1997). The 
role of the small terminase in the packaging process is not yet fully understood. It 
may actively participate in the regulation of the ATPase and nuclease activities of 
the large terminase during DNA translocation (Buttner et al, 2011). However, 
small terminases are not necessarily required for packaging pre-cut DNAs in most 
in vitro packaging systems (T4, T3, and λ) (Hamada et al, 1986; Rao & Black, 1988; 
Rubinchik et al, 1995).  
Biochemical and mutational analyses revealed that the small terminase consists of 
three domains, namely an N-terminal DNA-binding domain, a central 
oligomerisation domain, and a C-terminal large terminase-binding domain 
(Al-Zahrani et al, 2009). Over the past decade, considerable knowledge has been 
accumulated regarding the structure of the small terminases. The structures of the 
small terminase from several bacteriophages have been determined, including the 
cryo-EM and crystal structures of the small terminase from phage P22 (Nemecek 
et al, 2008; Roy et al, 2012), the NMR structure of the DNA-binding domain of the 
small terminase gpNu1 from phage λ (de Beer et al, 2002), the full-length crystal 
structures of the phage Sf6 (Podoviridae family) small terminase gp1 and the 
phage SF6 (Siphoviridae family) small terminase G1P (Buttner et al, 2011; Zhao et 
al, 2010) and the crystal structure of the central domain of the small terminase 
from a T4 family phage, phage 44RR, in two different oligomeric states (Sun et al, 
2012).  
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Although there is no significant overall sequence homology, the 3-D structures of 
the small terminases revealed several common structural motifs required for the 
DNA packaging process (Rao & Feiss, 2008). A helix-turn-helix (HTH) motif located 
at the N-terminus is often associated with DNA binding (Brennan & Matthews, 
1989). The central domain, consisting of two long antiparallel α-helices, plays a 
key role in oligomerisation (Kondabagil & Rao, 2006). The C-terminal domain is 
composed mainly of β-strands, which form an intersubunit β-Barrel. The crystal 
structure of the full-length small terminase from phage SF6 is shown in Figure 
1-10.  
 
Figure 1-10 A ribbon diagram of the full-length SF6 small terminase. 
For clarity, DNA binding domains (red ribbons) are shown only for five subunits. A 
10-bp dsDNA is fitted with the helix-turn-helix motif of a single subunit. The 
C-terminal β-barrel and the main body of the oligomerisation core domain are 
shown with individual subunits in alternating colours (white, yellow, blue). This 
figure was adapted from (Buttner et al, 2011). 
The oligomeric state of the small terminase varies from eightfold to twelve-fold, 
with full-length Sf6 small terminase dispaying eight-fold symmetry, the SF6 small 
terminase displaying nine-fold or ten-fold symmetry and the T4 family phage 
44RR small terminase displaying eleven-fold or twelve-fold symmetry (Sun et al, 
2012). Interestingly, the full-length SF6 small terminase exclusively forms 
nine-subunit assemblies, whereas protein constructs missing the C-terminal 
β-barrel form both nine-subunit and ten-subunit assemblies, indicating the 
importance of the C-terminus for defining the oligomeric state (Buttner et al, 
2011). 
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1.5 Aims of the Project  
As described above, the portal protein assembly is the major component of the 
DNA packaging molecular motor, which translocates the viral genomic DNA into a 
preformed procapsid protein shell fuelled by the energy of ATP hydrolysis. The 
oligomeric portal protein ring is situated at a unique vertex of the procapsid shell 
to form the conduit for DNA entry and exit.  The SPP1 portal protein is a circular 
homo-oligomer with an intrinsic 12-fold symmetry incorporated into the viral 
capsid, but forms a 13-mer assembly in its isolated form.  Although the 
three-dimensional structure of the isolated SPP1 portal protein is available, it is 
not for the wild-type form but for N365K mutant. This mutation results in 
reduction of the length of packaged DNA (Tavares et al, 1992). During my PhD 
studies, my work was mainly focused on the structural studies of the portal 
proteins from double-stranded DNA bacteriophages SPP1, T4 and CNPH82.  
My major aim was to produce gp6 in its biologically relevant dodecameric state for 
in vitro studies, to gain three-dimensional structural information on the wild-type 
portal protein and to understand structural reasons that result in the reduced 
length of packaged DNA in the case of capsid containing N365K portal protein. In 
order to promote the formation of the dodecameric gp6, two strategies involving 
protein engineering of fusion proteins and co-expression of gp6 with gp11, were 
designed and investigated using a combination of biochemical, biophysical and 
structural approaches. 
Finally, the portal proteins from bacteriophages CNPH82 and T4, cn3 and gp20 
respectively, were also studied to gain more general information about the 
assembly of portal proteins from other phages. The goal of this research was to 
explore methods of producing soluble proteins and to obtain diffracting crystals 
for structural studies. 
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2 Materials and Methods 
2.1 Introduction 
In this chapter, the general experimental procedures involved in the projects such 
as molecular cloning, protein production, purification and characterisation, 
protein crystallisation as well as macromolecular X-ray crystallography are 
summarised. The application of relevant techniques will be detailed in the 
following chapters.   
2.2 Molecular Cloning 
As a fundamental laboratory technique, molecular cloning facilitates the 
production of large quantities of protein, which would otherwise naturally be only 
found in small amounts, for use in structural and functional studies. It is also used 
to engineer protein molecules by allowing the introduction of mutations, 
truncations and tags etc. to the target protein. The process involves the insertion 
of a foreign DNA fragment into a vector capable of replicating autonomously in a 
host cell (usually Escherichia coli). Multiple copies of the inserted DNA will then be 
produced with the host cell growth.  
2.2.1 Insert Preparation  
2.2.1.1 Polymerase Chain Reaction (PCR) 
The polymerase chain reaction (PCR) has revolutionized molecular biology 
research since its invention by Kary Mullis in 1983 (Saiki et al, 1985). Nowadays, it 
has become a routine technique to amplify a large number of copies of a specific 
DNA fragment in vitro from trace amounts of the template material. PCR has a 
variety of applications in biological and medical research: gene isolation, 
DNA/genome sequencing, detection, diagnosis of genetic diseases, etc.  
Three distinct steps controlled by temperature are involved in PCR reactions – 
denaturation, annealing and elongation. Prior to the beginning of a PCR reaction, 
there is normally an extended denaturation step at ~95 °C for 2-5 minutes to 
ensure efficient denaturation of the template DNA. Double-stranded DNA template 
is first heated typically to 95 °C to separate its complementary single strands 
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during denaturation process. The reaction is then rapidly cooled to allow for 
primer-template hybridization, usually between 40 °C and 72 °C dependant on the 
melting temperature (Tm) of the oligonucleotide primers. Template single strands 
are too long and complex to reanneal within the same time frame. At last, DNA will 
be synthesised by a thermostable DNA polymerase at its optimal working 
temperature (e.g., 72 °C for Taq DNA polymerase). 20-40 cycles of the three PCR 
steps should be performed to obtain sufficient DNA products for a specific 
application purpose. Finally, there is an extended 72 °C incubation step to ensure 
full-length synthesis of PCR products. 
 
Figure 2-1 Schematic diagram of the PCR process.  
The three steps involved in PCR reactions – denaturation, annealing and elongation 
are illustrated. This figure was adapted from British Encyclopaedia. 
Short synthetic oligonucleotides are required in a PCR reaction, because DNA 
polymerases can only add new nucleotides to the 3’ end of an existing strand.  
Primers are designed to be reverse complementary sequences of the template 
DNA, and play a crucial role in guiding a precise DNA synthesis process. Optimal 
primer design is the most critical parameter for a successful PCR. Poorly designed 
primers can result in PCR reaction failure due to nonspecific amplification and/or 
primer-dimer formation even if all other parameters properly optimised (Apte & 
Daniel, 2009). Several factors should be taken into consideration for a successful 
PCR primer design, such as length, G-C content and Tm. It is crucial that the 
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forward primer and reverse primer have similar melting temperature, since 
annealing ought to occur simultaneously for both primers. Meanwhile, formation 
of secondary structures by intermolecular or intramolecular interactions should 
be avoided, because the presence of primer secondary structures can lead to poor 
or no yield of the PCR product.  
2.2.1.2 Agarose Gel Electrophoresis  
Agarose gel electrophoresis is an easy and effective way to separate, identify, and 
purify DNA fragments. DNA fragments are separated according to their sizes and 
visualised under a UV transilluminator after staining with a fluorescent dye such 
as ethidium bromide or SYBR®  Safe stain. When an electrical field is conducted, 
DNA, negatively charged at neutral pH due to its phosphate backbone, will migrate 
toward the anode. The migration rate of a linear DNA fragment through an agarose 
gel is inversely proportional to the log10 of its molecular weight. The migration 
rate can also be affected by the agarose concentration, the conformation of the 
DNA, the applied current, base composition and temperature. DNA fragments with 
sizes varying from 50 base pairs to several mega base pairs can be separated with 
appropriate percentage of agarose gel (from 0.75% to 2.0%) and electrophoresis 
condition. A DNA ladder normally runs alongside samples, as a reference to 
estimate the size of samples. 
A solution of agarose at an appropriate concentration (w/v) for separating DNA 
fragments with particular sizes was prepared in 1x TAE electrophoresis buffer 
containing 40mM Tris pH 8.0, 20mM acetic acid, and 1mM EDTA . Agarose slurry 
was heated in a microwave oven until fully dissolved. SYBR®  Safe DNA gel stain 
(10,000x concentrate in DMSO) was then added to agarose gel solution to a 1x 
final concentration after the gel solution cooled. DNA samples were mixed with 
blue or orange dye before loading, and a suitable DNA ladder (e.g., 2-Log DNA 
Ladder, New England Biolabs) was also loaded alongside samples. Agarose gels 
were usually run at 100-120 V for approximately 60 minutes. Gel pictures were 
taken on the Syngene Bio Imager.  
2.2.1.3 Quantitation of DNA Concentration 
DNA concentration can be quantified by optical density measurement, because 
nucleic acids maximally absorb UV light at 260 nm wavelength. 
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Spectrophotometric analysis provides an easy way to assess the concentration of 
DNA in solution, especially with a NanoDrop Spectrophotometer - a microvolume 
spectrophotometer that utilises a patented sample retention system and thus 
eliminates the need for cuvettes and capillaries. 2 µL of sample is pipetted directly 
onto the pedestal when the arm is open. With a closed arm, a sample column is 
formed between two optical surfaces. Then, the pedestal moves to automatically 
adjust for an optimal path length in vertical direction (0.05 mm - 1 mm). The 
concentration range of dsDNA varying between 2 ng/µL and 3700 ng/µL can be 
assessed by the measurement of absorbance at 260 nm wavelength using 
NanoDrop Spectrophotometer. 
2.2.2 Vector Preparation 
2.2.2.1 Vector 
Vectors are DNA molecules carrying exogenous DNA insert into host cells for the 
purpose of DNA cloning. There are three common features for all cloning vectors : 
(i) a replication origin for independent replication; (ii) a multiple cloning site (also 
called the polylinker region) with a number of unique restriction endonuclease 
cleavage sites where exogenous DNA fragments can be inserted; (iii) a selectable 
marker, usually antibiotic resistance genes or enzyme genes absent in the host cell, 
to distinguish positively transformed cells. Four major types of vectors were 
categorised based on the capacity to accommodate insert DNA into plasmids, viral 
vectors, cosmids, and artificial chromosomes with insert size of 10, 20, 45 and 
several hundred kilobases (kb), respectively.  
2.2.2.2 Plasmid Vector 
Plasmids are circular double-stranded DNA molecules, which can be found in 
almost all bacteria and yeast, and in some fungi, protozoa, plants and animals. 
They are separated from the chromosomal DNA as extrachromosomal 
self-replicating DNA molecules, and range in size from 1 to over 1000 kb. Plasmids 
from E. coli are commonly used for molecular cloning, as many have been 
artificially constructed for the optimal usage as vectors - the length dramatically 
reduced for easy manipulation with little more than the above-mentioned three 
essential elements. The pET vector system were originally designed by Studier and 
colleagues in 1986 (Studier & Moffatt, 1986) and further developed at Novagen. It 
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is the most widely used vector system for gene cloning and expression in E. coli, 
with different selectable markers and different characteristics. Transcription of 
the insert DNA is controlled by the strong T7 RNA promoter, which is specifically 
recognised by bacteriophage T7 RNA polymerase. T7 RNA polymerase is not 
naturally existed in E. coli cells, and therefore host E. coli cells are genetically 
engineered to incorporate the T7 RNA polymerase gene in the host chromosome 
under the control of the lac promoter. Once Lactose or lactose analogue IPTG 
(isopropyl-beta-D-thiogalactopyranoside) triggers the production of T7 RNA 
polymerase, transcription and translation of the insert DNA will be induced 
subsequently (Garrett & Grisham, 2010).  
2.2.2.3 pBlueScript II Phagemid System and Blue/White Screen 
The pBluescript II phagemids - plasmids with a phage origin and 21 restriction 
enzyme recognition sites in the polylinker region, are designed for cloning, 
sequencing, in vitro mutagenesis, and so on. The polylinker region is located within 
the lacZ’ gene, which encodes the N-terminal fragment of β-galactosidase also 
known as the α-peptide. Host E. coli cells with lacZ deletion mutant can only 
produce inactive mutant β-galactosidase, so a α-peptide produced by pBluescript 
vector is required to rescue the function of β-galactosidase and cleave colourless 
X-gal into blue coloured 5-bromo-4-chloro-indoxyl. Thus, blue coloured colonies 
indicate the existence of uninterrupted vectors with no insert DNA.  
 
Figure 2-2 Schematic representation of blue white screen  
(A) pBluescript II KS (+/-) vector, and (B) blue white screen. This figure was adapted 
from Stratagene.  
A B 
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2.2.3 Ligation Dependent Cloning 
A restriction enzyme digestion step and a ligation step are required for the 
classical ligation dependent cloning approach. The vector and insert DNA should 
contain the same endonuclease recognition site in order to be recognised and cut 
by the specific restriction endonucleases. Complementary sticky ends or blunt 
ends will be generated after a digestion step. The digested insert and linearised 
vector are joined together with covalent bonds by DNA ligase, most commonly T4 
DNA ligase. Dephosphorylation of linearised vectors to remove the 5’ phosphate 
group and prevent self-ligation of vectors is a crucial step for a successful ligation 
reaction. 
Double digestion using two different restriction endonucleases is usually 
performed to generate non-complementary sticky ends, which will inhibit 
self-ligation of vectors and ensure target DNA fragments are incorporated into 
vectors in the desired orientation.  In the digestion reaction, an appropriate 
amount of DNA, restriction endonucleases, the particular buffer for the specific 
restriction endonucleases and sometimes BSA protein solution are mixed and 
incubated at the optimal temperature for enzyme activity, usually 37 °C, for about 
one hour. Composition of a typical restriction digestion reaction is shown in Table 
2-1. Most restriction enzymes can be inactivated by heating at 65 °C for 20 minutes. 
An extra dephosphorylation of vector is performed by incubation with 1 µL 
Antarctic phosphatase (5 U/µL) and 1X phosphatase buffer at 37 °C for 20 minutes 
and subsequent heat inactivation at 65 °C for 10 minutes. 
Table 2-1 Composition of a typical double digestion reaction 
Component Amount 
Insert/ Vector ~1 µg 
Restriction endonuclease I (20 U/ µL,NEB) 5 µL 
Restriction endonuclease II (20 U/ µL,NEB) 5 µL 
Restriction endonuclease buffer (10X,NEB) 5 µL 
Milli-Q water Up to 50 µL 
 
For a ligation reaction to take place, three main components are required: (1) DNA 
fragments with compatible ends; (2) A buffer containing 0.25 mM - 1 mM ATP to 
provide the necessary energy for the reaction; and (3) T4 DNA ligase. Composition 
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of a typical restriction digestion reaction is shown in Table 2-2, and the ideal ratios 
for ligating insert to vector with sticky ends ranges between 1:1 and 3:1. 5 µL of 
ligation product is transformed into 100 µL of E. coli competent cells after 
overnight ligation at room temperature or 16 °C. 
Table 2-2 Composition of a typical ligation reaction 
Component Amount 
Double digested vector 100 ng 
Double digested insert X ng* 
T4 DNA ligase (400 U/ µL, NEB) 1 µL 
T4 DNA ligase buffer (10X,NEB) 2 µL 
Milli-Q water Up to 20 µL 
*the amount (ng) of the double digested insert added in a typical ligation reaction 
is normally calculated by the formula: 
                     [
                   
                   
]                    
2.2.4 Transformation 
Transformation is the process of introducing foreign DNA into bacterial strains. 
With successful transformation, the bacteria cells will inherit specific 
characteristics owing to the acquisition of foreign DNA. The delivery of foreign 
DNA into competent cells can be achieved via two main approaches - chemical 
transformation and electroporation. Only chemical transformation is employed in 
the projects reported here. During chemical transformation, bacterial cells are 
heat-shocked in a water bath, which opens pores on the cell membrane to allow 
for the entry of plasmid DNA into cells. 
5 μL of the ligation product was added into 100 μL of freshly thawed competent E. 
coli cells, mixed gently and incubated on ice for 30 minutes. Exactly one minute 
heat shock was carried out at 42 °C, followed by a further incubation on ice for 2 
minutes. 200 μL LB medium was added and the mixture was incubated in a shaker 
at 37 °C for one hour. The transformed cells were plated out on a LB-agar plate 
with appropriate antibiotics. After overnight incubation at 37 °C, colonies growing 
on the plate should carry foreign DNA, however further verification is necessary to 
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confirm the successful transformation. Meanwhile, appropriate positive and 
negative controls were treated identically for results interpretation.  
For general cloning, E. coli strains DH5α and NovaBlue were used, because they 
are competent for plasmid maintenance with high transformation efficiency and 
high plasmid yield. For the purpose of protein production, BL21 (DE3 lys) and 
B834 (DE3 lys) strains were used, because the lacI gene, lacUV5 promoter and T7 
RNA polymerase gene are incorporated in the chromosome of these strains to 
make them suitable for hosting the pET vector system. Additionally, the lack of lon 
protease and ompT outer membrane protease in these strains may prevent protein 
degradation during purification process.  
2.2.5 Colony PCR  
The appearance of numerous antibiotic resistant E. coli colonies after 
transformation can be a good indicator of a successful cloning reaction. However, 
further verifications by colony PCR or/and restriction analysis always prove to be 
necessary to confirm the existence of foreign DNA insert, especially when a 
significant number of colonies are also shown on the control plate.   
Colony PCR is a fast way to screen numerous colonies, during which the PCR 
reaction will only work on condition that the insert DNA is present using vector 
flanking primer pairs.  PCR premix solution was prepared according to the 
number of colonies for screening (Table 2-3). Some random colonies was picked 
using a sterile yellow tip, and transferred into the reaction mixture by pipetting up 
and down several times and streaked onto a fresh replicate agar plate. If bands 
relating to the PCR products with the expected lengths were observed on an 
agarose gel, the corresponding colonies growing on a replicate agar plate were 
cultured.  
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Table 2-3 Components to set up colony PCR premix  
Components Final concentration 1 x pre-mix 
Primer 1 (2 μM) 0.2 μM 2.5 µL 
Primer 2 (2 μM) 0.2 μM 2.5 µL 
10 X PCR buffer  1X 2.5 µL 
dNTPs (25 mM each) 0.2 mM 0.2 µL 
Taq Polymerase (5 U/µL) 0.05 U 0.25 µL 
dH2O  17.05 µL 
2.3 Expression of Recombinant Protein  
The production of recombinant protein requires an expression system involving a 
combination of a plasmid and a host (Sorensen & Mortensen, 2005).  In microbial 
expression systems, Escherichia coli is a widely used host for recombinant 
expression of heterologous proteins (Baneyx, 1999). In this study, DE3 lysogenic 
strains of BL21 and B834 were used to host pET vector system for the 
over-expression of target proteins controlled by T7 promoter.  
2.3.1 Small Scale Protein Expression  
A small-scale protein expression experiment is normally performed before a 
large-scale cell culture and purification, to optimise conditions for the expression 
and solubilisation of the target protein. The key factors involved for optimal 
protein expression and solubility are as follows: induction condition, cell strains, 
growth medium, incubation temperature and lysis buffer (Sivashanmugam et al, 
2009).  
For small-scale expression trials, two vials of 5 mL LB media with appropriate 
antibiotics were inoculated with starter cultures in a ratio of 1:100 (v/v) at 37 °C 
until an OD600 of between 0.6 and 0.8 was reached. 1 mL of cell culture was 
harvested by centrifugation and the cell pellet was kept at – 20 °C, before addition 
of 1 mM IPTG to the rest of the cell culture. Overnight incubation at 16 °C or three 
to five hours incubation at 37 °C was carried out for the over-expression of the 
target protein. Four aliquots of 1 mL cell culture were harvested by centrifugation 
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at 13000 g for one minute after OD600 measurement. Cells were re-suspended in 
200 μL lysis buffer and lysed by sonication (10 s, 3 cycles, 50% power). Cell debris 
was pelleted by centrifugation at 13000 g for 10 minutes. 15 μL of lysate 
containing total proteins and supernatant containing soluble proteins were 
analysed by SDS-PAGE to evaluate the expression, yield and solubility of the target 
protein in different cell strains, induction temperatures and lysis buffers. The 
expression conditions were optimised based upon the pilot experimental results to 
maximise the production of target proteins. High-throughput protein expression 
screenings and buffer condition screenings can be performed to identify the best 
buffer condition for solubilisation of the target protein.  
The auto-induction strategy was developed by F. W. Studier based upon the ability 
of lactose to induce protein expression in E. coli when cells reach saturation 
(Grabski et al, 2005; Studier, 2005). In the growth medium ZY-P-5052 for 
auto-induction, glucose is used as the early carbon source and prevents induction 
by lactose, while glycerol is the late carbon source. With the depletion of glucose, 
lactose can enter cells to turn on the synthesis of the T7 RNA polymerase. Cell 
cultures are inoculated and incubated for 20-24 hours at 37 °C with shaking at 300 
rpm to reach a typical cell density of approximately OD600 5-6. The yields of 
proteins produced by the auto-induction method are typically several fold higher 
than the conventional way involving IPTG induction (Studier, 2005).  
2.3.2 Large Scale Protein Expression 
Once optimum conditions have been identified for the over-expression of a specific 
recombinant protein, the volume of cell culture can be scaled up to produce 
sufficient proteins for purification and further structural or functional studies. 
Overnight cell culture of a single colony was used to inoculate a large volume of LB 
medium, usually 1 litre to 2 litres, in a ratio of 1:100. The over-expression of the 
target protein was conducted under the optimum conditions determined by the 
expression test. Cells were harvested by centrifugation at 5000 rpm for 30 minutes 
at 4 °C (JLA-8.100 rotor, Beckman Coulter Avanti J-HC). After decanting the 
supernatant, cell pellets were re-suspended with lysis buffer (5 mL buffer per 
gram cell) for purification, or stored at -80 °C.  
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Table 2-4 Components of auto-induction medium for protein expression 
Stock solutions 
100 mL 50× 5052 25 g glycerol 
2.5 g glucose 
10 g α-lactose 
73 mL water 
autoclave 
100 mL 20× NPS 6.6 g (NH4)2SO4 
13.6 g KH2PO4 
14.2 g Na2HPO4 
90 mL water 
autoclave 
N.B. pH of 20-fold dilution in water should be ~6.75 
1 L ZY 10 g N-Z-amine AS (or tryptone) 
5 g Yeast extract 
925 mL water 
autoclave 
100 mL 1000× metals Autoclave individual solutions before mixing 
50 mL 0.1M FeCl3-6H2O (in 
0.1M HCl) 
2 mL 1M CaCl2 
1 mL 1M MnCl2-4H2O 
1 mL 1M ZnSO4-7H2O 
1 mL 0.2M CoCl2-6H2O 
2 mL 0.1M CuCl2-2H2O 
1 mL 0.2M NiCl2-6H2O 
2 mL 0.1M Na2MoO4-5H2O 
2 mL 0.1M Na2SeO3-5H2O 
2 mL 0.1M H3BO3 
36 mL water 
To make 1L of auto-induction medium with kanamycin 
1M MgSO4 (sterile) 1 mL 
1000× metals 1 mL 
50× 5052 200 mL 
Mix well 
20× NPS 50 mL 
30 mg/mL kanamycin 1 mL 
ZY  To 1 L 
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2.4 Protein Purification 
Obtaining pure protein is a prerequisite for structural studies and biochemical 
assays. Isolation of a specific protein from a crude mixture requires individual 
purification strategies dependent upon the properties of the desired protein, such 
as size, physico-chemical properties, binding affinity and biological activity. The 
key to successful and efficient protein purification relies in the application of 
appropriate purification methods and procedures specific to an individual protein.  
2.4.1 Cell Lysis and Protein Extraction 
Cell lysis is the first step for protein extraction and purification, because cellular 
contents are separated from the extracellular environment by a plasma membrane. 
The plasma membrane of bacterial cell is also surrounded by a rigid peptidoglycan 
cell wall.  
Physical disruption using a sonicator is a common way to extract cellular contents. 
Before sonication, cell pellets were re-suspended with 5 mL/g freshly prepared 
lysis buffer. Additive components in the lysis buffer included lysozyme and 
protease inhibitors such as serine protease inhibitor 4-(2-Aminoethyl) 
benzenesulfonyl fluoride hydrochloride (AEBSF) and aspartyl proteases inhibitor 
pepstatin. Lysozymes can help to damage bacterial cell walls, and protease 
inhibitors are required to prevent protein degradation by unregulated endogenous 
protease. Since overheating may cause the formation of aggregates (Stathopulos et 
al, 2004), it is crucial to keep the sample on ice and have an interval between each 
sonication period. Four to five rounds of 20-second sonication pulses were 
performed using a Soniprep 150 sonicator (MSE) with two minutes interval 
between each sonication pulse. After sonication, the lysate was cleared by 
centrifugation to precipitate cell debris, and the supernatant was syringe filtrated 
through a 0.45 µm filter to remove any remaining aggregates.  
2.4.2 Affinity Chromatography 
Affinity chromatography is a technique used as a capture step with high selectivity, 
high resolution, and usually high binding capacity based on the ligand specificity of 
target proteins. Affinity purification requires a biospecific ligand covalently 
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attached to a chromatography matrix. The ligand can specifically bind to the target 
protein, and the binding between them should be reversible to allow for the 
elution of the target protein in an active form.  Target proteins are commonly 
engineered as fusion proteins to express the binding partner for affinity 
interaction with a specific ligand, such as poly-histidine for Ni2+ affinity 
chromatography and glutathione-S-transferase for GSH-affinity chromatography. 
Ni2+ based immobilized metal ion affinity chromatography (IMAC) is a purification 
method used to separate protein with poly-histidine tag based on the tendency of 
histidine to form complexes with divalent metal cations around neutral pH (Porath 
et al, 1975). A polyhistidine-tag is an amino acid motif of at least five histidine (His) 
residues, often at the N- or C-termini of proteins and can be cleavable or 
non-cleavable.  
In this study, the HiTrap Chelating HP and HisTrap HP columns (GE Healthcare) 
were used for Ni2+ affinity chromatography. The metal ions (Ni2+) have been 
coupled to the chelating agarose matrix of prepacked columns. Charged columns 
were first equilibrated with buffer A containing 20mM imidazole before loading 
cell lysate. A low concentration of imidazole (typically 20 mM) was included in 
buffer A to inhibit non-specific binding of contaminant proteins to the column. 
Separations were performed under the control of Äkta liquid chromatography 
equipment (GE Healthcare). After binding of the target protein to the column, 
around 10 column volumes of buffer A was washed through the column to 
eliminate any non-specifically bound impurity. The target protein was then eluted 
with a linear concentration gradient of imidazole by the addition of Buffer B, which 
normally contained the same components as buffer A except increasing the 
imidazole concentration to 500 mM. The elution fractions were collected and 
analysed by SDS-PAGE. The verified fractions were then pooled together for the 
following purification steps. Cleavable His-tag can then be removed by protease 
treatment and a second Ni2+ affinity chromatography 
2.4.3 Ion Exchange Chromatography 
Purification using ion exchange chromatography takes advantage of the 
interaction between charged solute molecules and immobilized ion exchange 
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groups. The ionic groups on the stationary phase surface electrostatically attract 
oppositely charged solute molecules, and molecules with the same charge will flow 
through. Anion exchange chromatography is usually performed to purify a 
negatively charged protein - dissolved in a buffer with a pH greater than its 
isoelectric point. Proteins with net negative charge interact with resin and are 
retained on column under low ionic strength condition, while positively charged 
molecules flow through the column. A wash step is then performed to remove any 
weakly or non-specifically bound proteins whilst the tightly bound proteins will be 
eluted by high ionic strength buffer.  
In this study, the low ionic loading buffer (referred to as buffer A) and the high 
ionic elution buffer (referred to as buffer B) were prepared to contain 50mM NaCl 
and 1M NaCl, respectively.  The pH values of both buffers were at least one unit 
greater than the pI value of the target protein predicted on the basis of its amino 
acids composition. MonoQ columns (GE Healthcare) were used for anion exchange 
chromatography, and separations were performed under the control of Äkta liquid 
chromatography equipment (GE Healthcare). The MonoQ column was 
pre-equilibrated with the buffer A before loading sample and a linear gradient 
concentration of NaCl was maintained by the Äkta to elute the target protein, after 
washing out any weakly or non-specifically bound proteins with 10 column 
volumes of buffer A. The elution fractions were collected and analysed by 
SDS-PAGE, and verified fractions were then pooled together for further 
purification. 
2.4.4 Ammonium Sulfate Precipitation 
Ammonium sulfate precipitation is a method used to purify proteins by altering 
their solubility in the solution, known as salting out. The solubility of proteins 
varies with the ionic strength of the solution. Salting in refers to the enhanced 
solubility of the protein with increasing salt concentration (i.e. increasing ionic 
strength), when the salt concentration is low. However, the solubility of the 
protein begins to decrease until a sufficiently high ionic strength is reached, at 
which point the protein completely precipitates out of solution. Salting out can be 
a very effective technique for separating proteins, because the solubility of 
proteins differs greatly at high ionic strength. 
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Ammonium sulfate is a commonly used salt for the purpose of purifying proteins 
by salting out. In this study, a certain amount of solid ammonium sulfate was 
added into protein solutions according to Table 2-5 to achieve a desired 
concentration of ammonium sulfate. The ammonium sulfate concentration that 
precipitated the maximum proportion of desired protein was identified by 
SDS-PAGE. Precipitated protein was recovered by dissolving precipitates in fresh 
buffer. 
 
2.4.5 Size Exclusion Chromatography 
Size Exclusion Chromatography (SEC), also called gel filtration chromatography, 
was used in the work described in this thesis as a polishing step to achieve the 
required level of purity by separating molecules on the basis of their size and 
shape (hydrodynamic radius). When molecules with different sizes pass through a 
gel filtration medium packed in a column, smaller molecules experience a more 
complex pathway to exit than larger molecules, causing differences in retention 
time. Both molecular weight and three-dimensional shape contribute to the degree 
of retention. Large molecules (e.g., aggregates) are eluted in or just after the void 
volume (Vo), which is equivalent to approximately 30% of the total column 
volume for a well-packed column. Small molecules (e.g., salts) are usually eluted 
just before one total column volume (Vt), since they have full access to the medium. 
Proteins are detected by monitoring UV absorbance at A280 nm, and salts are 
Table 2-5 Ammonium sulfate precipitation table  
 
This table was Adapted from (Dawson et al, 1986). 
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detected by monitoring the conductivity of the buffer. There are many types of 
media available, each with different fractionation ranges, such as Sephadex, 
Sephacryl, Superose. In conclusion, gel filtration is a useful technique in protein 
purification for final polishing, desalting and buffer exchange. 
A gel filtration column was chosen according to the size of the target protein, and 
the column was equilibrated with one column volume of elution buffer before 
loading the sample. The sample was concentrated to the volume that was less than 
2% of the column volume and precipitated aggregates were removed by 
centrifugation or syringe filtration. Separations were performed under the control 
of Äkta liquid chromatography equipment (GE Healthcare) with one column 
volume of elution buffer. The elution fractions containing protein of interest were 
collected and analysed by SDS-PAGE. 
2.5 Protein Characterisation 
2.5.1 Denaturing Polyacrylamide Gel Electrophoresis  
Denaturing polyacrylamide gel electrophoresis (SDS-PAGE) is used for separating 
proteins merely according to their size (no other physical feature) ranging from 5 
to 2,000 kDa. The denaturing detergent SDS (sodium dodecyl sulphate) is used to 
convert all proteins into the same linear shape with only primary structures, and 
impart all proteins with large net negative charges. Polyacrylamide is a polymer of 
acrylamide monomers, and the pore size is controlled by the concentration. The 
polymerisation of acrylamide is driven by free radicals formed by the addition of 
ammonium persulfate (APS) and promoted by the addition of 
N,N,N',N'-Tetramethylethylenediamine (TEMED). Typically, resolving gels can be 
made in 6%, 8%, 10%, 12% or 15%, and the percentage chosen depends on the 
size of the protein to be identified in the sample - the smaller the protein’s size is, 
the higher percentage the resolving gel should be. Stacking gel (3%) is poured on 
top of the resolving gel to concentrate the protein sample into very narrow bands 
prior to separation on the resolving gel, and a gel comb is then inserted to form 
wells and define lanes. When an electrical field is applied across the gel, SDS 
coated proteins will migrate towards the anode.  
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In this study, stacking gel (3%) was prepared with Tris-HCl buffer pH 6.8; 
resolving gel (12% or 15%) was prepared with Tris-HCl buffer pH 8.8 according to 
the recipe in Table 2-6. The samples were prepared by mixing with loading dye 
and heating to 95 °C for 5 minutes to ensure complete denaturation of proteins. A 
low range molecular weight marker (Bio-Rad) with bands at 97.4, 66.2, 45, 31, 
21.5 and 14.4 kDa was applied to run along with samples for the estimation of 
sample’s molecular weight. After loading samples, gels were usually run at 200V 
until the tracking dye reached the bottom of the gel. Gels were stained with 
coomassie brilliant blue, and then destained in 5% propan-2-ol and 7% acetic acid 
before visualising protein bands. Approximately 1-10 µg of protein was loaded for 
a clear band.  
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Table 2-6 SDS-PAGE components 
Stacking gel (3%) 
0.13 M Tris-HCl (pH 6.8) 
0.1% SDS 
3% acrylamide 
0.04% bis-acrylamide 
For polymerisation: 
0.025% APS 
Approx. 10 µL TEMED per 10 mL gel mixture 
Resolving gel (example, 15% polyacrylamide) 
0.38 M Tris-HCl (pH 8.8) 
0.1% SDS 
15% acrylamide 
0.2% bis-acrylamide 
For polymerisation: 
0.025% APS 
Approx. 10 µL TEMED per 10 mL gel mixture 
Running buffer 
25 mM Tris 
200 mM Glycine (pH 8.8) 
Loading dye (4×) 
60 mM Tris-HCl (pH 6.8) 
10% glycerol 
2% SDS 
0.02% Bromophenol blue 
5% β-mercaptoethanol (for reducing conditions) 
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2.5.2 Size Exclusion Chromatography Multi-Angle Laser Light 
Scattering (SEC-MALLS) 
Size Exclusion Chromatography coupled with Multi-Angle Laser Light Scattering 
(SEC-MALLS) is a characterisation method to estimate the molecular mass and as 
well as determine the oligomeric state of proteins (Mogridge, 2004). Fractionation 
is performed by a HPLC system (Shimadzu) on a gel filtration column. Fractions 
are then delivered to three detection systems: 1) a UV/Visible light spectrometer 
to monitor the protein elution; 2) a Refractive Index (RI) monitor to enable 
measurement of the protein’s concentration; and 3) a Light Scattering (LS) 
detection system to record light scattering data. The amount of light scattered by 
proteins in solution is directly proportional to the product of the weight-averaged 
molar mass and the macromolecular solute concentration, i.e., LS ~ Mw·c (Wyatt, 
1993).  
 
60 μL of protein sample at a concentration of 0.5 mg/mL was applied to a 
pre-equilibrated gel filtration column BioSep-SEC-s3000 column (Phenomenex). 
Size-exclusion chromatography was carried out on a Shimadzu HPLC system 
comprising LC-20AD pump, SIL-20A Autosampler and SPD20A UV/Vis detector. 
The elution of the target protein was monitored at 280 nm by the SPD20A UV/Vis 
detector. The light-scattering data were recorded by a Dawn HELEOS-II 18-angle 
light scattering detector and the concentration of the eluted protein was measured 
by an in-line Optilab rEX refractive index monitor (Wyatt Technology). Data were 
analysed with the ASTRA V software package. Molecular mass was calculated 
based on Zimm’s formalism of the Rayleigh-Debye-Gans light scattering model for 
dilute polymer solutions using 0.183 mL/g as the refractive index increment 
(dn/dc) value.   
2.5.3 Matrix-Assisted Laser Desorption/Ionization Mass 
Spectrometry (MALDI-MS) 
Mass spectrometry is an effective analytical technique tool routinely used for 
measuring the molecular mass of a protein sample (Gross & Strupat, 1998; Strupat, 
2005). Matrix-assisted laser desorption/ionization (MALDI) was developed as a 
soft ionization technique to produce gas-phase ions of proteins by laser irradiation 
(Hillenkamp & Karas, 1990; Karas et al, 1987). It provides an accurate and 
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sensitive method for measuring the molecular weights of large, non-volatile and 
labile molecules like proteins by mass spectrometry (Li et al, 1994).  
Usually time-of-flight mass spectrometry is used, in which the mass-to-charge 
ratio of the ion can be determined by the time measurement. As little as one pmol 
of sample is required to be detected. The experiments were performed by Simon 
Grist.  
2.5.4 Negative Staining Electron Microscopy 
Electron microscopy is a useful visualisation tool to examine the shape and 
stoichiometry of a large protein assembly. The negative staining technique uses 
heavy metal salts (e.g. uranyl acetate) to enhance the contrast between the 
background and the image of protein assembly.  
Protein samples were diluted to a certain concentration (~ 0.05 mg/mL) for the 
single-particle imaging. A 2 μL aliquot of the sample was applied to 
glow-discharged, continuous-carbon and formvar covered copper grids with a 
300-square mesh. The dried sample was washed with MiliQ water and then 
stained with 2% uranyl acetate for two minutes. The grids were air dried before 
being inspected on a 200 kV FEI F20 electron microscope at a magnification of 100, 
000x. Imaging was performed in a low electron dose mode. Approximately 10 
micrographs were recorded and 1200 protein particles were selected for image 
analysis. The experiments were performed with Yuriy Chaban and Elena Orlova at 
Birkbeck College, University of London.  
2.6 Crystallisation 
2.6.1 Theory of Crystallisation 
High-quality crystals are required to obtain the three-dimensional structure of 
proteins by single crystal diffraction method. However, producing diffracting 
crystals can be very challenging and sometimes a bottleneck in structure 
determination (Durbin & Feher, 1996). Proteins normally need to be pure with 
homogeneity of 95% at high concentration (> 5 mg/mL) to form crystals. The 
crystallisation of molecules is a phase transition phenomenon driven by the 
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minimisation of free energy (Weber, 1991). When the concentration of protein is 
higher than its solubility limitation and it reaches the supersaturation state, the 
transformation from liquid phase to solid crystalline phase occurs. A phase 
diagram (Figure 2-3) is used to illustrate the process of crystallisation, during 
which the stable state as liquid, crystalline or precipitate is formed under a variety 
of crystallisation parameters such as the concentration of protein, precipitant(s), 
additive(s) and so on (Chayen, 2004).  
 
Figure 2-3 Schematic illustration of a typical protein crystallisation phase diagram.  
This figure was adapted from (Chayen, 2004).  
Four zones representing different degrees of supersaturation are shown on the 
diagram: proteins will precipitate in the zone of “high supersaturation”; 
spontaneous nucleation will take place in the zone of “moderate supersaturation”; 
the growth of well-ordered crystals will occur under suitable conditions in the 
metastable zone of “lower supersaturation”; and in the zone of “undersaturation”, 
proteins are fully dissolved and will never crystallise. Ideally, the concentration of 
protein solution will drop with the formation of nuclei, which will lead the system 
into the metastable zone to promote the growth of single crystals.  
52 
2.6.2 Initial Screening 
A crystallisation experiment is usually started with a flexible sparse matrix initial 
screen for the identification of initial crystallisation conditions. The roles of pH, 
precipitant, additives, and temperature are examined in the initial screen whilst 
precipitants are used to decrease the solubility of the protein. Polymers such as 
PEG, salts, and organic solvents are the most popular precipitants in protein 
crystallisation experiments. Since pH can greatly affect a protein’s solubility due to 
ionisation of charged residues at the surface, a suitable buffer must be present 
during crystallisation (e.g. MES, HEPES, Tris). Most proteins display a strong 
solubility dependence on temperature, and crystallisation experiments are usually 
carried out at 4 °C or 25 °C, because extreme temperature tends to cause 
denaturation of proteins. 
To enhance the possibility of crystal formation, initial crystallisation screens are 
usually designed based on a rational combination of chemical conditions. There 
are large numbers of commercial screens available, such as INDEX, PACT, JCSG, 
and MPD (D'Arcy et al, 2003). After setting up initial screening trays by a 
pipetting robot, plates should be inspected under a microscope at regular time 
intervals (e.g., after 1 day, 2 days, 5 days, and 10 days), and the conditions that 
generate initial crystallisation hits will be further optimised for better quality 
crystals.  
2.6.3 Crystallisation Optimisation 
Once an initial condition is identified through initial screenings, optimisation of 
the condition is usually necessary to grow a well-diffracting crystal. The 
optimisation process takes the initial conditions with promising hits and then 
varies the concentration of the protein, precipitant, salt and additives in a 
systematic manner. The additives could be biologically relevant cofactors, 
substrates and so on. The optimisation trays can be set up either manually or using 
a Mosquito robot. 
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3 Engineering Fusion Constructs between the SPP1 
Portal and TRAP Proteins 
3.1 Introduction 
3.1.1 The Bacteriophage SPP1 Portal Protein – Gp6  
Bacteriophage SPP1, a lytic phage that infects Bacillus subtilis, was first described 
by Riva et al. (Riva et al, 1968). SPP1 belongs to the Siphoviridae family and 
comprises an isometric icosahedral capsid attached to a long (177 nm), flexible, 
non-contractile tail (Riva et al, 1968). The tail fibre at the tip of the tail is 
responsible for host cell attachment (Alonso et al, 2006).   
 
Figure 3-1 Structure and genetic map of bacteriophage SPP1. 
(A): An SPP1 virion visualised by negative staining electron microscopy. The bar 
represents 50 nm. (B): A diagram illustrates the structural organisation of the 
mature SPP1 virion. (C): Physical and genetic map of bacteriophage SPP1. This figure 
was adapted from (Alonso et al, 2006). 
In the mature SPP1 phage, the viral genome, a linear double-stranded DNA 
molecule of ∼45.9 kb, is enclosed within the viral capsid (Droege & Tavares, 2005). 
The complete nucleotide sequence of the SPP1 genome was reported in 1997, with 
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a size of 44007 bp and a base composition of 43.7% dG + dC (Alonso et al, 1997). 
The complementary DNA strands can be separated into a purine-rich heavy strand 
and a light strand (Riva et al, 1968). The DNA circularises upon its infection of the 
Gram-positive bacterium Bacillus subtilis, and only the heavy strand is transcribed 
during the asymmetric transcription process (Alonso et al, 1997; Riva, 1969). 
Functionally related gene modules were identified, which comprise clusters of 
genes encoding proteins with complimentary functions. Approximately 47% of the 
genome encodes proteins involved in phage assembly and DNA packaging (Alonso 
et al, 1997). Bacteriophage SPP1 is used as a model system for viral capsid 
assembly, because it is one of the most highly characterised phages whose 
biochemistry and structure have been studied in considerable detail.  
The assembly of the SPP1 capsid follows a pathway common among tailed 
bacteriophages and herpes viruses, shown in Figure 3-2 (White et al, 2012). Firstly, 
a spherically shaped protein shell “procapsid” is formed by many copies of the 
major capsid protein gp13, 100–180 copies of internal scaffolding proteins gp11, 
one 12-subunit portal protein gp6, and several copies of the minor protein gp7 
(Becker et al, 1997; Droge et al, 2000). The scaffolding protein gp11 is often 
required for a functional procapsid to ensure the polymerisation of gp13 into a 
shell with the correct geometry (T=7). Stable complexes of portal protein gp6 and 
minor protein gp7 were detected both in vivo and in vitro. In vitro studies showed 
gp7 was not a structural necessity for the formation of biologically active 
procapsids, although the biological activity would be reduced 5 to 10-fold in the 
absence of gp7 (Droge et al, 2000). 
A complex consisting of the viral terminases and the viral DNA docks on to the 
portal protein to assemble the DNA translocation molecular motor. The DNA 
packaging motor is composed of the portal protein gp6, the small terminase gp1 
and the large terminase gp2, which pump the viral genome into the procapsid with 
~4% terminal redundancy controlled by a headful packaging mechanism. The 
packaging of DNA is accompanied by the release of the internal scaffolding protein 
and the expansion of the procapsid size from ~55 nm to ~61 nm in diameter 
(White et al, 2012). Upon the termination of DNA encapsidation, head completion 
proteins (gp15 and gp16) sequentially attach to the portal vertex to form a 
head-to-tail connector following the detachment of gp1 and gp2 from the portal. 
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Lastly, an independently assembled long non-contractile tail attaches to the portal 
protein to yield an infective virion.  
Figure 3-2 Morphogenesis process of bacteriophage SPP1. This figure was adapted 
from (Orlova et al, 2003). 
The portal protein of bacteriophage SPP1 is encoded by the gene gp6. Each subunit 
of the portal protein consists of 503 amino acids with a molecular weight of 57 
kDa. Although the amino acid sequence of gp6 shows no significant similarity to 
portal proteins from other bacteriophages, gp6 plays the same role in the 
morphogenesis process to initiate the formation of procapsid, whilst providing a 
site for the attachment of the DNA packaging motor to the procapsid and the tail to 
the filled capsid (Alonso et al, 2006; Droge et al, 2000; Tavares et al, 1992). 
The SPP1 portal protein gp6 is a circular homo-oligomer situated at a single vertex 
of the icosahedral capsid. The three-dimensional structure of gp6 was first 
determined using electron microscopy at liquid-helium temperatures and angular 
reconstitution, which revealed a 13-fold symmetric oligomer with three distinct 
regions: stem, wing and a fringe of small 'tentacles' (Orlova et al, 1999). The 
structures of the connector - a complex of gp6 and the head completion proteins 
gp15 and gp16, and the isolated gp6 alone were then determined at 10 Å and 9 Å 
resolution respectively by cryo-electron microscopy and single particle analysis 
(Orlova et al, 2003). Statistical analysis revealed the intrinsic 12-fold symmetry 
within gp6 from the connector in comparison to the 13-mer of isolated gp6. In 
spite of the difference in oligomeric state, similar overall structural organisations 
were observed from gp6, with the exception of some conformational changes at 
the bottom of the stem region. The base of the stem moved outwards to interact 
with and accommodate gp15 (Figure 3-3). 
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Figure 3-3 Cut-away views of the SPP1 connector and isolated portal protein by 
cryo-EM. 
The isolated portal protein is shown in yellow (A), and the portal protein in the 
connector is shown in blue, gp15 in green and gp16 in orange (B). The domains of 
gp6 are outlined: the crown in orange, the wing in green, the stem stalk in magenta, 
the stem foot in purple and the gp16 stopper in red. This figure was adapted from 
(Orlova et al, 2003). 
The X-ray structure of the 13-subunit assembly of isolated gp6 at 3.4 Å resolution 
provided more information to help elucidate the structural basis for DNA 
translocation (Lebedev et al, 2007). A single gp6 subunit can be divided into four 
regions, namely the clip, stem, wing and crown (Figure 3-4). The basal clip region 
has an α/β fold and is exposed to the viral head exterior. The stem is composed of 
two helices, α3 and α5, tilting relative to the central tunnel axis by ~50° and ~30°, 
respectively, and connects the clip to the wing. The wing region is largely made up 
of α-helices, with helix α6 being 40-residue long and spanning from the central 
tunnel to the peripheral rim. There is a 45° kink at the distal end of helix α6, which 
is stabilised by interaction with the C-terminus of helix α5. A 15-residue loop, 
referred to as the “tunnel loop”, protrudes into the tunnel and connects helix α5 
and α6. These tunnel loops constitute the most constrained part of the portal 
channel with a diameter of 27.7 Å in a 13-mer assembly. Meanwhile, the crown is 
composed of three α-helices and there are 40 additional residues at the C-terminus 
that are disordered. 
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Figure 3-4 X-ray structure of the SPP1 portal protein 13-subunit assembly. 
(A, B) Ribbon diagrams of the portal protein along and perpendicular to the 13-fold 
axis. (C) Ribbon diagram of a single portal protein subunit to illustrate the four 
major domains: crown, wing, stem and clip with the tunnel axis in vertical 
orientation. This figure was adapted from (Lebedev et al, 2007). 
Because no crystallographic structure is available for the dodecameric SPP1 portal 
assembly, the pseudo-atomic structure of the 12-mer gp6 was generated by fitting 
single subunits taken from the X-ray structure of the 13-mer into the EM map of 
the connector (10 Å resolution). The accuracy of such a procedure was assessed by 
fitting subunits as rigid bodies into the EM map of the isolated 13-mer of gp6 (9 Å 
resolution), and the reconstructed structure proved to be in excellent agreement 
with the X-ray structure. The overall architecture of gp6 subunits in the two 
different oligomeric states was very similar. However, conformational changes in 
some specific segments occurred when switching from the 13-mer to the 12-mer: 
(i) the N-terminal end of α6 moved ~3 Å towards helix α5 (Figure 3-5); (ii) an 
outer loop of the clip region moved outwards; and (iii) the tunnel loops had more 
conformational variability. Accompanying the oligomeric state transition from 
13-mer to 12-mer, the diameter of the tunnel loop belt was significantly decreased 
from 27.7 Å to 18.1 Å due to subunits reorientation - the decrease of 
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approximately 10 Å appeared to be much greater than a simple scaling down by a 
factor of 12/13 (Figure 3-5). 
The SPP1 portal protein is consistently found to be a dodecameric assembly 
incorporated into procapsids (Lurz et al, 2001), but presented as 13-mer in the 
isolated form (Dube et al, 1993). How is gp6 capable of assembling into different 
homo-oligomeric rings? A possible explanation lies in the flexible inter-subunit 
interactions (Lebedev et al, 2007). The direct main-chain/main-chain 
inter-subunit hydrogen bonds are only within the clip, which is the most stable 
region. The rest of the structure has relatively few contacts between neighbouring 
subunits, with only 4.3 hydrogen bonds observed per 1000 Å2 (12 per 2800 Å2), 
half the expected number of direct inter-subunit hydrogen bonds (Lebedev et al, 
2007). The determinant factor for the stoichiometric transition of SPP1 portal 
protein from 12-mer to 13-mer remains unknown, and there is no method to 
produce an isolated gp6 dodecamer for in vitro studies yet. 
It has been found that the 13-subuint assembly of purified gp6 is dependent on the 
ionic environment and forms a monodispersed population of 13-mers in the 
hundred millimolar range of univalent salt (≥ 250mM NaCl), or in the presence of a 
millimolar range of bivalent cations (≥ 5mM MgCl2). In the absence of bivalent 
cations and at univalent salt concentrations below 250 mM, there will be an 
association-dissociation equilibrium mainly between the monomer and the 
13-mer with a minor population of intermediate oligomers (Jekow et al, 1999). 
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Figure 3-5 Structural changes upon 13/12-mer transition of gp6. 
(A, B) The superposition of single subunits from the gp6 12-mer (coloured in 
magenta) and 13-mer (coloured in cyan) showed the N-terminal end of α6 moved ~3 
Å towards helix α5; (C,D) Two diametrically arranged subunits from the 13-mer and 
12-mer are shown for the clip, tunnel loops and crown areas with the van der Waals 
size of the tunnel diameter. The simple packing model schematized in black shows 
how the diameter of 12-mer tunnel is considerably reduced compared to the 13-mer 
tunnel by this rocking motion. This figure was adapted from (Lebedev et al, 2007).  
3.1.2 Engineering of the Portal-TRAP Fusion Proteins  
Protein engineering has proved to be pivotal in developing a fundamental 
molecular understanding of natural protein construction, and in the adaption of 
proteins to generate novel proteins. The coding sequence responsible for folding, 
structure, and function of the protein may be tractably manipulated during the 
protein engineering process. The approaches and technologies that have enabled 
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protein engineering include: simple site directed mutagenesis, advanced 
computational design, development of new and useful biocatalysts, integration of 
functional biological parts with fabricated devices, and construction of next 
generation biopharmaceuticals.  
In the case of the SPP1 portal protein, previous attempts to obtain 12-subunit 
SPP1 portal protein in vitro by means of truncation and site directed mutagenesis 
have been unsuccessful. In this study, SPP1 gp6 is fused at its C-terminus with the 
TRAP protein (Figure 3-6) in order to promote the formation of portal protein 
oligomers containing 12 subunits. The reason that TRAP is chosen to construct the 
fusion proteins with gp6 is that TRAP forms an extremely stable dodecameric ring 
with much stronger subunit-subunit interactions than gp6. It is hoped that the 
oligomeric state of the fusion proteins could be dominated by TRAP as shown in 
the model (Figure 3-6), when the fusion proteins are over-expressed in E. coli cells.  
 
Figure 3-6 Model of the portal-TRAP fusion protein assembly. SPP1 gp6 is fused at 
its C-terminus with the TRAP protein. 
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3.1.3 The Tryptophan RNA-Binding Attenuation Protein 
The tryptophan RNA-binding attenuation protein (TRAP), encoded by gene mtrB, 
is a ring-shaped oligomer involved in the regulation of tryptophan biosynthesis in 
Bacilli (Gollnick et al, 2005; Szigeti et al, 2004). TRAP regulates the trp operon by a 
transcription attenuation mechanism. When tryptophan is in excess, TRAP is 
activated and binds to the triplet repeats of the trp operon, favouring the 
formation of an intrinsic terminator hairpin to stop RNA synthesis (Figure 3-7B).  
When tryptophan is limiting, TRAP is not activated, allowing the formation of the 
alternative antiterminator hairpin and the transcription of the trp synthesis and 
transport genes (Figure 3-7A). 
 
Figure 3-7 Model of the B. subtilis trpEDCFBA operon transcription attenuation 
mechanism.   
(A) When tryptophan is limiting, TRAP is not activated, and antiterminator structure 
is formed to allow transcriptional readthrough. (B) When tryptophan is in excess, 
TRAP becomes activated by tryptophan and binds to the triplet repeats. The 
formation of an intrinsic terminator hairpin stops RNA synthesis of the downstream 
trp synthesis and transport genes. This figure was adapted from (McGraw et al, 
2009). 
TRAP from Bacillus halodurans, an alkaliphilic bacterium can grow at pH higher 
than 9.5, is 76-amino acid long and shares ~71% sequence identity with Bacillus 
subtilis TRAP. The Bacillus stearothermophilus mtrB gene encodes a 74-amino acid 
long polypeptide with 77% sequence identity compared to TRAP from B. subtilis. 
Three conserved residues - Lys37, Lys56 and Arg58 in B. subtilis TRAP - were 
identified to be involved in RNA binding (Yang et al, 1997). 
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X-ray structures of B. subtilis, B. stearothermophilus and B. halodurans TRAP 
revealed circular homo-oligomers with essentially identical architecture (Antson 
et al, 1995; Chen et al, 2011a; Chen et al, 1999). Like the bacteriophage portal 
protein, TRAP forms oligomers composed of multiple subunits. While B. subtilis 
TRAP and B. stearothermophilus TRAP exist as 11-mers, B. halodurans TRAP is a 
natural 12-subunit assembly. Removal of the five C-terminal residues in B. 
stearothermophilus TRAP or introducing a point mutation S72N in B. subtilis TRAP 
can induce the formation of  stable 12-subunit oligomers (Bayfield et al, 2012; 
Chen et al, 2011a). The β-strands are the fundamental secondary structural 
elements in the TRAP monomer, which is composed of two β-sheets lying 
face-to-face. These β-sheets form extended inter-subunit β-sheets through main 
chain-main chain interactions to reinforce the oligomeric structure.  
 
Figure 3-8 Structure of B. halodurans TRAP (3ZZL).  
Ribbon diagram viewed along the 12-fold axis. This figure was adapted from (Chen et 
al, 2011a). 
 
The stability of several wild type and mutant TRAP proteins in the presence of 
L-tryptophan were examined by dye-based scanning fluorimetry and CD 
spectroscopy (Figure 3-9). Among the wild type TRAPs, B. stearothermophilus 
TRAP is found to be the most stable, whilst B. subtilis TRAP is the least stable one. 
Significantly, the thermal stability of the mutant 12-subunit assemblies is 
increased compared to the wild-type 11-mers.  
63 
 
Figure 3-9 Melting temperatures of different TRAP oligomers assessed by dye-based 
scanning fluorimetry.  
The dependence of melting temperature as a function of L-tryptophan concentration 
for six TRAP oligomers is show. From the top: B. stearothermophilus E71stop 12-mer 
(triangle), B. stearothermophilus wild type 11-mer (square), B. halodurans wild type 
12-mer (diamond), B. subtilis K71stop 12-mer (open cross), B. subtilis S72N 12-mer 
(circle), B. subtilis wild type 11-mer (crossed square). This figure was adapted from 
(Bayfield et al, 2012).  
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3.2 Materials and Methods 
3.2.1 Cloning of Fusion Protein Constructs with N-terminal His-tag 
SPP1 genomic DNA was used as a template for PCR amplification of gp6 coding 
fragments; and plasmid DNA with B. halodurans mtrB gene in pET28a or plasmid 
DNA with B. stearothermophilus mtrB gene in pET9a was the template for TRAP 
encoding gene amplification.  Primers were designed to introduce specific 
restriction recognition sites to the termini of PCR products: NheI and BamHI 
restriction sites to gp6 fragments for fusions with B. halodurans TRAP, BamHI and 
XhoI sites to B. halodurans mtrB; BamHI and NotI restriction sites to gp6 fragments 
for fusions with B. stearothermophilus TRAP, and NotI and XhoI restriction sites to 
B. stearothermophilus mtrB. A summary of the primers used in this study is listed 
in Table 3-1. The primers were synthesised by Eurofins MWG Operon, Ebersberg, 
Germany (purification level: salt free). For gp6 and B. halodurans TRAP fusion 
constructs, double digested PCR products of gp6 and B. halodurans mtrB as well as 
NheI and XhoI double digested pET28a (Novagen) were ligated together in one vial 
using T4 DNA ligase (NEB, UK) at room temperature for two hours. For the ligation 
of gp6 and B. stearothermophilus TRAP fusion constructs, double digested PCR 
products of gp6 and B. stearothermophilus mtrB as well as BamHI and XhoI double 
digested pCDFDuet-1 vector (Novagen) were ligated together in one vial as above. 
The correct inserts were verified by DNA sequencing (GATC Biotech) and 
alignment analysis (Clustal W).  
3.2.2 Expression and Puriﬁcation of Portal-TRAP Fusion Proteins 
The plasmids coding for gp6-B. halodurans TRAP fusion constructs were 
transformed into Escherichia coli expression strain BL21(DE3) cells, and the 
plasmids coding for gp6-B. stearothermophilus TRAP fusion constructs were 
transformed into Escherichia coli expression strain B834 cells. A single colony 
from a Luria–Bertani (LB) agar plate containing the appropriate antibiotics (30 
µg/mL kanamycin for pET28a vector and 50 µg/mL streptomycin for pCDFDuet-1 
vector) was picked to inoculate a small overnight culture at 37 °C. 5 ml aliquots of 
the overnight culture were used to inoculate a 500 mL culture the following day. 
The 500 mL Culture were grown at 37 °C until the mid-log phase (OD600 of 0.6–
0.8) was reached, at which point protein expression was induced by the addition 
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of isopropyl-d-1-thiolgalactopyranoside (IPTG) to a final concentration of 1 mM. 
Lastly, overnight incubation of the culture at 16 °C and 180 r.p.m was carried out 
for the over-expression of the fusion proteins. Cells were recovered by 
centrifugation in SORRALL®  RC 5B plus for 20 min at 5000 g, 4 °C. Supernatant 
was removed and cell pellet was stored at -20 °C.  
Table 3-1 Primers used for cloning of portal-TRAP fusion protein constructs  
Primer Sequence(5’-3’) 
Gp6-F 1 CCCCTAGCTAGCGCAGAACCGGACACAACCATG 
Gp6-R1 CGCGGATCCTTGGTTCATTTCCTCTTCTATGCG 
Gp6-R2 CGCGGATCCGCCCTGCATTTCAGCGTATTGG 
Gp6-R3 CGCGGATCCGCCCTCATCGTCGAGTAGGTTGC 
Gp6-R5 CGCGGATCCTGTAACGCCTTGTACCTGACTC 
TRAP-F1 CGCGGATCCTCATCAAACTTTTTTGTCATAAAAGCAAAGG 
TRAP-F2 CGCGGATCCTCAGGTTCTTCGTCAAACTTTTTTGTCATAAAAGCAAAGG 
TRAP-F3 CGCGGATCCTCAGGTTCTTCAGGATCATCGTCAAACTTTTTTGTCATAAAAGCAAAGG 
TRAP-F4 CGCGGATCCTCAGGTTCTTCAGGATCATCGATGAACGTGGGGGATAACTCAAAC 
TRAP-F5 CGCGGATCCTCAAACTTTTTTGTCATAAAAGCAAAGG 
TRAP-R1 GGGCCGCTCGAGTTATTCATCTTTCTCCGTATCTAGCG 
GP6_I425Q_F GACAGCGAGCAGGTTCAGAGT 
GP6_I425Q_R ACTCTGAACCTGCTCGCTGTC 
GP6N27EcoR GGAATTCGGCGGAACCGGATACCACCATGATTCAGAAACTG 
GP6R479Not1 ATAGTTTAGCGGCCGCAGCAGCGCCTTCATCATCCAGCAGGTTGCCCT 
TRAP_stea_F1 ATAAGAATGCGGCCGCAGCTAGCGACTTTGTTGTCATT 
TRAP_stea_F2 ATAAGAATGCGGCCGCAGCTGCTAGCGACTTTGTTGTCATT 
TRAP_stea_R1 CCGCTCGAGTTACTTTTTCCCTTCCGA 
 
The cell pellet was re-suspended in nickel affinity chromatography binding buffer 
supplemented with a combination of 100 µg/mL lysozyme and protease inhibitors 
(1 mM AEBSF and 0.7 µg/mL pepstatin). For all the gp6-B. halodurans TRAP fusion 
proteins, the binding buffer was 50 mM imidazole pH 8.0, 250 mM NaCl, and 10 
mM MgCl2. Cells were disrupted by sonication with a large probe in a glass beaker 
using short pulses of 30 seconds, with a two-minute resting time in between 
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pulses. The sonication was carried out on ice, with caution to minimise thermal 
damage to the protein extract. The cell debris was removed by centrifugation at 
38758 g for 30 minutes at 4 °C using a Sorvall SS34 rotor. The supernatant was 
collected and then cleared with a 0.45 mm ﬁlter (Millipore). The ﬁltrate was 
digested overnight by a combination of RNase A and RNase T1 to remove RNA 
contamination at 4 °C. It was then loaded onto a 5 mL HiTrap column (GE 
Healthcare) and equilibrated with binding buffer for nickel afﬁnity 
chromatography puriﬁcation.  
The nickel-bound protein was eluted with an increasing proportion of elution 
buffer containing 500 mM imidazole. For all the gp6-B. halodurans TRAP fusion 
proteins, the elution buffer was 500 mM imidazole pH 8.0, 250 mM NaCl, 10 mM 
MgCl2 and 10% glycerol. Fractions containing the portal-TRAP fusion proteins 
were pooled together, and concentrated using Vivascience 30kDa molecular 
weight cut-off concentrators. The concentrated sample (less the 10 mg/mL) was 
applied to a Superose 6 size-exclusion chromatography column as a ﬁnal polishing 
step to remove any high-molecular-weight aggregates and obtain fusion proteins 
with the appropriate molecular weight. The fusion proteins were eluted with GF 
buffer (50 mM imidazole pH 8.0, 250 mM NaCl, and 10 mM MgCl2), concentrated to 
at least 10 mg/mL and stored at -80 °C for crystallisation.  
3.2.3 Size-Exclusion Chromatography coupled with Multi-Angle 
Laser Light Scattering (SEC–MALLS) 
The molecular mass was determined by size-exclusion chromatography coupled 
with multi-angle laser light scattering (SEC–MALLS). The protein sample (60 µL, 
0.5 mg/mL) was applied on a BioSep SEC-s3000 gel filtration column 
(Phenomenex) equilibrated with buffer containing 50 mM imidazole pH 8.0, 250 
mM NaCl, and 10 mM MgCl2. Size-exclusion chromatography was carried out on a 
Shimadzu HPLC system and the elution was monitored at 280 nm by an SPD20A 
UV/Vis detector. Light-scattering data were recorded by a Dawn HELEOS-II 
18-angle light-scattering detector and the concentration of the eluting protein was 
measured by an in-line Optilab rEX refractive-index monitor (Wyatt Technology). 
Data were analysed with the ASTRA V software package (Wyatt Technology). 
Molecular mass was calculated using Zimm’s formalism of the Rayleigh–Debye–
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Gans light-scattering model for dilute polymer solutions and a refractive-index 
increment (dn/dc) of 0.183 mL/g was used for the protein molecular mass 
estimation. 
3.2.4 Crystallisation 
The sitting-drop vapour diffusion method was used for the initial crystallisation 
screening. Drops containing 150 nL protein solution and 150 nL reservoir solution 
were dispensed by a Mosquito Nanolitre Pipetting robot (TTP Lab-tech) in 96-well 
plates, and equilibrated against 60 µL of reservoir solution. To obtain initial crystal 
hits, crystal trays with several commercial screens such as Index, PACT, Clear 
Strategy Screens I and II, Morpheus and MPD were set up. Conditions in which 
small crystals grew were optimised in 24-well hanging-drop plates with manual 
pipetting. Crystals were tested using a Rigaku RU-H3R X-ray generator with 
rotating anode, equipped with Osmic multilayer optics and a MAR345 
(MarResearch) imaging-plate detector. 
3.2.5 Negative Staining Electron Microscopy 
The purified fusion proteins and the wild-type SPP1 portal protein were diluted to 
~ 0.05 mg/mL for the single-particle imaging. A 2 μL aliquot of the sample was 
applied to glow-discharged, continuous-carbon and formvar covered copper grids 
with a 300-square mesh. The dried sample was washed with MiliQ water and then 
stained with 2% uranyl acetate for two minutes. The grids were air-dried before 
being inspected on a 200 kV FEI F20 electron microscope at a magnification of 100, 
000x. Imaging was performed in a low electron dose mode. 10 micrographs were 
recorded and approximately 1200 protein particles were selected for image 
analysis. The experiments were performed with Yuriy Chaban and Elena Orlova at 
Birkbeck College, University of London.  
3.2.6 Dissociation-Reassociation Experiments of the Fusion 
Protein GP6(27-466)-GSSGSS-TRAP(7-76) (YM92) 
To probe if re-association could generate 12-subunit oligomers, a 
dissociation-re-association experiment was designed. This was based on the 
observation that the assembly of portal protein oligomer is dependent on the ionic 
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environment, forming a 13-subunit assembly at and above 250 mM NaCl or at and 
above 5 mM MgCl2. Subunit contacts in TRAP were deemed to be strong enough to 
preserve the 12-subunit oligomeric state of TRAP, which can then lead to the 
assembly of a 12-mer gp6-TRAP fusion construct after gp6 segment was 
dissociated at low salt concentration followed by re-association with the addition 
of MgCl2. The fusion protein GP6(27-466)-GSSGSS-TRAP(7-76) was partially 
dissociated by overnight dialysis from the original purification buffer to low salt 
buffer containing 20 mM HEPES pH7.7, 150 mM NaCl, 1 mM L-Tryptophan at 4 °C. 
The re-association was achieved by adding a 2 M MgCl2 solution to the final 
concentration of 10 mM. The re-associated assembly was inspected by negative 
staining electron microscopy to determine the subunit number. 
3.3 Results 
3.3.1 Design of the Portal-TRAP Fusion Proteins  
SPP1 portal protein and TRAP were fused together using a short peptide linker 
between the two proteins. The linkers were composed of flexible residues such as 
glycine and serine so that the adjacent proteins are free to move relative to one 
another. The linkers were designed to have an appropriate length, to impose 
enough assembling power from TRAP on the portal protein. We reasoned that if 
the linker was too long, the assemblies would not direct each other. However, if 
the linker was too short, the correct folding of each protein could be affected.  
I. Protein constructs (YM91-YM100) were designed to fuse the truncated SPP1 
portal protein Δ27-466, Δ27-472, Δ27-479 with a natural 12-subunit TRAP from B. 
halodurans using linkers GSS, (GSS)2 or (GSS)3.  
II.  In order to reduce the difference between the tunnel diameters of the portal 
and TRAP, two fusion constructs were designed with a longer truncation to the 
C-terminus of portal protein. The tunnel diameter of gp6 Δ27-434 is the same as in 
TRAP, at approximately 30 Å. Shorter linkers (GSS and GS) were chosen to 
strengthen the contact and reduce flexibility between the gp6 and TRAP domains 
of the fusion protein. 
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Table 3-2 Constructs of gp6-B. halodurans TRAP fusion proteins 
 
Plasmid Fusion protein constructs 
pYM91 GP6(27-466)-GSS-TRAP(7-76) 
 
pYM92 GP6(27-466)-GSSGSS-TRAP(7-76) 
 
pYM93 GP6(27-466)-GSSGSSGSS-TRAP(7-76) 
 
pYM94 Gp6(27-472)-GSS-TRAP(7-76) 
 
pYM95 Gp6(27-472)-GSSGSS-TRAP(7-76) 
 
pYM96 Gp6(27-472)-GSSGSSGSS-TRAP(7-76) 
 
pYM97 Gp6(27-479)-GSS-TRAP(7-76) 
 
pYM98 Gp6(27-479)-GSSGSS-TRAP(7-76) 
 
pYM99 Gp6(27-479)-GSSGSSGSS-TRAP(7-76) 
 
pYM100 Gp6(27-479)-GSS-TRAP(1-76) 
 
pYM147 Gp6(27- 434)-GS-TRAP(7-76) 
 
pYM148* Gp6(27- 434 L429Q I425Q)-GSS-TRAP(7-76) 
 
*Double mutations (L429Q and I425Q) are introduced to improve solubility and 
stability 
III. Based on the thermal stability analysis, the oligomeric state of B. 
stearothermophilus TRAP is the most stable among all TRAP species. Two 
constructs were designed to fuse the SPP1 portal protein (residues 27-479) with a 
natural 11-subunit TRAP from B. stearothermophilus (residues 5-74) using 
polyalanine linkers (6 x Ala and 7 x Ala).  
Table 3-3 Constructs of gp6-B. Stearothermophilus TRAP fusion proteins 
Plasmid Fusion protein constructs 
pYM198 Gp6 (27-479)-A6-TRAP (5-74) 
 
pYM199 Gp6 (27-479)-A7-TRAP (5-74) 
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3.3.2 Cloning, Expression and Purification of the Portal-TRAP 
Fusion Proteins  
3.3.2.1 Fusion proteins of truncated SPP1 gp6 with natural 12-subunit 
Bacillus halodurans TRAP 
The DNA segments encoding the truncated portal gp6-B. halodurans TRAP fusion 
proteins were cloned into the restriction sites BamHI and XhoI of vector pET28a 
for the expression of N-terminal hexahistidine-tagged protein.  
The fusion proteins were successfully overexpressed in E. coli B834 as a soluble 
form. Pure and homogenous proteins were obtained after Ni2+ affinity 
chromatography and size-exclusion chromatography in 50 mM imidazole pH 8.0, 
250 mM NaCl, and 10 mM MgCl2. Overnight digestion was performed to 
remove/eliminate RNA contamination during the purification process using a 
combination of RNase A and RNase T1. The eluted proteins from the major peak of 
the size-exclusion chromatography corresponded to the oligomer of portal-TRAP 
fusion proteins (Figure 3-10). 
 
 
 
 
 
(A) Typical elution profiles of the two-step purification process containing Ni2+ 
affinity chromatography and size-exclusion chromatography. The elution profiles of 
A 
B 
Figure 3-10 Purification of the gp6-B. halodurans TRAP fusion protein. 
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the protein YM92 duirng the purification process is shown here as an exmaple. (B) 
Characterisation of purified fusion proteins YM91-YM100 on a 12% SDS–PAGE gel.  
3.3.2.2 Fusion proteins of SPP1 gp6 Δ27-479 with natural B. 
stearothermophilus 11-subunit TRAP Δ5-74 
The DNA segments encoding the protein product gp6 Δ27-479 and B. 
stearothermophilus TRAP Δ5-74 were ligated and cloned into the restriction sites 
BamHI and XhoI of vector pCDFDuet-1 for the expression of fusion proteins with 
an N-terminal hexahistidine tag.  
The fusion proteins were successfully over-expressed in Escherichia coli strain 
B834 at 16 °C. However, the majority of the protein was insoluble (Figure 3-11A). 
To improve the solubility, a buffer screen was carried out to investigate the effect 
of pH, salt type, salt concentration or additive on the solubility of the target protein. 
According to SDS-PAGE results (Figure 3-11B), the overexpressed protein was 
found to show preference for 20 mM Tris, pH 6.5, 500 mM NaCl and 5% glycerol 
with regard to solubility.  
 
Figure 3-11 Expression and solubility test of the gp6-B. stearothermophilus TRAP 
fusion protein.  
(A) “-IPTG” indicates expression cell lysate obtained before induction of the fusion 
proteins; “+IPTG” indicates the sample after induction of protein expression. Intense 
bands with the molecular weight of 66 kDa, highlighted, from the ‘Total’ lanes of 
both constructs were detected. However, only a thin band was present in the soluble 
sample. (B) Solubility test of crude cell extract in different buffers. Lane T contained 
total protein, while the rest contained only the soluble proteins. Lanes 1-4: solubility 
comparison with buffers of different pH, the most intense band at 66 kDa was shown 
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with 20 mM Tris pH 6.5. Lanes 5-9: the effects of salt type and concentration on the 
protein solubility were compared, and protein showed preference towards NaCl, but 
was not sensitive to the concentration of NaCl. Lanes 10 and 11 tested two additives, 
5% glycerol and 0.1% triton X-100, an intense band was observed in lane 10, with 5% 
glycerol. 
Nickel affinity chromatography was then performed using the buffer identified 
from the solubility screen as promoting the highest solubility (20 mM Tris, pH 6.5, 
500 mM NaCl and 5% glycerol) with the addition of 10 mM MgCl2 and 0.1 mM 
L-tryptophan. The addition of 10 mM MgCl2 could facilitate the oligomerisation of 
gp6 (Jekow et al, 1999), and 0.1 mM L-tryptophan may bind and stabilise TRAP 
(McElroy et al, 2002). According to Figure 3-12, the fusion protein was eluted 
when the concentration of imidazole in the buffer was approximately 250 mM and 
300 mM (40%~50% buffer B).  However, the solubility and yield of the protein 
was insufficient for further characterisation and crystallisation.  
 
 
 
 
 
 
 
 
 
To further improve the stability, a buffer screen at pH 8.5 was carried out, because 
the theoretical isoelectric point of the fusion proteins is approximately 4.9. The 
Figure 3-12 Nickel affinity chromatography of gp6-B. stearothermophilus TRAP fusion 
protein. 
20 mM Tris, 500 mM NaCl, 5% glycerol, 10 mM MgCl2, 0.1 mM L-tryptophan, 10 mM 
imidazole, pH 6.5 was used as binding buffer. For the elution of bound his-tagged protein 
YM198, Gp6 (27-479)-A6-TRAP (5-74) , elution buffer with an imidazole concentration 
of 500 mM was used as Buffer B. Fractions indicated by arrows were resolved in SDS 
PAGE. The comparison of total and soluble samples of crude cell extract suspended in 
binding buffer showed the low solubility of the protein from a large-scale expression. FT: 
flow-through from the nickel column. 
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effect of MgCl2 on the solubility was also investigated. According to Figure 3-13, 
the fusion protein was shown to tolerate low NaCl concentrations, and was most 
soluble at 100 mM NaCl. By comparing lanes 2 and 5 of both gel images, the 
addition of 10 mM MgCl2 was shown to reduce the protein solubility. By comparing 
lane 3 of both gel images, the fusion protein was also shown to be more soluble in 
buffer with a pH of 8.5 than of 6.5. As a result, a buffer at pH 8.5 with no MgCl2  
was chosen for the following experiment.  
 
Figure 3-13 Solubility tests of gp6-B. stearothermophilus TRAP fusion protein. The 
target protein is protein construct YM198: Gp6 (27-479)-A6-TRAP (5-74). Comparing 
the solubility dependency on NaCl concentration and effects of 10mM MgCl2 in pH 6.5 
(left) and 8.5 (right). Lane 5 of both gels has the same buffer composition as lane 2 
but with 10mM MgCl2 added.  
To purify the fusion protein, nickel affinity chromatography followed by 
size-exclusion chromatography was performed. The N-terminal histidine tagged 
protein (6xHis-tag) could bind to a nickel column and eluted at 300 mM imidazole 
(Figure 3-14A, B). Purification by size-exclusion chromatography generated 
aggregates with either 100 mM NaCl or 500 mM NaCl in the purification buffer, 
impeding purification. Decreasing the sample’s concentration to ~1 mg/mL didn’t 
help to resolve this issue (Figure 3-14C). Anion exchange chromatography was 
performed using a 1mL HiTrap Q HP column (GE Healthcare). The initial binding 
buffer was 20 mM Tris pH 8.5, 0.1 mM L-tryptophan, and varied with different 
NaCl concentrations of 0, 20 and 50 mM (data not shown). This likewise proved 
unsuccessful in improving solubility or yield.  
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Figure 3-14 Purification of gp6- B. stearothermophilus TRAP fusion proteins.  
(A-B) Nickel affinity chromatography purification of YM199: binding buffer was 20 
mM Tris pH 8.5, 500 mM NaCl, 0.1 mM L-tryptophan, 20 mM imidazole, and 
imidazole concentration was raised to 500mM in elution buffer. Fractions indicated 
by arrows were resolved in SDS PAGE (B), FT: flow-through from the nickel column. 
(C) Gel filtration with different buffer conditions and sample concentrations. Protein 
concentration listed were final sample concentration loaded onto the gel filtration 
column, determined using the Bradford assay. Buffer conditions were varied with 
regard to NaCl concentration and buffer type. Chromatogram of 13-subunit control 
obtained from a previously characterised gp6-B. halodurans TRAP fusion protein.  
3.3.3 Characterisation of Portal-TRAP Fusion Proteins 
3.3.3.1 Molecular weight determination by MALDI-MS 
For the fusion proteins of SPP1 gp6 truncations fused with natural B. halodurans 
12-subunit TRAP, the purified protein was firstly analysed by MALDI-MS for rapid 
identification. The molecular weight of the fusion subunit detected by MALDI-MS 
was shown to be consistent with the theoretical molecular weight (an example 
shown in Figure 3-15). Also, the MALDI data excluded the possibility of 
contamination by Chaperone GroEL during the process of purification, because 
there was no peak corresponding to 57356.9 Da - the molecular weight of the 
GroEL subunit. 
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3.3.3.2 Protein Identification by Trypsin Digestion and Mass Spectrometry 
The gp6-B. stearothermophilus TRAP fusion proteins have a theoretical molecular 
weight of approximately 62 kDa. However, the estimated molecular weight of the 
over-expressed fusion protein based on the migration of protein band on a 12% 
SDS PAGE was significantly larger than expected. SDS PAGE bands of fractions 
from nickel affinity chromatography purification containing reasonably pure 
target protein were submitted for identification by trypsin digestion and mass 
spectrometry. Sequence alignment confirmed the purified proteins as gp6-TRAP 
fusions. 
3.3.3.3 Oligomeric State Analysis by size-exclusion chromatography coupled 
with multi-angle laser light scattering (SEC-MALLS)  
The theoretical molecular mass of each gp6-B. halodurans TRAP fusion protein was 
calculated by ProtParam based on the amino acids composition. During 
SEC-MALLS analysis, a single monodispersed peak was observed for samples 
YM91, YM92, YM93, YM96, and YM97, with a mean molecular weight of the eluted 
species close to that expected for 13 subunits per oligomer (Figure 3-16, Table 
3-4). In contrast, fusion protein YM94, YM95, YM98, YM99, and YM100 showed 
polydispersity, giving broad peaks in gel filtration elution profiles, probably due to 
the sample heterogeneity and potential aggregation. The molecular weight of the 
peak containing target proteins indicated 13 subunits per oligomer for YM95 and 
YM98 constructs and 12 subunits per oligomer for YM94, YM99, and YM100 
fusions (Figure 3-16, Table 3-4). 
76 
 
Figure 3-15 The molecular weight of the purified YM92 subunit characterised by 
MALDI-MS.  
Only one major peak was detected corresponding to the molecular weight of 
62325.07 Da, very close to theoretical molecular weight of 62399.3 Da.  
Table 3-4 Estimated molecular weight of the fusion proteins by SEC-MALLS 
Protein Length (aa) Mw (subunit, Da) SEC-MALLS data (kDa) Subunits number per 
oligomer 
YM91 536 61239.2 837.5 ± 6 13.7 
M92 539 61470.4 808.3 ± 8 13.1 
YM93 542 61701.6 805.2 ± 6 13.1 
YM94* 542 61919 766.0 ± 5 12.4 
YM95 545 62150.2 779.7 ± 5 12.5 
YM96 548 62381.4 795.4 ± 6 12.7 
YM97 549 62675.7 809.1 ± 6 12.9 
YM98 552 62906.9 815.5 ± 90 12.9 
YM99* 555 63138.2 757.3 ± 4 12.0 
YM100* 555 63306.4 768.9 ± 4 12.2 
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Figure 3-16 Characterisation of the oligomeric state by SEC–MALLS. 
The thin line corresponds to the absorbance monitored at 280 nm. The thick line 
shows the molecular weight calculated for the eluted species. Fusion protein YM91, 
YM92, YM93, YM96, and YM97 showed single monodispersed peaks from gel 
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filtration elution profiles, while the fusion proteins YM94, YM95, YM98, YM99, and 
YM100 showed polydispersity giving broad peaks in gel filtration elution profiles. 
3.3.3.4 Oligomeric State Characterisation by Negative Staining Electron 
Microscopy 
Negative staining electron microscopy was employed as an effective and accurate 
method in characterising the oligomeric state of the fusion assemblies. Ring-like 
particles were distributed throughout the electron micrographs, with a detectable 
extra ring of TRAP above the gp6 ring in the fused proteins compared to the 
wild-type gp6. The preliminary analysis of eigen images performed in Prof. 
Orlova’s laboratory (Birkbeck College, London) clearly showed the 13-fold 
symmetry for fusion proteins containing truncated gp6 Δ27-466, Δ27-472 and 
Δ27-479 (Figure 3-17). Furthermore, no oligomeric state change was observed 
from the 13-mer YM92 fusion protein (containing gp6 Δ27-466) after the 
dissociation-re-association procedure. For the fusion constructs containing gp6 
Δ27-434, the preliminary results indicated mixtures of 13-mer and 14-mer 
assemblies (data not shown).  
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Figure 3-17 Electron microscopy of negative stained fusion proteins of gp6-B. 
halodurans TRAP.  
Fragments of EM micrographs, selected raw particles, class averages and eigen 
images were shown for each sample: A- control wild type gp6, B - YM92, C - YM97 
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and D - YM96. Red circles indicate an extra ring corresponding to TRAP protein, and 
the bar represents 100 nm.  
3.3.3.5 Crystallisation 
Among all TRAP fusion constructs formed with Δ27-466, Δ27-472 and Δ27-479 
gp6 (YM91-YM100), the construct YM96, with truncated 26 N-terminal residues, 
31 C-terminal residues and (GSS)3 linker, formed crystals most readily. The 10 
mg/mL protein solution was in 50 mM imidazole pH 8.0, 250 mM NaCl, and 10 mM 
MgCl2. YM96 formed ~50 μm cubic crystals with the reservoir containing 0.2 M 
NaCl, 40% MPD. A number of different plate-like crystals were obtained with 
reservoirs containing either 0.2 M ammonium acetate, 0.1 M BIS-TRIS pH 5.5, 45% 
MPD, or 0.2 M ammonium acetate, 0.1 M BIS-TRIS pH 6.5, 45% MPD (Figure 3-18, 
IndexTM screen, Hampton Research). Crystals grown with 0.2 M MgCl2 and 40% 
MPD in the reservoir diffracted to ~16 Å and crystals grown with 0.2 M ammonium 
acetate, 0.1 M BIS-TRIS pH 5.5, 45% MPD in the reservoir diffracted to ~17 Å. 
Optimisation of the conditions giving initial crystal hits did not generate crystals 
with enhanced diffraction. There were no crystals obtained for fusion proteins 
containing gp6 Δ27-434 that appeared to be mixtures of 13-mers and 14-mers 
according to preliminary EM analysis (data not shown).  
 
3.4 Discussion 
The fusion proteins of the SPP1 portal protein with B. halodurans TRAP can be 
successfully overexpressed in E. coli BL21 cells with an N-terminal histidine tag. 
These fusion proteins can be purified by Nickel affinity chromatography followed 
by size-exclusion chromatography, in which the major peak was shown to 
Figure 3-18 Crystals of portal-TRAP fusion protein YM96. 
 
81 
correspond to the stable oligomer. According to the SEC-MALLS measurements, 
the molecular weights of most purified fusion proteins are closer to the theoretical 
molecular weight of a 13-subunit oligomer, with the exception of three 
polydispersed protein samples that appeared to contain 12-mer assemblies. The 
accuracy of the SEC-MALLS technique however does not allow for a decisive 
conclusion about the oligomeric state of proteins containing more than ~10 
subunits. This is due to a typical systematic error of 5% during the molecular 
weight determination (Folta-Stogniew & Williams, 1999).  
By electron microscopy studies, ring-like particles are distributed throughout the 
electron micrograph. Compared to the wild-type gp6, an extra ring corresponding 
to the TRAP assembly is detectable above the gp6 ring in the fusion proteins. The 
preliminary analysis of eigen images clearly demonstrated the 13-fold symmetry 
of fusion proteins with gp6 truncations Δ27-466, Δ27-472 and Δ27-479 (Figure 
3-17). However, whether the TRAP protein contains 12 or 13 subunits in these 
assemblies is unknown. 
For the fusion proteins with gp6 Δ27-434, the preliminary results indicated 
mixtures of 13-mer and 14-mer assemblies (data not shown). According to 
previous studies, the removal of the whole crown domain (α7- α9) would result in 
14-mer assembly of gp6 (personal communication with Paulo Tavares). Since gp6 
Δ27-434 keeps only the α7 helix in the crown domain, the removal of α8 and α9 
helices might explain the co-existence of the 13-mer and 14-mer assemblies in 
solution. The heterogeneous oligomeric state of these proteins is the likely reason 
for these proteins not forming crystals.  
The oligomeric state of the gp6 fusion construct YM92 did not change after the 
dissociation re-association procedure, with the protein still found in the 
13-subunit oligomerisation state. The dissociation-re-association experiment was 
aimed to determine which of the two oligomeric proteins (gp6 or TRAP) defines 
the oligomeric state of the fused construct. The result suggests that the oligomeric 
state of the fusion proteins is determined by gp6, whose size is significantly larger 
than TRAP (50.7 kDa per subunit versus 8.3 kDa in the case of TRAP), although its 
subunit-subunit interactions are much weaker than TRAP.  
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The study of the TRAP oligomer stability from different Bacilli showed that B. 
stearothermphilus wild type and E71Stop TRAP form the most stable oligomers. 
Hence, these are most likely suitable for further fusion proteins studies with the 
portal protein. However, several fusion proteins constructs with the B. 
stearothermphilus TRAP, generated in this study, proved to be insoluble. 
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4 Co-expression of the SPP1 Portal Protein with the 
Scaffolding Protein  
4.1 Introduction 
Viral assembly is a multistep process involving a specific order of protein-protein 
and protein-nucleic acid interactions. For the assembly of biologically active SPP1 
procapsids, three essential structural components are required - the major capsid 
protein gp13, the scaffolding protein gp11 and the portal protein gp6. The 
geometrically correct polymerisation of gp13 is directed by the scaffolding protein 
(Becker et al, 1997), while the formation of regularly sized procapsids is controlled 
by the portal protein, which influences the copolymerisation of gp11 and gp13 
(Droge et al, 2000). Procapsid-like structures formed when the scaffolding protein 
and major capsid protein encoding genes 11 and 13 were co-expressed in a 
heterologous host. However, there was no interaction observed between the two 
proteins, when they were produced alone and then mixed in vitro (Becker et al, 
1997; Droge et al, 2000). Similarly, stable interactions between the portal protein 
gp6 and scaffolding protein gp11 could be detected only when the proteins were 
coproduced (Droge et al, 2000). The interaction between the portal and scaffolding 
proteins was also observed in the cryo-EM studies of phage P22 (Chen et al, 
2011b). 
The SPP1 portal protein is a cyclical dodecamer in the virion (Lurz et al, 2001), 
while the protein produced in vitro is a 13-subunit assembly (Lebedev et al, 2007). 
It was proposed that the interaction of the portal protein with other procapsid 
proteins, scaffolding protein or major capsid protein, would impose an increased 
bend between gp6 subunits and maintain a 12-mer assembly (Lurz et al, 2001). In 
this study, the SPP1 portal protein and scaffolding protein were co-expressed in 
the heterologous host E. coli, with the aim of promoting the assembly of a 
12-subunit portal protein.  
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4.2 Methods and Materials 
4.2.1 Cloning Strategy for Co-Expression of Gp6 and Gp11 
The plasmid pYM70 encoding gp6 Δ27-472 was first transformed into E. coli B834 
cells. The transformant was treated with calcium chloride to make E. coli B834 
competent cells carrying plasmid pYM70. The plasmid pYM184 encoding 
full-length gp11 was transformed into the E. coli B834 competent cells with 
plasmid pYM70.  
4.2.2 Purification of the Gp6 and Gp11  
A single colony carrying plasmids pYM70 and pYM184 was picked from a Luria–
Bertani (LB) agar plate containing 30 µg/mL kanamycin and 50 µg/mL 
chloramphenicol to inoculate a small overnight culture at 37 °C. 5 mL aliquots of 
the overnight culture were used to inoculate 500 mL cultures the following day. 
The 500 mL cultures were grown at 37 °C until the mid-log phase (OD600 of 0.6–
0.8) was reached, at which point protein expression was induced by the addition 
of isopropyl-d-1-thiolgalactopyranoside (IPTG) to a final concentration of 1 mM. 
Lastly, overnight incubation of the culture at 16 °C and 180r.p.m was carried out 
for the over-expression of proteins. Cells were recovered by centrifugation at 5000 
g (SORVALL®  RC 5B Plus rotor) at 4 °C for 20 minutes. Supernatant was removed 
and cell pellet was stored at -20 °C.  
The cell pellet was re-suspended in nickel affinity chromatography binding buffer, 
20 mM Tris pH 7.5, 150 mM NaCl, 10 mM MgCl2, 50 mM Imidazole, supplemented 
with a combination of 100 µg/mL lysozyme and protease inhibitors (1 mM AEBSF 
and 0.7 µg/mL pepstatin). Cells were disrupted by sonication with large probe in 
glass beaker using short pulses of 30 seconds, with a 2 minutes resting time in 
between pulses. The sonication was carried out on ice, with caution to minimise 
thermal damage to protein extract. The cell debris was removed by centrifugation 
at 38758 g for 30 minutes at 4 °C using a Sorvall SS34 rotor. The supernatant was 
collected and then cleared with a 0.45 mm ﬁlter (Millipore). The ﬁltrate loaded 
onto a 5 mL HiTrap column (GE Healthcare) equilibrated with binding buffer for 
nickel afﬁnity chromatography puriﬁcation. The bound protein was eluted with an 
increasing proportion of elution buffer containing 20 mM Tris pH 7.5, 150 mM 
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NaCl, 10 mM MgCl2, and 500 mM imidazole. Fractions containing both gp6 and 
gp11 were pooled together, and concentrated using Vivascience 30 kDa molecular 
weight cut-off concentrators. The concentrated sample (less the 10 mg/mL) was 
applied to a HiPrep 16/60 Sephacryl S-500 HR column (GE Healthcare) for size 
exclusion chromatography. The proteins were eluted with 20 mM Tris pH 7.5, 150 
mM NaCl, 10 mM MgCl2, and concentrated to at least 10 mg/mL and stored at -80 
°C before crystallisation.  
4.2.3 His Tag Pull-Down Assay 
400 µg of individually purified His6-gp11 were immobilized by 400 µL nickel 
chelate beads and incubated with 87.5 µg of individually purified untagged gp6 
Δ27-472 in 20 mM Tris pH 7.5, 150 mM NaCl, 10 mM MgCl2 (total volume: 465 µL) 
for one hour at room temperature. The beads were washed three times with 
binding buffer to remove unbound proteins. Samples of total proteins, unbound 
proteins and bound proteins were analysed by 12% SDS-PAGE. As a control, the 
untagged gp6 Δ27-472 alone and the untagged gp11 alone were also incubated 
with 200 µL nickel chelate beads in buffer 20 mM Tris pH 7.5, 150 mM NaCl, 10 
mM MgCl2 for one hour at room temperature.  
4.2.4 Size-Exclusion Chromatography coupled with Multi-Angle 
Laser Light Scattering (SEC–MALLS) 
The molecular mass was determined by size-exclusion chromatography coupled 
with multi-angle laser light scattering (SEC–MALLS). The protein sample, 60 µL of 
fraction A12 from size chromatography using a Superose 6 HR 10/30 column 
containing both gp6 Δ27-472 and gp11 at a concentration of 0.5 mg/mL, was 
applied to a BioSepTM SEC-s3000 gel filtration column (Phenomenex) equilibrated 
with buffer containing 20 mM Tris pH 7.5, 150 mM NaCl, 10 mM MgCl2. As a 
control, the separately purified gp6 Δ27-472 was analysed under the same 
conditions. Size-exclusion chromatography was carried out on a Shimadzu HPLC 
system and the elution was monitored at 280 nm by an SPD20A UV/Vis detector. 
Light-scattering data were recorded on a Dawn HELEOS-II 18-angle 
light-scattering detector and the concentration of the eluting protein was 
measured by an in-line Optilab rEX refractive-index monitor (Wyatt Technology). 
Data were analysed with the ASTRA V software package (Wyatt Technology). 
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Molecular mass was calculated using Zimm’s formalism of the Rayleigh–Debye–
Gans light-scattering model for dilute polymer solutions and a refractive-index 
increment (dn/dc) of 0.183 mL/g was used for the protein molecular mass 
estimation. 
4.2.5 Negative Staining Electron Microscopy 
The fraction A12 from size exclusion chromatography using a Superose 6 HR 
10/30 column containing both gp6 Δ27-472 and gp11 was diluted to a 
concentration suitable for single particle observation (~ 0.05 mg/mL). A 2 μL 
aliquot of the sample was applied to glow-discharged, continuous-carbon and 
formvar covered copper grids with a 300-square mesh. The dried sample was 
washed with MiliQ water and then stained with 2% uranyl acetate for two minutes. 
The grids were air-dried before inspection on a 200 kV FEI F20 electron 
microscope at a magnification of 100, 000x. Imaging was performed in a low 
electron dose mode. 10 micrographs were recorded and approximately 1200 
protein particles were selected for image analysis. These experiments were 
performed by Elena Orlova at Birkbeck College, University of London. 
4.2.6 Crystallisation and Data Collection 
The sitting-drop vapour diffusion method was used for initial crystallisation 
screening. Drops containing 150 nL protein solution and 150 nL reservoir solution 
were dispensed by a Mosquito Nanolitre Pipetting robot (TTP Lab-tech) in 96-well 
plates, and equilibrated against 60 µL of reservoir solution. To obtain initial crystal 
hits, crystal trays with the MPD screen were set up. Conditions in which small 
crystals grew were optimised in 24-well hanging-drop plates by manual pipetting. 
Crystals were tested in-house using a Rigaku RU-H3R rotating-anode generator 
equipped with Osmic multilayer optics and a MAR Research MAR345 
imaging-plate detector. Native data were collected from a single crystal on the 
Diamond I04-1 beamline at the synchrotron to 2.8 Å resolution at 0.92 Å 
wavelength. Cryosolutions were not added for crystal freezing as 40% MPD was 
already present in the crystallisation condition. The data were processed using 
XDS.  
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4.2.7 Structure Determination and Refinement 
All crystallographic calculations were performed using the CCP4 program package 
(Winn et al, 2011b). The X-ray structure of gp6 Δ27-472 was solved by molecular 
replacement using PHASER (Mccoy et al, 2007) with a single subunit of gp6 
Δ29-466 as the search model. The search model was generated by the combination 
of two structures - residues 29 to 340 (including the disordered wing region) from 
a 2.9 Å resolution structure of 14-mer (unpublished data available in the group), 
and residues 341 to 466 from the 3.4 Å resolution structure of 13-mer.  
Refinement was carried out by REFMAC (Murshudov et al, 1997). The model was 
built using COOT (Emsley & Cowtan, 2004), and further corrected using maps 
calculated with maximum likelihood-weighted coefficients 2|Fo| - |Fc| and |Fo| - |Fc|. 
All figures were generated using PyMOL (Schrodinger, 2010).  
4.3 Results 
4.3.1 Cloning, Co-expression and Purification of Portal Protein 
and Scaffolding Protein  
The gene encoding full-length gp11 was cloned into the restriction sites NdeI and 
XhoI of vector pET28a to form plasmid pYM184 for the expression of N-terminal 
hexahistidine-tagged protein, and the plasmid pYM70 was successfully cloned with 
the gene encoding gp6 Δ27-472 ligated into the NcoI and BamHI sites of vector 
pACYCDuet to express the untagged gp6 Δ27-472. The plasmids pYM70 and 
pYM184 with compatible replicon and antibiotic resistance were transformed into 
the same competent E. coli cell for the co-expression of the His-tagged full-length 
scaffolding protein gp11 and the untagged truncated portal protein gp6 Δ27-472.  
Gp6 Δ27-472 and full-length gp11 were both over-expressed in soluble form in the 
same E. coli B834 cells at 16 °C (Figure 4-1). The purification was performed by 
nickel affinity chromatography followed by size exclusion chromatography. The 
fractions containing both gp6 and gp11 were eluted at an imidazole concentration 
between 162 mM and 255 mM (Figure 4-2A). During size exclusion 
chromatography, the elution profile on a Superose 6 HR 10/30 column showed 
peaks corresponding to aggregate, fractions containing both gp6 and gp11 
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(A11-B2), and fractions containing excess gp11 (Figure 4-2B). However, the 
elution profile on a HiPrep 16/60 Sephacryl S-500 HR column corresponded to an 
overlapping elution of the two separate proteins, but no fraction containing both 
proteins was eluted before the gp6 fractions (Figure 4-2C). 
 
Figure 4-1 Co-expression of gp6 Δ27-472 and full-length gp11. 
The co-expression of the two proteins was carried out in E. coli B834 cells induced at 
16 °C.  
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Figure 4-2 Purification of the co-expressed gp6 Δ27-472 and gp11.  
(A) Purification by nickel affinity chromatography; (B) Purification by size exclusion 
chromatography on a Superose 6 HR 10/30 column, the sample loaded on the 
column was the pool of fractions containing both gp6 and gp11 from nickel affinity 
chromatography (Fractions D3-F5), and the running buffer was 20 mM Tris pH 7.5, 
150 mM NaCl, 10 mM MgCl2; (C) Purification by size exclusion chromatography on a 
HiPrep 16/60 Sephacryl S-500 HR column, the sample loaded on the column was the 
pool of fractions containing both gp6 and gp11 from nickel affinity chromatography 
(Fractions D3-F5), and the running buffer was 20 mM Tris pH 7.5, 150 mM NaCl, 10 
mM MgCl2. The elution profile was shown on the top panel. The same protein samples 
at 16 mg/mL (coloured in blue) and 1 mg/mL (coloured in red) were separately run 
on the column to compare the effect of the sample’s concentration on the elution 
profile. Samples containing gp6 alone (coloured in black) and gp11 alone (coloured 
in green) were run as controls. As shown on the bottom panel, the elution fractions 
from the run of the concentrated sample at 16 mg/mL were analysed by 12% 
SDS-PAG. S: the sample for purification containing both gp6 and gp11 from nickel 
affinity chromatography (Fraction D3-F5). A1-B9: the purification fractions as 
illustrated on the elution profile on the top panel. 
4.3.2 Probing If a His-Tag Pull-Down Assay Could Be Used to 
Detect Interaction between the Portal Protein and the 
Scaffolding Protein 
Because the full-length gp11 was expressed with an N-terminal histidine affinity 
tag and the gp6 Δ27-472 didn’t contain a histidine tag, the initial plan was to detect 
the interaction between gp6 and gp11 by His-tag pull down assays. Unexpectedly, 
preliminary results showed that the untagged gp6 Δ27-472 and the untagged gp11 
were both able to bind to nickel-chelate beads in the absence of the polyhistidine 
tag (Figure 4-3). Consequently, His tag pull down assays cannot be employed to 
detect interactions between the two proteins. 
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Figure 4-3 His-tag pull down assays of gp6 Δ27-472 and gp11.  
Untagged gp6 Δ27-472 and untagged gp11 were able to bind to nickel chelate beads. 
(A) Pull down assay with samples: his-tagged gp11, untagged gp6, and the mixture of 
His-tagged gp11 with untagged gp6; (B) Pull down assay with samples his-tagged 
gp6 and untagged gp11. Total proteins, unbound proteins and bound proteins were 
analysed by 12% SDS-PAGE.  
4.3.3 Oligomeric State Analysis by SEC-MALLS  
The recombinant protein construct YM70 consists of 446-amino acid long 
untagged portal protein gp6 Δ27-472 and two residues introduced by the vector - 
Met and Gly. The theoretical molecular mass calculated by ProtParam is 51615.6 
Da. 
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In order to determine the oligomeric state of the portal protein after co-expression 
with the scaffolding protein, the fraction A12 from size-exclusion chromatography 
on a Superose 6 HR 10/30 column containing both gp6 and gp11 was investigated 
by SEC-MALLS on a BioSepTM SEC-s3000 gel filtration column (Phenomenex) 
equilibrated with 20 mM Tris (pH 7.5), 150 mM NaCl, and 10 mM MgCl2.  
The elution profile of the size-exclusion chromatography on a BioSepTM SEC-s3000 
gel filtration column showed separate peaks corresponding to gp6 alone and gp11 
alone respectively, but there was no peak corresponding to the complex of the two 
proteins. SEC-MALLS data showed the mean molecular weight of the peak 
corresponding to gp6 Δ27-472 alone as 629.2 kDa, or ~12.2 subunits per oligomer 
in solution (Figure 4-4). Meanwhile, the separately produced gp6 Δ27-472 was 
also subject to SEC-MALLS characterisation under the same experimental 
conditions as a control. The molecular weight of gp6 Δ27-472 control was 
determined to be 679.3 kDa, or ~13.2 mer subunits per oligomer, which suggested 
gp6 as a 13mer in solution.  
 
Figure 4-4 Characterisation of the oligomeric state of the co-expressed gp6 by SEC–
MALLS.  
The thin line corresponds to the absorbance monitored at 280 nm. The thick line 
shows the molecular weight calculated for the eluted species. Separately produced 
gp6 was applied as a control and coloured in blue, whereas the elution of 
co-expressed gp6 was coloured in red. 
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4.3.4 Determination of the Oligomeric State by Negative Staining 
Electron Microscopy 
The fraction A12 from size exclusion chromatography on a Superose 6 HR 10/30 
column containing both gp6 Δ27-472 and gp11 was also investigated by negative 
staining electron microscopy to characterise the oligomeric state of gp6, and the 
interaction between gp6 and gp11. Gp6 ring-like particles were observed and the 
preliminary analysis of eigen images clearly showed 13-fold symmetry of gp6 
(Figure 4-5). Interestingly, there seemed to be several gp11 molecules attached to 
the gp6 complex as well.  
 
Figure 4-5 Negative staining electron microscopy analysis of the co-expressed gp6 
and gp11.  
The bottom row represented averages of end views (not symmetrised), and arrows 
indicated possible positions of gp11. The sample subject to observation was the 
fraction from gel filtration purification containing the mixtures of gp6 Δ27-472 and 
gp11. 
4.3.5 Crystallisation of Gp6 Δ27-472 
The protein sample used for crystallisation was prepared after co-expression with 
gp11, nickel affinity chromatography and size exclusion chromatography on a 
HiPrep 16/60 Sephacryl S-500 HR column. The fractions containing gp6 alone 
were collected and concentrated to 19 mg/mL. Here, gp6 Δ27-472 exhibited a very 
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high crystallisation propensity under MPD screen conditions. The best diffracting 
crystals were produced under the conditions 0.2 M Lithium acetate, 40% MPD 
(condition B12 of MPD screen) and 0.1 M Tris pH 8.0, 40% MPD (condition F5 of 
MPD screen). Crystals from both conditions were tested in-house, with diffraction 
extending to approximately 3.7 Å resolution. The best crystals were stored and 
shipped to the Diamond Light Source for collection of a complete data set. Sets of 
complete X-ray data were collected from three different crystals. The best data set 
extended to a resolution of 2.8 Å (beamline I04-1, Diamond Light Source, Figure 
4-6).  
 
Figure 4-6 Diffraction image.   
Resolution at the edges of the plate is 1.88 Å. 
4.3.6 Structure Determination 
The X-ray dataset from the best crystal was indexed and integrated using XDS and 
the space group was determined to be C2 with unit cell dimensions of a=224.8 Å, 
b=176.8 Å, c=208.1 Å, β=112.45°. The data were further processed using the CCP4 
program AIMLESS. Statistics of the merged data are shown in Table 4-1. 
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The crystallographic calculations were performed using the CCP4 program 
package (Winn et al, 2011b). The structure of gp6 Δ27-472 was solved by 
molecular replacement using PHASER (Mccoy et al, 2007), with a single subunit of 
gp6 Δ29-466 as the search model. The model was refined at 2.8 Å to the final Rfree 
of 26.6% (Rfactor=20.7%) (Table 4-1). The electron density of the wild type gp6 is 
well defined for most amino acids, including Asn365 (Figure 4-7 shows electron 
density at 2 σ coutouring level). This is the residue which was substituted by lysine 
in the previously determined structure of gp6 (Lebedev et al, 2007).  
Like N365K mutant gp6, the isolated wild type protein forms 13-subunit assembly 
(Figure 4-8). The superposition of Cα traces for the subunits of the wild type and 
the N365K mutant gp6 reveals identical folds (Figure 4-9). Most significant 
conformational differences are found in the tunnel loop segment, a loop in the clip, 
and in the crown domain (Figure 4-9). In addition, the segment from residue 170 
to 238, which was poorly defined in the structure of N365K gp6, is well defined in 
the current model. 
 
Figure 4-7 Electron density of the residue Asn365 in the WT gp6 shown on 2|Fo| - |Fc| 
map. 
The coutouring level is 2 σ. 
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Figure 4-8 Structure of the wild-type gp6.                                 (A) 
(A) Ribbon diagram representing the top view of the wild-type gp6; (B) Ribbon 
diagram representing a side view of the wild-type gp6. 
 
Figure 4-9 Superposition of Cα traces for the subunit of the WT gp6 and the N365K 
mutant gp6.   
The wild type gp6 is coloured in green, and the N365K mutant gp6 structure is coloured in 
magenta.  
 
In both wild type and mutant gp6, residue 365 is involved in subunit-subunit 
interactions. In the wild type gp6, Asn356 participates in the formation of two 
hydrogen bonding interactions with Asn349 of adjacent subunit: one hydrogen 
bond is formed between the side chain amine hydrogen of Asn356 and the 
backbone carbonyl oxygen of Asn349, and the other hydrogen bond is formed 
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between the side chain carbonyl oxygen of Asn356 and the side chain amine 
hydrogen of Asn349 (Figure 4-10A). In contrast, in the N365K gp6, Lys365 forms 
only one hydrogen bonding interaction, between its side chain amine hydrogen 
and the backbone carbonyl oxygen of Gly357 from an adjacent subunit (Figure 
4-10B). The side chain of this lysine residue also makes van der waals interactions 
with Asn349 of this tunnel loop, being directed towards its centre by the hydrogen 
bonding interactions. These inter-subunit interactions could play an important 
role in maintaining the functional structure of the 15-residue tunnel loops 
(345-359), which constitute the most constricted part of the tunnel and would 
form close contacts with DNA during its translocation (Lebedev et al, 2007). The 
flexibility of tunnel loops is considered to be crucial for the packaging of DNA into 
procapsids. It is noteworthy that the residues involved in the hydrogen bonding 
contacts with Asn365/Lys356 are different - Gly357 in the mutant gp6 and Asn349 
in the wild type gp6. Both residues are located within the tunnel loop, however, 
occupy opposite positions - Gly357 is situated at the top , close to the C-terminus 
of the tunnel loop, while Asn349 is at the bottom in the N-terminal part of the loop. 
Compared to the wild type gp6, the inter-subunit hydrogen bonding interaction 
between Gly357 and Lys365 and van der Waals interactions in the mutant gp6 
could restrict tunnel loop’s conformation reducing its flexibility. This suggestion is 
supported by comparison of the tunnel loop’s electron density which reveals it is 
better defined in the case of the N365K mutant gp6. The reduced flexibility of the 
tunnel loops could account for the different behaviour of capsids containing the 
mutant gp6: previous studies showed that the N365K substitution resulted in 
reduction of the length of the encapsidated DNA, although the DNA packaging 
process was not impaired (Tavares et al, 1992).  
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Figure 4-10 Comparison of the hydrogen-bonding interactions formed by Asn365 in 
the WT gp6 and Lys365 in the mutant gp6.   
(A) Two hydrogen bonds are formed between Asn365 and Asn349 in the wild type 
gp6, (B) one hydrogen bond is formed between Lys365 and Gly357 in the mutant gp6. 
All strong hydrogen bonding interactions are shown as dotted lines, and the adjacent 
subunits are coloured in green and magenta, respectively.  
Table 4-1 Crystallographic statistics 
Data collection statistics  
X-ray source I04-1,  Diamond 
Wavelength, Å 0.92 
Temperature, K 100  
Space group C2 
Unit cell parameters, Å a=224.8, b=176.8, c=208.1 
 α=90°,  β=112.5°,  γ=90° 
Resolution Range, Å 48.30 – 2.80 (2.85-2.80) 
No. of unique reflections 179891(8876) 
Rmergea, % 10.1 (107.5) 
Completeness, % 98.9 (98.8) 
Redundancy 3.5 (3.5) 
Average I/ σ(I) 9.4 (1.1) 
Refinement statistics  
No. reflections 178069 
Rwork/ Rfree,% 20.7/26.6 
Number of water molecules 328 
R.m.s deviation from ideal bond length, Å 0.0046 
R.m.s deviation from ideal bond angles, ° 0.8391 
Ramachandran Plot, %  
  In preferred regions 94.72 
  In allowed regions 
 
4.72 
  Outliers 0.56 
aRmerge = ∑hkl ∑i |Ii (h,k,l)-<I(h,k,l)>| / ∑hkl ∑i Ii (h,k,l), where I(h,k,l) is the intensity of 
reflection, <I(h,k,l)> is the average value of the intensity, the sum ∑hkl is over all measured 
reflections and the sum ∑i is over i measurements of a reflection. Values in parentheses 
are for the highest-resolution shell. 
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4.4 Discussion 
In this study, the full-length SPP1 scaffolding protein gp11 was co-expressed with 
the portal protein gp6 Δ27-472 in E. coli cells with the aim to induce the formation 
of a 12-subunit gp6 assembly in the presence of the capsid morphogenesis protein 
gp11.  The two proteins were successfully co-expressed in the same cell. 
Purification of the two proteins was carried out by nickel affinity chromatography 
and size exclusion chromatography. Fractions containing both proteins were 
eluted from size exclusion chromatography with a Superose 6 HR 10/30 column, 
whereas fractions eluted from a HiPrep 16/60 Sephacryl S-500 HR column 
corresponded to separate proteins. His-tag pull-down assays revealed the 
untagged gp6 Δ27-472 was able to bind to nickel chelate beads. Therefore, the 
binding of untagged gp6 to a HiTrap affinity column was unlikely to be caused by 
the interaction with his-tagged gp11. Moreover, fractions containing both proteins 
that were eluted from size exclusion chromatography are more likely due to an 
overlapping elution of the two separate proteins instead of the gp6-gp11 complex.  
The SEC-MALLS data on the size-exclusion chromatography fraction containing 
both gp6 and gp11 showed two peaks corresponding to individual proteins. 
Calculated oligomeric state of the peak corresponding to gp6 was 12.2 subunits, 
suggesting a 12-mer assembly. A control experiment with separately produced 
gp6 had a calculated oligomeric state of 13.2 subunits, indicating a 13-mer 
assembly. However, the oligomeric state of the gp6 co-expressed with gp11 was 
shown to be 13 subunits by negative staining electron microscopy and by 
crystallographic analysis. These observations demonstrate that the SEC-MALLS 
data could be misleading in determining the oligomeric state of proteins 
containing more than ~10 subunits. This is due to the limitation on the accuracy of 
a single SEC/LS experiment, which is ±5% for protein standards ranging from 12 
to 475 kDa (Folta-Stogniew & Williams, 1999). Compared to SEC-MALLS, analysis 
of oligomers by negative staining electron microscopy can provide more reliable 
data for characterisation of large assemblies like gp6. 
The 2.8 Å resolution structure of the wild type gp6 Δ27-472 shows that the 
architecture of the 13-fold symmetrical molecule is the same as observed 
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previously in the 3.4 Å resolution structure of the  N365K mutant protein (PDB 
entry: 2JES). The structure reveals differences in interaction between tunnel loops 
of adjacent subunits, notably differences in hydrogen bonding interactions, which 
are likely to be important for normal functioning of the motor. Residues from 170 
to 238, poorly defined in the structure of the mutant gp6, are resolved in the 
current structure.  
Research described in this thesis used truncated gp6 protein lacking 31 residues at 
the C-terminus. Such truncation has led to better diffracting crystals of the portal 
protein. The C-terminal segment is negatively charged due to the presence of 
stretches of Asp and Glu residues. Since the C-terminus is exposed towards the 
interior of the capsid, this negatively charged segment could be important for the 
interaction with gp11. Future work should be directed towards co-expressing gp6 
containing a complete C-terminus with the full-length gp11 and characterising the 
oligomeric state of gp6 by negative staining electron microscopy. Crystallographic 
analysis would be carried out if the natural 12-mer assembly of portal protein, 
observed in mature viral particles, could be obtained.  
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5 The SPP1 Scaffolding Protein 
5.1 Introduction 
5.1.1 Scaffolding Proteins from dsDNA Bacteriophages  
The procapsid is a transient precursor structure composed of the portal protein, 
coat proteins and scaffolding proteins present in double-stranded DNA 
bacteriophages and herpes viruses. Some viruses require both internal scaffolding 
proteins and external scaffolding proteins to accomplish procapsid assembly, and 
others only require internal scaffolding proteins. Scaffolding proteins play a 
catalytic role in the polymerisation of coat proteins with correct geometry. In 
several viral systems, a mixture of purified scaffolding and coat proteins can yield 
virus-like particles in vitro (Cerritelli & Studier, 1996; Dokland et al, 2002; Fu et al, 
2007; Lee & Guo, 1995; Newcomb et al, 1999; Prevelige et al, 1988; Wang et al, 
2000). Absence of scaffolding proteins will result in an aberrant procapsid 
structure and thus a non-infectious viral particle. Scaffolding proteins act as 
chaperones to prevent improper interactions and ensure the fidelity of the 
assembly process (Morais et al, 2004), but are subsequently removed during DNA 
encapsidation and are absent from the mature virion (Chang et al, 2008; 
Ziegelhoffer et al, 1992). 
One of the most well characterised scaffolding proteins is from Salmonella 
typhimurium Bacteriophage P22, a member of the Podoviridae family. P22 
scaffolding protein is found to initiate shell assembly and regulate the 
polymerisation of coat subunits into icosahedral procapsids in vitro (Prevelige et al, 
1988). There are approximately 250 molecules of internal scaffolding proteins 
located in the interior of the procapsid. Truncation mutants designed to define the 
regions of scaffolding protein responsible for the different aspects of its function 
(Weigele et al, 2005) revealed that amino acids 1-20 are nonessential. The 
scaffolding protein interacts with the coat protein via the C-terminal coat 
protein-binding domain (residues 238-303), with residues 280-294 constituting 
the minimal coat protein-binding site. The observations indicated that the 
N-terminal 57 residues are important for sensing the scaffolding protein release 
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signal to allow the scaffolding protein to exit the procapsid. Several residues 
between 229 and 238 are required for portal protein recruitment. 
Structural characteristics of the C-terminus from P22 scaffolding protein have 
been studied using circular dichroism, and nuclear magnetic resonance (NMR) 
(Parker et al, 1997; Sun et al, 2000). Stable secondary structure elements are 
present in the 163-amino acid carboxyl-terminal fragment (Parker et al, 1997), 
and a helix-loop-helix motif stabilized by a hydrophobic core is defined by NMR in 
the solution structure of the coat protein-binding domain (residues 238-303, 
Figure 5-1) (Sun et al, 2000). The association of scaffolding and coat proteins is 
mediated mainly by ionic interactions. Residues R293 and K296 are particularly 
important for coat protein binding (Cortines et al, 2011; Padilla-Meier et al, 2012). 
There is limited knowledge of the structure of the P22 scaffolding protein beyond 
the NMR structure of the extreme C-terminus coat protein-binding domain. It is 
suggested that the full-length protein structure is predominantly composed of two 
α-helical elongated domains connected by unstructured regions (Tuma et al, 1998). 
A conformational change upon assembly occurs, because the N-terminus and the 
C-terminus are proximate in solution, however, the N-terminus is no longer 
accessible to the C-terminus when assembled into procapsids (Padilla-Meier & 
Teschke, 2011). 
 
Figure 5-1 The structure of the coat protein-binding domain of the P22 scaffolding 
protein.  
(A) The minimal coat binding domain is highlighted; (B) The hydrophobic residues 
involved in the hydrophobic core are illustrated in purple and basic residues in blue. 
A B 
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The structure was determined by NMR, and the figure was adapted from (Sun et al, 
2000).   
The reconstructed P22 procapsid at 8.7Å resolution by cryo-EM (Chen et al, 2011b) 
showed a set of scaffolding subunits interacting with both the portal and coat 
subunits (Figure 5-2). The “loop” in the helix-loop-helix motif of the scaffolding 
protein is in close contact with the wing domain of the portal protein indicating an 
extensive interaction, and the number of scaffolding protein interacting with the 
portal is suggested to be 10 (Figure 5-2).    
 
Figure 5-2 Cryo-EM reconstruction of the P22 procapsid. 
(A) The C termini of 10 scaffolding proteins are labelled from 1 to 10, from five 
hexamers (circled) surrounding the portal vertex. (B) Side view of the interaction 
model among the 10 scaffolding protein C termini (red cylinders), coat proteins 
(ribbons), and the 12-fold averaged portal density (grey). The figure was adapted 
from (Chen et al, 2011b). 
Scaffolding proteins have been successfully purified from other bacteriophages 
such as bacteriophage λ (Ziegelhoffer et al, 1992), SPP1 (Poh et al, 2008), and 
phi29. Biophysical data indicate that scaffolding proteins possess an unusually 
elongated shape (Ziegelhoffer et al, 1992). Currently, the only available x-ray 
structures of scaffolding proteins are from phi29, from both before and after 
prohead assembly (Figure 5-3). The structures revealed that phi29 scaffolding 
protein is a homodimer that resembles an arrow with a four helix bundle 
composing the arrowhead and a coiled coil forming the tail (Morais et al, 2003). 
A B 
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The α-helical structure of the scaffolding protein is shown to be a conserved 
characteristic, which assists the association of the major capsid protein (Morais et 
al, 2003; Sun et al, 2000).   
 
Figure 5-3 Ribbon diagram of the structure of the phi29 scaffolding protein.  
The figure was adapted from (Morais et al, 2003). 
5.1.2 The SPP1 Scaffolding Protein 
The SPP1 scaffolding protein is gp11, with the full-length protein being 214 amino 
acids in size and having a subunit molecular mass of 23.5 kDa. A study on head 
morphogenesis genes discovered the importance of gp11 in the formation of 
normal proheads by the major capsid protein gp13 (Becker et al, 1997). Gp11 
directs the polymerisation of major capsid protein subunits to form the required 
correct geometry for the icosahedral procapsid structure (Becker et al, 1997). 
Gp11 only interacts with gp13 when they are co-produced where they can yield 
procapsid-like structures, whilst no interaction was detected when synthesised 
separately and mixed in vitro (Droge et al, 2000).  When gp11 is co-expressed 
with gp6 and gp13, biologically active procapsids competent for DNA packaging in 
vitro can be formed. The stable interaction between gp6 and the two major 
procapsid proteins gp13 and gp11 was detected only when the three proteins 
were co-produced (Droge et al, 2000). 
As with internal scaffolding proteins from other phages, the SPP1 scaffolding 
protein is also predicted to be an α-helix rich molecule with a very elongated shape. 
The organisation of purified oligomeric gp11-His6 was characterised to be a 
tetramer in solution. The MALDI mass spectra of gp11-His6 cross-linked with 0.25% 
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glutaraldehyde implied the tetramer is a dimer formed from gp11-His6 dimers 
(Poh et al, 2008). There is very low amino acid sequence similarity shown among 
the scaffolding proteins from the bacteriophage SPP1, P22 and phi29. 
 
Figure 5-4 Multiple sequence alignment of scaffolding proteins from the 
bacteriophage SPP1, P22 and phi29. The alignment was performed using ClustalW. 
5.2 Methods and Materials 
5.2.1 Cloning of Gp11 Constructs 
The SPP1 genomic DNA was served as the template for the PCR reaction. The 
primers were designed to introduce specific endonuclease restriction sites and 
amplify the required DNA fragments (Table 5-3) and synthesised by Eurofins 
MWG Operon, Ebersberg, Germany (purification level: salt free).  Ampliﬁcation of 
the required ORF by PCR was performed in a 50 L reaction vial with the 
components listed in Table 5-1 under thermocycling conditions shown in Table 
5-2. The insert was cloned into vectors pET28a, pCDFDuet-1, pGEX6P-3, Lic (-), Lic 
(+), and pET22b for different purposes. The correct inserts were verified by DNA 
sequencing (GATC Biotech) and alignment analysis (Clustal W).  
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   Table 5-1 PCR reaction components 
Component Amount in 50 μL reaction  Final concentration 
F Primer (2 µM) 12.5 µL 0.5 µM 
R Primer (2 µM) 12.5 µL 0.5 µM 
5X Phusion HF Buffer 10 µL 1X 
dNTPs (25 mM each) 0.4 µL 0.2 mM 
Phusion®  DNA Polymerase 0.5 µL 1.0 unit 
Template DNA 0.5 µL < 250 ng 
dH2O Up to 50 µL  
 
Table 5-2 Thermocycling conditions for a routine PCR 
Step Temperature Time 
Initial Denaturation  98 °C  2 minutes 
30 Cycles  98 °C 
55 °C 
72°C  
30 seconds 
30 seconds 
15-30 seconds per kb  Final Extension   °C  5 minutes  
Hold  4 °C    
Table 5-3 Primers for the cloning of gp11 constructs 
Primer Sequence (5’-3’) 
GP11-F1 GGG AAT TCC ATA TGA TGA GTT TGA AAG AGC AG 
GP11-R1 GAG CCG CTC GAG TTA CTG TGC TTC TGC TTG TAG 
GP11_F2_BamH1 CGG GAT CCA TGA GTT TGA AAG AGC AGT TAG  
GP11-R2  GAG GAG AAG GCG CGT TAC TGT GCT TCT GCT TGT AGC  
GP11-F3  CAC CAC CAC CAC CCG AAA GAA AAG TTT GAC GCT GTT  
GP11-F3_3c  CCA GGG ACC AGC ACC GAA AGA AAA GTT TGA CGC TGT T  
GP11-F4  CAC CAC CAC CAC TTT GAC GCT GTT AAC AGT GAG AAG  
GP11-F4_3c  CCA GGG ACC AGC ATT TGA CGC TGT TAA CAG TGA GAA G  
GP11-F5  CAC CAC CAC CAC GGC CCG GAT TTC AAC CTC A  
GP11-F5_3C  CCA GGG ACC AGC AGG CCC GGA TTT CAA CCT CA  
GP11-R3  GAG GAG AAG GCG CGT TAA CCT TTA AAG AGA TAG TCC TC 
Gp11_infusion_F1 AAG GAG ATA TAC ATA TGA TGA GTT TGA AAG AGC AGT TAG G 
Gp11_infusion_R1 GTG CGG CCG CAA GCT TTT ATT TAA AGA GAT AGT CCT CTT GT 
Gp11_infusion_F2 ATC ACC ACC ACC ACA TGA GTT TGA AAG AGC AGT TAG G 
Gp11_infusion_R2 TGA GGA GAA GGC GCG TTA TTT AAA GAG ATA GTC CTC TTG T 
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5.2.2 Expression and Puriﬁcation of Gp11 
The plasmids were transformed into Escherichia coli expression strain Rosetta2 
cells. The plasmid pYM209 encoding the N-terminal GST tagged gp11 and the 
plasmids (pYM210, pYM212, pYM222, pYM223, and pYM224) encoding the 
truncated gp11 were transformed into E. coli expression strain B834. A single 
colony from a Luria–Bertani (LB) agar plate containing the appropriate antibiotics 
for the different vectors (e.g. 30 µg/mL kanamycin for pET28a vector and 50 
µg/mL streptomycin for pCDFDuet-1 vector) was picked to inoculate a small 
overnight culture at 37 °C. 5 mL aliquots of the overnight culture were used to 
inoculate a 500 mL culture the following day. The 500 mL Culture were grown at 
37 °C until the mid-log growth phase (OD600 of 0.6–0.8) was reached, at which 
point protein expression was induced by the addition of 
isopropyl-d-1-thiolgalactopyranoside (IPTG) to a final concentration of 1 mM. 
Lastly, overnight incubation of the culture at 16 °C and 180 r.p.m was carried out 
for the over-expression of proteins. Cells were recovered by centrifugation in 
SORRALL®  RC 5B plus for 20 minutes at 5000 g, 4 °C. Supernatant was removed 
and the cell pellet was stored at -20 °C.  
The cell pellet was resuspended in nickel affinity chromatography binding buffer, 
20 mM Tris pH 7.5, 150 mM NaCl, 50 mM Imidazole, supplemented with a 
combination of 100 µg/mL lysozyme and protease inhibitors (1 mM AEBSF and 0.7 
µg/mL pepstatin). Cells were disrupted by sonication with a large probe in glass 
beaker using short pulses of 30 seconds, with a two-minute resting time between 
pulses. The sonication was carried out on ice, with caution to minimise thermal 
damage to the protein extract. The cell debris was removed by centrifugation at 
38758 g for 30 minutes at 4 °C using a Sorvall SS34 rotor. The supernatant was 
collected and then cleared with a 0.45 mm ﬁlter (Millipore). The ﬁltrate loaded 
onto a 5 mL HiTrap column (GE Healthcare) equilibrated with binding buffer for 
nickel afﬁnity chromatography puriﬁcation.  
The bound protein was eluted with an increasing proportion of elution buffer 
containing 20 mM Tris pH 7.5, 150 mM NaCl, and 500 mM imidazole. Fractions 
containing gp11 were pooled together. To obtain untagged gp11, a thrombin 
digestion step was performed to remove the histidine tag. Instead of a second 
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nickel affinity chromatography, MonoQ high-resolution ion-exchange 
chromatography was carried out to remove thrombin and the cleaved histidine tag, 
because the untagged gp11 can also bind to nickel. To ensure the complete 
removal of the histidine tag, an excess amount of thrombin (Amersham 
Biosciences) was used - 10 cleavage units of thrombin solution per mg for 
overnight digestion at 4 °C.  The cleavage of the tag was confirmed by MALDI-MS. 
Once digestion was complete, the buffer was exchanged by extensive dialysis 
against the low ionic loading buffer 20 mM Tris pH 7.5, 50 mM NaCl for ion 
exchange chromatography. 
Fractions containing gp11 from nickel affinity chromatography and buffer 
exchanged against the Ion exchange chromatography loading buffer were loaded 
onto an 8 ml column of Mono Q 10/100 GL (GE Healthcare) equilibrated with 
loading buffer 20 mM Tris pH 7.5, 50 mM NaCl, and washed with 10 column 
volumes of the loading buffer to wash out unbound proteins. The bound protein 
was eluted with an increasing proportion of elution buffer containing 20 mM Tris 
pH 7.5, 1 M NaCl. Fractions containing gp11 were pooled together, and 
concentrated using Vivascience 30 kDa molecular weight cut-off concentrators.  
The concentrated sample (less the 10 mg/mL) was applied to a HiPrep 16/60 
Sephacryl S-500 HR column (GE Healthcare) for size exclusion chromatography as 
the ﬁnal polishing step to remove any high-molecular-weight aggregates and 
obtain the fusion proteins with the appropriate molecular weight. The proteins 
were eluted with GF buffer (20mM Tris pH 7.5, 150 mM NaCl), concentrated to at 
least 10 mg/mL and stored at -80 °C for crystallisation.  
5.2.3 Size-Exclusion Chromatography coupled with Multi-Angle 
Laser Light Scattering (SEC–MALLS) 
The molecular mass was determined by size-exclusion chromatography coupled 
with multi-angle laser light scattering (SEC–MALLS). The protein sample (60 µL) 
with a concentration of 0.5 mg/mL was applied on a BioSep SEC-s3000 gel 
filtration column (Phenomenex) equilibrated with buffer containing 20mM Tris pH 
7.5, 150 mM NaCl. Size-exclusion chromatography was carried out on a Shimadzu 
HPLC system and the elution was monitored at 280 nm by an SPD20A UV/Vis 
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detector. Light-scattering data were recorded by a Dawn HELEOS-II 18-angle 
light-scattering detector and the concentration of the eluting protein was 
measured by an in-line Optilab rEX refractive-index monitor (Wyatt Technology). 
Data were analysed with the ASTRA V software package (Wyatt Technology). 
Molecular mass was calculated using Zimm’s formalism of the Rayleigh–Debye–
Gans light-scattering model for dilute polymer solutions and a refractive-index 
increment (dn/dc) of 0.183 mL/g was used for the protein molecular mass 
estimation. 
5.2.4 Crystallisation 
The sitting-drop vapour diffusion method was used for the initial crystallisation 
screen. Drops containing 150/300 nL protein solution and 150 nL reservoir 
solution were dispensed by a Mosquito Nanolitre Pipetting robot (TTP Lab-tech) 
in 96-well plates, and equilibrated against 54 µL of reservoir solution at 20 °C or 
4 °C. The search for suitable crystallisation conditions was performed using 
several commercial screens such as Index, PACT, Clear Strategy Screens I and II, 
Morpheus, JCSG, Ammonium sulphate and MPD. Conditions from MorpheusTM 
screen (Molecular Dimensions) growing small crystals were optimised in 24-well 
hanging-drop plates with manual pipetting. Crystals were tested using a Rigaku 
RU-H3R rotating-anode X-ray generator equipped with Osmic multilayer optics 
and a MAR Research MAR345 imaging-plate detector. 
5.2.5 Limited Proteolysis 
Chymotrypsin concentration used in proteolysis studies was 50 ng/µL, and the 
protein concentration used was 2 mg/mL. The total volume of the reaction was 10 
µL, and 20mM Tris pH 7.5, 150mM NaCl was the buffer for the reaction. Untagged 
full-length gp11 (after tag removal from YM184) and chymotrypsin were mixed in 
ratios of 1:200, 1:100 and 1:50, and incubated for one hour at room temperature. 
The digestion of gp11 by chymotrypsin was monitored on 15% SDS – PAGE. The 
reaction was quenched by the addition of PMSF to the final concentration of 2 mM 
before the sample was sent for analysis by electrospray ionisation mass 
spectrometry.   
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Table 5-4 Conditions for chymotrypsin digestion of full length gp11 
 Reaction YM184  
(2 mg/ml) 
Chymotrypsin 
(50 ng/µL) 
Buffer Protease: protein 
ratio 
Time 
1 5 µL 1 µL 4 µL 1:200 1hr 
2 5 µL 2 µL 3 µL 1:100 1hr 
3 5 µL 4 µL 1 µL 1:50 1hr 
 YM184  
(2 mg/ml) 
Chymotrypsin 
(50 ng/µL) 
Buffer Protease: protein 
ratio 
Time 
4 5 µL 1 µL 4 µL 1:200 45 min 
5 5 µL 2 µL 3 µL 1:100 45 min 
6 5 µL 4 µL 1 µL 1:50 45 min 
7- Control 5 µL 0 µL 5 µL NA NA 
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5.3 Results 
5.3.1 Cloning, Expression and Purification of the Full-Length Gp11 
The gene encoding full-length gp11 was cloned into the restriction sites NdeI and 
XhoI of vector pET28a to form plasmid pYM184 for the expression of N-terminal 
hexahistidine-tagged protein, and cloned into the restriction sites NdeI and XhoI of 
vector pCDFDuet-1 to form plasmid pYM185 for the expression of untagged 
protein. Also, the full length gp11 encoding DNA sequence was cloned and ligated 
into the BamHI and XhoI sites of vector pGEX6P-3 to form plasmid pYM209 for the 
expression of the protein with an N-terminal glutathione S-transferase tag.  
The full-length gp11 with an N-terminal hexahistidine tag or N-terminal 
glutathione S-transferase tag were both successfully overexpressed in E. coli in 
soluble form. Pure and soluble His-tagged gp11 protein was obtained by a 
three-step purification procedure consisting of nickel affinity chromatography, 
MonoQ high-resolution ion-exchange chromatography, and size exclusion 
chromatography. The yield of the His-tagged gp11 from a 500 mL culture was up 
to ~75 mg with a concentration of 30 mg/mL in 20 mM Tris pH 7.5, 50 mM NaCl.  
An extra thrombin digestion step with an excess amount of thrombin and 
overnight digestion was used to completely remove the histidine tag. GST-tagged 
gp11 was purified by batch method with Glutathione SepharoseTM 4B, and then 
polished by gel filtration using a Superose®  6 HR 10/30 column. After the two-step 
purification the protein was not pure enough for further biochemical analysis, with 
several impurities still present (Figure 5-5A).  
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Figure 5-5 Purification of the GST-tagged full-length gp11.  
(A) The purification procedure of the GST-tagged gp11 by batch method using 
Glutathione Sepharose 4B beads was monitored on a 15% SDS PAGE gel, and the 
protein samples of cell lysate, soluble proteins, unbound proteins, bound proteins and 
eluted proteins were shown respectively; (B) The purification of the GST-tagged gp11 
by gel filtration using a Superose 6 HR 10/30. The elution profile was shown on the 
left panel with the red line indicating A260 abosorbance and the blue line indicating 
A280 absorbance. The corresponding fractions A8-B8 were analysed by 15% SDS 
PAGE gel as shown on the right panel. 
B 
A 
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5.3.2 Characterisation of the Full Length Gp11 by MALDI-MS and 
SEC-MALLS 
The hexahistidine-tagged gp11 consists of 234 amino acids including the 16-amino 
acid long thrombin cleavable histidine tag (HHHHHHSSGLVPRGSH) with a 
theoretical molecular mass of 25626.6 Da. The purified protein was analysed by 
MALDI-MS for the rapid identification and characterisation of the subunit 
molecular weight. The molecular weight detected by MALDI-MS was 25657.48 Da, 
which was in good agreement with the theoretical molecular weight (Figure 5-6 
A).  
A single monodispersed peak was observed during the size-exclusion 
chromatography, although the elution profile was broad, possibly due to the 
elongated shape of the scaffolding protein. SEC-MALLS data showed the mean 
molecular weight of the eluted species as 53.5 kDa, or ~2.1 subunits per oligomer, 
suggesting that gp11 is a dimer in solution (Figure 5-6 B).  
5.3.3 Gradual Degradation and Limited Proteolysis of Full-Length 
Gp11 
The full-length gp11 degraded gradually at 4 °C with a series of protein fragments 
detected on 15% SDS PAGE gel (Figure 5-7 A). A limited proteolysis experiment 
was performed to probe the stable truncated gp11. Gp11 was fully digested by 
chymotrypsin after 30 minutes at room temperature. The protein fragment after 
chymotrypsin digestion was subject to electrospray ionisation mass spectrometry, 
and the major peak detected corresponded to a molecular mass of 17.48 kDa 
(Figure 5-7 B). The potential digestion sites of gp11 by chymotrypsin were 
predicted using the ExPASy PeptideCutter tool (Wilkins et al, 1999). Chymotrypsin 
preferentially cleaves peptide amide bonds where the carboxyl side of the amide 
bond (the P1 position) is a tyrosine, tryptophan, or phenylalanine. According to 
the online tool and the molecular mass of the digested fragment determined by 
ESI-MS, three possible sets of digestion sites were predicted 40-199, 64-214, and 
1-153. 
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Figure 5-6 Analysis of His-tagged full-length gp11 by MALDI-MS (A) and SEC-MALLS 
(B).  
A 
B 
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Figure 5-7 Limited proteolysis analysis of full-length gp11. 
(A) Gradual degradation of the full-length gp11 was shown on a 15% SDS-PAGE gel; 
(B) The full length gp11 was digested with different protein: chymotrypsin ratios and 
digestion times, and the samples after digestion were analysed on a 15% SDS-PAGE 
gel shown on the top panel. The sample after digestion was also analysed by ESI-MS 
shown on the bottom panel, and the ESI-MS spectrum showed the major peak with a 
molecular weight of 17.48 kDa corresponding to the digested gp11 fragment that 
was highlighted on the top panel. 
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5.3.4 Design, Cloning, Expression and Purification of the 
Truncated Gp11 
Truncated constructs were designed based on the information from chymotrypsin 
digestion and disorder prediction, which suggested the C terminus starting from 
amino acid 155 was extremely disordered (Figure 5-8, Table 5-5). The 
corresponding DNA sequences were cloned and ligated into the vectors Lic (-), Lic 
(+), and pET22b to express the protein with: a non-cleavable N-terminal his tag, a 
cleavable N-terminal his tag and without any tag, respectively.  
 
Figure 5-8 Disorder in the C- terminal segment of gp11 starting from amino acid 
155. 
The prediction was performed by PrDOS (Ishida & Kinoshita, 2007). 
Table 5-5 List of truncated constructs of gp11 
plasmid Constructs Vector Tag 
pYM210 39-214 Lic(-) N-His6 
pYM212 39-155 Lic(-) N-His6 
pYM222 35-214 Lic(+) N-His6 
pYM223 39-155 Lic(+) N-His6 
pYM224 1-154 pET22b No tag 
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All the truncated gp11 proteins were produced in soluble form. Purification of the 
His-tagged protein was carried out by nickel affinity chromatography, MonoQ 
high-resolution ion-exchange chromatography, and lastly size exclusion 
chromatography. For the untagged protein, a Q FF column was used for the first 
step. Although it was possible to purify the truncated proteins, they proved to be 
less soluble and stable in comparison with the full-length gp11 and precipitated at 
protein concentrations higher than 10 mg/mL.  
5.3.5 Crystallisation of the Full-Length Gp11 
Among all the gp11 construct variants, the full-length gp11 exhibited higher 
crystallisation propensity than the constructs with truncated N- and C-termini. 
The hexahistidine-tagged gp11 at a concentration of 10 mg/mL in 20 mM Tris pH 
7.5, 50 mM NaCl was crystallised under reservoir conditions of 10% PEG 4000, 20% 
glycerol, 0.03 M of each divalent cation (CaCl2 and MgCl2), 0.1 M bicine/Trizma 
base pH 8.5 (condition A11 of MorpheusTM screen, Figure 5-9A). Optimisation 
based on this condition with variation of the PEG concentration generated more 
crystals of larger size - 50µm×45µm×35µm - that were checked for diffraction 
using the in-house Rigaku X-ray generator with Mar345 detector (Figure 5-9B). 
However, there was no diffraction observed from the optimised crystal. When the 
histidine tag was cleaved, the full length gp11 at a concentration of 14 mg/mL 
formed crystals under conditions of 10% PEG 4000, 20% glycerol, 0.03 M of each 
divalent cation (CaCl2 and MgCl2), 0.1 M bicine/Trizma base pH 8.5 (A11 of 
MorpheusTM screen, Figure 5-10 A), 10% PEG 8000, 20% ethylene glycol, 0.02 M of 
each alcohol, 0.1 M MOPS/HEPES-Na pH 7.5 (D6 of MorpheusTM screen, Figure 
5-10 B), and 10% PEG 8000, 20% ethylene glycol, 0.03 M of each ethylene glycol, 
0.1 M MOPS/HEPES-Na pH 7.5 (E6 of MorpheusTM screen,  Figure 5-10 C). 
Further optimisation of the untagged gp11 based on these conditions also failed to 
produce better diffracting crystals.  
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5.4 Discussion 
The full-length scaffolding protein gp11 from bacteriophage SPP1, with and 
without an N-terminal histidine tag, was successfully cloned, purified and 
crystallised. The GST-tagged version of the full-length gp11 was also cloned, but 
purification was not satisfactory, with considerable amounts of impurities 
presented after a two-step purification by batch method with Glutathione 
SepharoseTM 4B beads followed by size exclusion chromatography. The oligomeric 
state of the histidine tagged scaffolding protein in solution was determined to be 
dimeric. This result contradicts previous observations on the SPP1 gp11 that 
showed that a C-terminally histidine tagged protein formed tetramers in solution: 
a dimer of dimers was observed by sedimentation equilibrium centrifugation and 
MALDI mass spectrometry of cross-linked protein samples (Poh et al, 2008).  
The full-length gp11 protein was observed to degrade gradually and therefore a 
series of truncations were designed aiming to improve stability based on the 
Figure 5-9 Crystals of his-tagged full-length gp11.  
Crystals obtained using MorpheusTM screen condition A11 before (A) and after (B) 
optimisation. 
Figure 5-10 Crystals of untagged full-length gp11.  
Initial hits from MorpheusTM screen conditions A11 (A), D6 (B) and E6 (C). 
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results of limited proteolysis experiments and disorder prediction analysis. The 
truncated proteins were also successfully cloned and purified. Surprisingly the 
full-length gp11 exhibited higher crystallisation propensity than the N- and 
C-terminally truncated constructs, which were initially expected to feature less 
degradation and be more suitable for production of diffracting crystals. The N- and 
C-terminally truncated proteins showed less solubility and stability compared 
with the full-length gp11 during the purification process, and formed amorphous 
precipitates in the majority of drops during crystallisation, with no crystal 
formation. 
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6 Recombinant Portal Protein from Staphylococcus 
epidermidis Bacteriophage CNPH82 Is A 13-Subunit 
Oligomer 
6.1 Introduction 
CNPH82 is a bacteriophage infecting the opportunistic pathogen Staphylococcus 
epidermidis. S. epidermidis is normally a human skin commensal bacterium but 
turns into a very common nosocomial infection pathogen in immunocompromised 
patients with implanted medical devices (Otto, 2009; Ziebuhr et al, 2006). The 
therapeutic challenge of treating the S. epidermidis infections originates from its 
rapid development of antibiotic resistance and formation of biofilms (Otto, 2009). 
Upcoming multiresistency to several S. epidermidis strains was connected to 
horizontal gene transfer, which is commonly mediated by bacteriophages. One of 
those phages is CNPH82, a member of the Siphoviridae family and the Caudovirales 
order. 
Transmission electron microscopy micrographs showed that CNPH82 contains an 
isometric head and noncontractile tail (Figure 6-1) (Daniel et al, 2007). The 
complete genome of CNPH82 has been sequenced (Daniel et al, 2007). However, 
unlike the well characterised double-stranded DNA bacteriophages such as T4, T7, 
P22 and SPP1, no X-ray structural information has yet been deduced for proteins 
of this essential pathogen related phage.  
The portal protein serves as a major component of the ATP-dependent genome 
translocation molecular motor in tailed bacteriophages and herpes viruses 
(Casjens, 2011). As an essential requirement during viral morphogenesis process, 
the portal protein plays indispensable roles in several aspects: it initiates 
pro-capsid assembly, and is a central component of the DNA translocation 
molecular motor, headful sensor and connector assembly (Rao & Feiss, 2008). The 
portal proteins from different tailed bacteriophages and herpes simplex viruses 
vary dramatically in both amino acid sequence and molecular mass, but share a 
common characteristics: cyclical homo-oligomers arranged radially with a 
turbine-like shape and a central channel for DNA passage (Orlova et al, 1999; Rao 
& Feiss, 2008). In the functional mature virion or in the isolated connector bound 
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to tail factors, portal proteins were consistently presented as 12-subunit 
assemblies (Olia et al, 2011; Orlova et al, 2003; Simpson et al, 2000b). 
Nevertheless, the oligomeric state of portal proteins from some viruses, like SPP1 
and herpes virus, could change to 13 when heterologously expressed in E. coli, 
possibly due to conformational rearrangements (Cardone et al, 2007; Lebedev et al, 
2007; Orlova et al, 2003; Trus et al, 2004b). Each subunit of SPP1 portal protein 
consists of four regions – termed the clip, stem, wing and crown (Lebedev et al, 
2007). CNPH82 portal protein shares 32% amino acid sequence identity with the 
SPP1 portal protein. Moreover, high sequence similarity between other head 
morphogenesis proteins such as the major capsid and scaffolding proteins of 
CNPH82 and SPP1, imply similar morphogenesis processes. 
 
Figure 6-1 Ultrastructures of the phage CNPH82. 
The structure was observed by transmission electron microscopy, and the figure was 
adapted from (Daniel et al, 2007). 
6.2 Materials and Methods  
6.2.1 Cloning, Expression and Purification of CNPH82 Portal 
Protein 
The partial gene encoding truncated portal protein cn3 (E25-Q456) was amplified 
by PCR and ligated into the NheI/HindIII sites of vector pET28a (Novagen). 
Sequencing and alignment was performed to confirm the correct insert. The portal 
protein cn3 with a cleavable N-terminal hexahistidine tag was overexpressed in 
Escherichia coli strain B834 cells. Cells were grown in Luria–Bertani medium with 
30 µg/ml kanamycin at 310 K to the mid-log phase (OD600 around 0.6-0.8). The 
portal protein expression was induced by the addition of 1mM IPTG carried out for 
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20 h at 289 K. The cell pellet was lysed using a cell disruptor (Constant Cell 
Disruption Systems) at 4° C with a pressure of 25 kpsi in lysis buffer containing 20 
mM Tris (pH 7.5), 500 mM NaCl, 10 mM MgCl2, 10 mM Imidazole, 100 µg/ml 
lysozyme, 1 mM AEBSF, 0.7 µg/ml pepstatin. Nickel Affinity chromatography was 
performed on a 5 mL HiTrapTM chelating HP column (GE Healthcare) and the 
protein sample was further purified on a Superose 6 size-exclusion column (GE 
Life Sciences). Purity was assigned by denaturing polyacrylamide 
gel-electrophoresis. The molecular mass of the purified sample was confirmed by 
matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). 
6.2.2 Molecular weight determination by SEC-MALLS 
The molecular mass of cn3 (E25-Q456) was determined by Size Exclusion 
Chromatography coupled with Multi-Angle Laser Light Scattering (SEC-MALLS). 
The protein sample (60 μl) with a concentration of 0.5 mg/ml was applied on a 
BioSepTM SEC-s3000 Gel Filtration column (Phenomenex) equilibrated with 
buffer containing 20 mM Tris (pH 7.5), 500 mM NaCl, 10 mM MgCl2. Size-exclusion 
chromatography was carried out on a Shimadzu HPLC system and the elution was 
monitored at 280 nm by a SPD20A UV/Vis detector. Light-scattering data were 
recorded by a Dawn HELEOS-II 18-angle light scattering detector and the 
concentration of the eluting protein was measured by an in-line Optilab rEX 
refractive index monitor (Wyatt Technology). Data were analysed with ASTRA V 
software package. Molecular mass was calculated using Zimm’s formalism of the 
Rayleigh-Debye-Gans light scattering model for dilute polymer solutions and a 
refractive-index increment (dn/dc) of 0.183 ml g-1 was used for the protein 
molecular mass estimation. 
6.2.3 Crystallisation 
The protein cn3 (E25-Q456) was crystallized at 293 K by the sitting drop vapour 
diffusion method using 15 mg/ml protein solution in 20 mM Tris (pH 7.5), 500 mM 
NaCl, 10 mM MgCl2. Drops containing 300 nl cn3 solution and 150 nl reservoir 
solution were dispensed by a Mosquito Nanolitre Pipetting robot (TTP Lab-tech) 
and equilibrated against 60ul of reservoir solution. To overcome the hurdle of high 
salt concentration in the protein solution, 500mM NaCl was added into the 
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reservoir solution after the screen was set up. The best crystal was obtained with 
the reservoir containing 0.2 M ammonium acetate and 40 % (v/v) MPD. 
6.2.4 X-ray Data Collection and Processing 
X-ray data were collected from a single crystal at the ESRF beam line ID14-4 at a 
wavelength of 0.9393Å with the crystal-to-detector distance of 652.7 mm. Data 
were collected at 100 K using an oscillation range of 0.5 per image with a total 
crystal rotation of 180. Diffraction images were indexed and integrated using 
HKL-2000 (Otwinowski & Minor, 1997) and were further analysed with CCP4 
program package (Winn et al, 2011). The self rotation function was calculated 
using MOLREP (Vagin & Teplyakov, 2010), in the resolution range 5 – 10 Å with 
the radius of integration sphere of 87 Å. To solve the structure by molecular 
replacement, BALBES (Long et al, 2008), MOLREP (Vagin & Teplyakov, 2010) and 
Phaser (Mccoy et al, 2007) were tried and SPP1 portal protein gp6 was used as a 
search model (PDB access code 2JES ). 
6.3 Results  
6.3.1 Cloning, Expression and Purification 
The portal protein was cloned and overexpressed in E. coli B834 cells. 
Homogeneous protein was obtained after Ni-affinity and size-exclusion 
chromatography. The protein was concentrated to ~35 mg ml-1 in solution 
containing 20 mM Tris (pH 7.5), 500 mM NaCl, 10 mM MgCl2.  
6.3.2  Oligomeric State of CNPH82 Portal Protein Cn3 
The truncated CNPH82 portal protein cn3 (E25-Q456) consists of 432 amino acids 
with a theoretical molecular mass of 53.074 kDa. The molecular weight of the 
purified protein measured by matrix-assisted laser desorption/ionization mass 
spectrometry (MALDI-MS) is 53.094 kDa, in good agreement with the theoretical 
value. A single monodispersed peak was observed during the size-exclusion 
chromatography of cn3. SEC-MALLS showed the mean molecular weight of the 
eluted species of 685.9 kDa, or ~12.9 subunits per oligomer, suggesting that cn3 
contains 13-subunits per oligomer in solution (Figure 6-2). 
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Figure 6-2 Characterization of cn3 oligomeric state by SEC–MALLS.  
The thin line corresponds to the absorbance monitored at 280 nm. The thick line 
shows the molecular weight calculated for the eluted species. 
6.3.3 Crystallisation  
Several hits appeared in the initial MPD crystallisation screen (Hampton) with the 
best diffracting crystals growing from 40% MPD containing either 0.2 M 
ammonium nitrate or 0.2 M ammonium acetate. Both conditions were optimised. A 
complete native data set to a resolution of 4.2 Å was collected at ESRF using a 
crystal grown from 0.2 M ammonium acetate and 40 % (v/v) MPD (Figure 6-3). 
 
Figure 6-3 Diffraction image.  
Resolution at the edge of the plate is 3.9 Å. 
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6.3.4 Crystallographic Analysis  
The crystal belongs to the space group C2221, with a = 252.4 Å, b = 367.0 Å, c = 
175.5 Å (Table 6-1). The self-rotation function R (Φ,Ψ,К) (Crowther, 1972) was 
calculated to deduce the internal symmetry of the CNPH82 portal protein. The 
13-fold symmetry was identified from peaks appearing in κ sections 360°/13 and 
κ = 180° (Figure 6-4). Peaks in the κ = 180° section were spaced from each other 
by 27.7° (Figure 6-4A). Although the sequence identity between cn3 and the portal 
protein, gp6, of SPP1 is as high as 32%, attempts to solve the structure by 
molecular replacement proved unsuccessful. 
Table 6-1 X-ray data statistics  
X-ray source ID14-4,  ESRF 
Wavelength, Å 0.9393 
Temperature, K 100  
Space group C2221 
Unit cell parameters, Å a=252.4, b=367.0, c=175.5 
Resolution Range, Å 100 - 4.2 (4.35 – 4.20) 
No. of unique reflections 54776 (4970) 
Rmergea, % 12.6 (65.4) 
Completeness, % 98.1 (90.1) 
Redundancy 3.6 (2.9) 
Average I/sigma(I) 8.2 (1.4) 
Values in parentheses are for the highest resolution shell.  
a Rmerge = ∑hkl∑i|Ii(h) - <I(h)>|/∑hkl∑iIi(h), where I(h) is intensity of reflection h, 
<I(h)> is average value of intensity, the sum ∑hkl is over all measured reflections 
and the sum ∑i is over i measurements of a reflection.  
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Figure 6-4 Stereographic projections =180° (A) and κ = 27.7° (B) of the self-rotation   
function. 
 
6.4 Conclusions 
In conclusion, the truncated portal protein cn3 of bacteriophage CNPH82 was 
successfully purified and crystallised. The X-ray data set collected from a native 
crystal was to the resolution of 4.2 Å. The oligomeric state was characterised to be 
13 mer by SEC-MALLS and crystallographic analysis. Elucidating the structure of 
the portal protein will provide insights into the phage assembly, in particular the 
mechanism of viral DNA encapsidation. 
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7 The bacteriophage T4 portal protein – Gp20 
7.1 Introduction 
7.1.1 Bacteriophage T4 
Bacteriophage T4 is a large tailed double-stranded DNA (dsDNA) virus that infects 
Escherichia coli. It belongs to Myoviridae family, and is the the most thoroughly 
investigated representative of the T-even phages (Calendar, 2006). The mature T4 
virion consists of a 1200 Å long, 860 Å wide prolate icosahedral head with a 172 
kb dsDNA chromosome; a 1000 Å long, 210 Å diameter cocylindrical contractile 
tail, terminated with a 460 Å diameter baseplate; and six 1450 Å long fibers 
attached to the baseplate (Leiman et al, 2003). The assemblies of head, tail, and 
fibers are independent processes, and these components will join together to form 
a mature virion.  
The T4 DNA translocation machinery is one of the fastest and most powerful 
packaging motors reported to date, with a packaging velocity of 2,000 bp/s (Fuller 
et al, 2007). It is composed of three components: the dodecameric portal gp20 (61 
kDa), the pentameric large terminase gp17 (70 kDa) and the 11- or 12-meric small 
terminase gp16 (18 kDa). With the ubiquitous distribution of T4-type 
bacteriophage, the tailed DNA phage T4 has served as an excellent model for the 
elucidation of the mechanisms underlying head assembly of T-even phages as well 
as general large icosahedral viruses (Rao & Black, 2010). 
 
Figure 7-1 The DNA-packaging motor of phage T4. 
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(A): A three-dimensional cryo-electron microscopy reconstruction of the phage T4 
procapsid with bound subunits of the large terminase subunit (TerL). (B): A 
magnification of the portal vertex. The white areas represent electron density, in 
which ribbon diagrams for TerL and the portal protein are modeled. (C): A view 
along the central channel of the indicated ring of electron density. This figure was 
adapted from (Casjens, 2011). 
7.1.2 Studies of T4 Portal Protein Gp20 
Bacteriophage T4 portal protein is the product of gene 20, encoding a 61 kDa 
polypeptide of 524 amino acids. The T4 portal gp20 is well documented to 
perform multiple functions: initiation of prohead assembly, initiation of 
core/scaffolding assembly, terminase interaction in DNA packaging, the headful 
packaging gauge, prohead expansion and stabilization, and head to tail connection.  
Purification and crystallisation studies of gp20 began nearly two decades ago, but 
limited progress has been made due to its hydrophobic properties (Driedonks et al, 
1981). Gp20 was first purified from proheads in the presence of certain amount of 
detergents, such as 0.5% of Nonidet P-40 and 8M urea (Driedonks et al, 1981). 
Then, fusion proteins of gp20 with Green Fluorescent Protein (GFP), still purified 
in the presence of 8M urea, were constructed for in vitro functional study 
(Baumann et al, 2006). The gp20 structure was finally observed by negative 
staining electron microscopy with the majority of particles displaying a ring-like 
appearance (Driedonks et al, 1981)  (Figure 7-2). As expected, the overall 
structure of gp20 shares common characteristics with homologues from other 
double-stranded bacteriophages as a dodecamer with a central DNA channel 
(Driedonks, 1981). As observed by cryo electron microscopy, the narrower end of 
gp20 protrudes out of the capsid, and the wider end is inside the capsid (Leiman et 
al, 2004). However, a high-resolution atomic structure of gp20 remains 
unavailable, because high quality crystals cannot be obtained in conditions 
containing such high concentrations of urea. 
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Figure 7-2 Negative-staining EM analysis of the T4 portal protein.  
The portal protein from bacteriophage T4 was shown to be a 12-subunit assembly, and the 
figure was adapted from (Driedonks et al, 1981).  
 
As a central component of the DNA translocation machinery, gp20 forms a channel 
with a diameter of ~35 Å, through which the DNA is translocated into the 
procapsid. However, the exact role of gp20 in viral DNA translocation is not yet 
clear. A recent study using direct binding assays, mutagenesis, and structural 
analyses, confirmed the specific interaction between gp20 and the large terminase 
gp17, and identified the interaction sites: part of the protruding αβ domain in gp20 
and a conserved helix-turn-helix (HLH) in subdomain II of gp17. Therefore, a 
molecular lever mechanism coupling ATP hydrolysis to DNA movement has been 
proposed for the T4 DNA translocation motor (Hegde et al, 2012). 
7.1.3 Aim of the Project 
According to previous studies on the T4 portal protein gp20, a soluble protein can 
only be purified in the presence of harsh denaturing agents such as a high 
concentration of urea (Driedonks et al, 1981) which presents a big challenge for 
obtaining high quality crystals for X-ray structural studies. In this project, different 
cloning strategies and purification methods were carried out in order to produce 
soluble portal protein suitable for structural analysis. 
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7.2 Materials and Methods 
7.2.1  Cloning of the Gp20 Constructs  
The plasmid pAF20 with the full-length gene 20 in the expression vector pET14b 
was used as the template for the PCR reaction. The primers (Table 7-2) were 
designed to introduce NheI and XhoI restriction sites within the PCR product of 
gp20 DNA. Ampliﬁcation of required ORF by PCR was performed in a 50 L 
reaction vial (Table 7-1). The cycling conditions were as follows: initial 
denaturation at 98 °C for 30 s, denaturation of the template at 98 °C for 10 s, 
primers annealing at 55 °C for 20 s, extension at 72 °C for 1 min and final 
extension at 72 °C for 5 min. The three steps – denaturation, annealing and 
extension were repeated 29 cycles. The insert was then cloned into vector pET28a 
to express gp20 with an N-terminal cleavable His tag, or vector pGEX 6P-3 to 
express the protein with a cleavable N-terminal GST tag. The correct inserts were 
verified by DNA sequencing (GATC Biotech) and alignment analysis (Clustal W).  
 
Table 7-1 Components of PCR reaction (items were added in this order) 
Total  reaction volume Amount/reaction (ul) Final concentration 
dH2O 13.6  
5 × Phusion®   HF buffer  10 1× 
dNTPs (25 mM each) 0.4 0.2 mM each 
Primer 1 (2 μM) 12.5  0.5 μM 
Primer 2 (2 μM) 12.5  0.5 μM 
Template DNA 0.5  
Phusion®  DNA Polymerase(2 U/μl) 0.5 0.02 U/ μl 
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Table 7-2 Primers for cloning of gp20 constructs 
Primer Sequence(5’- 3’) 
Gp20-F1 CCCCTAGCTAGCATGAAATTTAATGTATTAAGTTTGTTTG 
Gp20-R1 GGGCCGCTCGAGTTAAAAATCCTCTTGTTCTTGG 
Gp20-R2 GGGCCGCTCGAGTTAAGTCATCTGCAAAATGTC 
Gp20-R3 GGGCCGCTCGAGTTATTCTATTTCTTCATCAGTCAT 
GP20-R4 GGGCCGCTCGAGTTACTCTTTAGACTCTTCTTCAA 
Gp20-F2 CGCGGATCCGAAAAAGAAGATCTTGTTTCC 
 
7.2.2 Expression and Puriﬁcation of the T4 Portal Protein Gp20 
7.2.2.1 Low Temperature (12 °C) Expression of Gp20  
The plasmid pYM145 was transformed into Escherichia coli ArcticExpressTM 
(DE3)RIL cells (Stratagene). A single colony from a Luria–Bertani (LB) agar plate 
containing 30 mg/µL kanamycin was picked to inoculate a small overnight culture 
at 37 °C. At this stage, 20 mg/µL gentamycin was also added into the LB medium 
for the selection of the chaperonin-encoding plasmid. 5 mL aliquots of the 
overnight culture were used to inoculate a 500 mL culture the following day. The 
500 mL culture was grown at 37 °C until the mid-log phase (OD600 of 0.6–0.8) was 
reached, at which point protein expression was induced by the addition of IPTG to 
a final concentration of 1 mM. Lastly, overnight incubation of the culture at 12 °C 
and 180 r.p.m was carried out for the over-expression of gp20. Cells were 
recovered by centrifugation in SORRALL®  RC 5B plus for 20 minutes at 5000g at 4 
°C. Supernatant was removed and cell pellet was stored at -20 °C.  
7.2.2.2 Autoinduction 
The plasmid pYM145 was transformed into Escherichia coli B834 cells 
(Stratagene). A single colony from a Luria–Bertani (LB) agar plate containing 30 
µg/mL kanamycin was picked to inoculate in LB medium overnight at 37 °C to 
make a starting culture. 1L of autoinduction medium with 30 µg/mL kanamycin 
was prepared. Cell cultures were inoculated (1:100) and grown overnight with 
shaking at 180 r.p.m at 16 °C to produce gp20. Cells were recovered by 
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centrifugation in SORRALL®  RC 5B plus for 20 minutes at 5000 g, 4 °C. Supernatant 
was removed and cell pellet was stored at -20 °C. 
7.2.2.3 Nickel affinity chromatography  
The cell pellet was re-suspended in nickel affinity chromatography binding buffer 
containing 20mM Tris pH 8.0, 250 mM NaCl, 10 mM MgCl2, and 50 mM imidazole 
supplemented with a combination of 100 µg/mL lysozyme and protease inhibitors 
(1 mM AEBSF and 0.7 µg/mL pepstatin). Cells were disrupted by sonication with a 
large probe in a glass beaker using short pulses of 30 seconds, with a 2 minutes 
resting time in between pulses. The sonication was carried out on ice, with caution 
to minimise thermal damage to protein extract. The cell debris was removed by 
centrifugation at 38758 g for 30 minutes at 4 °C using a Sorvall SS34 rotor. The 
supernatant was collected and then cleared with a 0.45 mm ﬁlter (Millipore). The 
ﬁltrate loaded onto a 5 mL HiTrap column (GE Healthcare) equilibrated with 
binding buffer for nickel afﬁnity chromatography puriﬁcation. The bound protein 
was eluted with an increasing proportion of elution buffer containing 20 mM Tris 
pH 8.0, 250 mM NaCl, 10 mM MgCl2, and 500 mM imidazole. The samples were 
analysed by 12% SDS-PAGE. 
7.2.2.4 Ammonium sulphate purification of gp20 (M1-T494) 
Appropriate amount of solid ammonium sulphate, as indicated in the Table 2-5, 
was added into the protein solution to precipitate gp20 at room temperature in 
the presence of different concentrations of ammonium sulphate using the 
following step-wise increase of its concentration: 20%, 25%, 30%, 35% and 40%. 
Fresh buffer 20 mM HEPES pH 7.0, 50 mM NaCl and 10% glycerol was 
subsequently used to dissolve the precipitated gp20.  
7.2.2.5 Batch Purification of the GST Fused Gp20 Δ24-494 
The protein was produced from 1 litre of E. coli B834 cells grown in LB medium. A 
standard induction protocol entails shifting log-phase cultures (A600 = ~0.6) from 
37 °C to 16 °C and adding IPTG to a final concentration of 1 mM. After an overnight 
of constant vigorous shaking, bacterial cells were recovered by centrifugation at 
5000 g (SORVALL®  RC 5B Plus rotor) at 4 °C for 20 minutes and stored at -80 °C 
until purification.   
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A solubility screen was performed with conditions shown in Table 7-3 before 
attempting the affinity purification, and the solubility of the protein sample was 
visualised by 12% SDS-PAGE. The cell pellets were lysed by sonication in 20 mL 
lysis Buffer 20 mM Tris pH 8.5, 150 mM NaCl, and the insoluble cell debris was 
removed by centrifugation at 38758 g for 30 minutes at 4 °C using a Sorvall SS34 
rotor. To immobilise the GST fused gp20 Δ24-494 on Glutathione Sepharose, the 
clarified lysate was incubated with Glutathione-Sepharose 4B (AP Biotech) on a 
tumbler at 4 °C for 4 hours (or one hour at room temperature) in 20 mM Tris pH 
8.5, 150 mM NaCl. The resin was washed four times before elution of the GST-gp20 
Δ24-494 with 50 mM reduced glutathione added in 20 mM Tris pH 8.5, 150 mM 
NaCl. The samples were analysed by 10% SDS-PAGE. 
Table 7-3 Buffer conditions for solubility test 
 Buffer / 20mM Tris Salt (mM) Additives 
1 pH 5.5 150 mM NaCl - 
2 pH 6.5 - 
3 pH 7.5 - 
4 pH 8.5 - 
5 pH 7.5 50 mM NaCl - 
6 300 mM NaCl - 
7 500 mM NaCl - 
8 150 mM KCl - 
9 500 mM KCl - 
10 150 mM NaCl 5% glycerol 
11 0.1% Triton X-100 
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7.3 Results 
7.3.1 Cloning, Expression and Purification of the Full-Length T4 
Portal Protein Gp20 
The DNA segment encoding the full-length gp20 was cloned into the restriction 
sites NheI and XhoI of vector pET28a (forming construct pYM145) for the 
expression of a recombinant protein containing an N-terminal hexahistidine tag 
with a thrombin cleavage site. 
Results of the initial small-scale expression test showed temperature was the key 
factor affecting the solubility of the target protein. The low temperature 
expression in E. coli ArcticExpressTM (DE3)RIL cells at 12 °C and autoinduction in E. 
coli B834 cells at 16 °C both significantly improved the solubility (Figure 7-3). 
However, the solubility of gp20 from large-scale ArcticExpress cell culture was 
significantly reduced in comparison with the solubility shown from the small-scale 
expression test. In addition, a considerable amount of cold-adapted chaperones 
Cpn60/Cpn10 were co-purified with gp20 (Figure 7-3).  
The purification of full-length gp20 produced by autoinduction at 16 °C in E. coli 
B834 cells was performed by nickel affinity chromatography and size exclusion 
chromatography (Figure 7-4). The molecular mass of the protein sample after this 
two-step purification was determined by MALDI-MS. The major peak from the 
MALDI mass spectrum, with an approximate mass of 74 kDa (Figure 7-5), 
corresponded to the E. coli chaperone protein DnaK (Hsp70). However, there was 
no peak with the molecular mass of 63.1 kDa corresponding to the gp20 subunit 
with the N-terminal hexahistidine tag.  
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Figure 7-3 Purification of the full-length gp20. 
(A) Small-scale expression test of the full-length gp20. A considerable amount of 
gp20 was soluble when produced in E. coli ArcticExpress (DE3)RIL cells at 12 °C and 
in E. coli B834 cells by autoinduction at 16 °C. The red arrow indicated the 
co-expression of the cold-adapted chaperones Cpn60/Cpn10 in E. coli ArcticExpress 
cells at 12 °C. (B) Nickel affinity purification of the full-length gp20 over-expressed in 
ArcticExpress cells at 12 °C. The fractions corresponding to elution peaks were 
resolved on a 12% SDS-PAGE gel L: low molecular weight ladder; T: the total protein 
lysate; S: soluble proteins after centrifugation; FT: flow-through;X1-B12: fractions 
from nickel affinity chromatography. 
 
Figure 7-4 Purification of the full-length gp20 produced by autoinduction at 16°C.  
(A) Chromatogram profile of size exclusion chromatography of the full-length gp20 
on a Superdex 200 column. Absorption at 280 nm was shown in blue, 260 nm in red. 
(B)The fractions corresponding to elution peaks from size exclusion chromatography 
Cpn60/Cpn10 
A B 
A B 
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were analysed on a 12% SDS-PAGE gel. L: low molecular weight marker (BioRad); S: 
loaded sample; A9-B1: fractions from size exclusion chromatography. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
7.3.2 Cloning, Expression and Purification of the C-terminally 
Truncated Gp20  
In order to design constructs with enhanced solubility, a secondary structure 
analysis by Jpred (Figure 7-6) and disorder prediction by PrDOS (Figure 7-7) were 
carried out to locate potentially disordered regions in gp20. The last 30 amino 
acids at the C-terminus appear to be disordered. Accordingly, a C-terminally 
truncated construct gp20 Δ1-494 was designed. 
Figure 7-5 MALDI-MS characterisation of the sample after purification of the full-length 
gp20.  
The protein was purified after the two-step purification. The major peak in the MALDI 
mass spectrum, with an approximate mass of 74 kDa, corresponds to the E. coli 
chaperone protein DnaK (Hsp70). 
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Figure 7-6 Secondary structure prediction of gp20.  
Only ~40 amino acid N-terminal and ~40 amino acid C-terminal segments are shown. The 
prediction was performed by Jpred. 
 
Figure 7-7 Disorder prediction of gp20. The prediction was performed by PrDOS. 
 
The DNA segment encoding the C-terminally truncated gp20 Δ1-494 was cloned 
into the restriction sites NheI and XhoI of vector pET28a (forming construct 
pYM149) for the expression of a recombinant protein containing an N-terminal 
hexahistidine tag with a thrombin cleavage site. 
The protein was over-expressed in E. coli B834 cells by autoinduction at 16 °C, and 
a solubility screen with different buffers was performed to optimise the solubility 
of the protein (Figure 7-8). According to SDS-PAGE, the over-expressed protein 
was soluble in 20 mM HEPES pH 7.0, 50 mM NaCl and 10% glycerol. The same 
SDS-PAGE gel was stained with His-tag in-gel stain for visualisation of the 
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His-tagged proteins, which confirmed the over-expressed protein as the target 
protein gp20. 
 
Figure 7-8 Solubility screen of the C-terminally truncated gp20 Δ1-494. 
(A) Solubility screen of gp20 Δ1-494 with different buffers produced in E. coli B834 
cells by autoinduction at 16°C. L: low molecular weight marker (BioRad); T: the total 
protein lysate; S: soluble protein after centrifugation. Proteins were resolved on a 12% 
SDS-PAGE gel; the red arrow indicated the His-tagged control sample. (B) The SDS 
PAGE gel was stained with His-tag In-gel stain to visualise His-tagged protein. 
Nickel affinity chromatography was then performed using the best buffer 
identified - 20 mM HEPES pH 7.0, 50 mM NaCl and 10% glycerol. However, the 
protein did not bind to the nickel column, with the majority of the soluble gp20 
Δ1-494 going directly to the flow-through (Figure 7-9). The incapability of gp20 
Δ1-494 to bind to nickel was also confirmed by a following nickel beads pull down 
assay. 
Other purification techniques without the involvement of histidine tag, such as 
ammonium sulphate precipitation and anion exchange chromatography were tried 
with no success. During ammonium sulphate precipitation, most soluble gp20 was 
precipitated in the presence of 40% ammonium sulphate (Figure 7-9). However, 
the precipitated protein could not be recovered by centrifugation and dissolved in 
fresh buffer. During anion exchange chromatography, the soluble gp20 Δ1-494 
protein didn’t bind to the MonoQ column or HiTrapQ column in the binding buffer 
20 mM HEPES pH 7.0, and 50 mM NaCl. 
A B 
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Figure 7-9 Purification of gp20 Δ1-494.  
(A)Nickel affinity chromatography showed that most of the soluble protein (S) went 
to the flow-through (FT). (B), Ammonium sulphate precipitation showed that most of 
the soluble gp20 Δ1-494 precipitated in the presence of 40% ammonium sulphate. L: 
low molecular weight marker (BioRad); T: total protein lysate; S: soluble protein 
after centrifugation; P: precipitated protein. Proteins were resolved on a 12% 
SDS-PAGE gel. 
7.3.3 Cloning, Expression and Purification of GST Fused Gp20 
Δ24-494 
The DNA fragment encoding the 80.6 kDa GST fused gp20 Δ24-494 with both 
N-terminal and C-terminal truncations was cloned within the BamH1-Xho1 sites of 
the vector pGEX 6P-3, forming construct pYM170, to express the recombinant 
protein with a cleavable N-terminal GST tag (26 kDa). GST fused gp20 Δ24-494 
was over-expressed in E. coli B834 cells. A solubility screen was performed to 
investigate the effect of pH and NaCl concentration on the solubility of the protein 
(Figure 7-10 A, buffer conditions shown in Table 7-3), during which the best buffer 
was identified as 20 mM Tris pH 8.5 and 150 mM NaCl.   
The GST fused gp20 Δ24-494 was purified by binding to Glutathione-Sepharose 
beads and then eluted with 50 mM glutathione. The protein was able to bind to 
Glutathione-Sepharose beads, and 50 mM glutathione successfully competed with 
GST tag to elute the fusion protein (Figure 7-10 B). Further purification of the 
eluted proteins using size exclusion chromatography or anion exchange 
chromatography was not successful. The protein (GST fused gp20 Δ24-494) was 
A 
B 
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lost during the purification process possibly due to precipitation. PreScission 
Protease Cleavage was used for the removal of the GST tag, and further 
concentrating of the cleaved protein induced precipitation. The eluted proteins 
from Glutathione-Sepharose beads during batch purification were concentrated 
and checked by MALDI-MS to confirm the existence of the GST fused gp20 Δ24-494. 
However, there was no signal detected corresponding to the GST fused gp20 
Δ24-494, which could be caused by protein precipitation during concentration. 
 
 
(A) Solubility screen of the GST fused gp20 Δ24-494 with different buffer conditions. 
Lane T indicates the total protein lysate, lanes 1 to 11 correspond to the soluble 
protein in different buffers listed in Table 7-3. (B) Batch purification of the GST fused 
gp20 Δ24-494 using Glutathione-Sepharose beads. Proteins were resolved on a 12% 
SDS-PAGE gel. 
A 
B 
Figure 7-10 Purification of GST fused gp20 Δ24-494. 
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7.4 Discussion  
Solubility is an intrinsic characteristic of a particular protein. The protein 
solubility can be affected by multiple factors including expression cell strains, the 
rate of protein synthesis, expression temperature and expression tags. In the case 
of the T4 portal protein gp20, the expressed protein is insoluble and accumulates 
in inclusion bodies when expressed at 37 °C. In this study, the solubility of the 
full-length gp20 was significantly improved when the protein was over-expressed 
in E. coli ArcticExpress RIL cells at 12 °C. The Cpn10 and Cpn60 chaperones were 
co-expressed to facilitate protein folding at 12 °C. However, the solubility of gp20 
in large-scale ArcticExpress cell culture was significantly reduced in comparison to 
its solubility during small-scale expression tests, with considerable amounts of 
chaperones co-purified.  
Solubility enhancement of the full-length gp20 was also observed when the 
protein was produced by autoinduction at 16 °C in E. coli B834 cells. The protein 
obtained after a two-step purification using nickel affinity chromatography and 
size exclusion chromatography turned out to be the E. coli chaperone protein DnaK, 
while soluble gp20 was lost during the purification process. 
The C-terminal truncated gp20 Δ1-494, with the C-terminal disordered region 
removed, showed significant improvement with regard to the solubility.  The 
protein was over-expressed in soluble form in E. coli B834 cells by autoinduction 
at 16 °C. However, this truncated protein could not bind to the nickel column with 
its N-terminal histidine tag, which might imply the misfolding of the protein. 
Alternative purification methods such as anion exchange chromatography and 
ammonium sulphate precipitation have also proved to be unsuccessful for the 
purification of gp20 Δ1-494.  
The gp20 Δ24-494 was fused to a GST tag, which can bind to 
Glutathione-Sepharose beads and be eluted by 50 mM glutathione. The further 
purification by size exclusion chromatography or anion chromatography was 
unsuccessful with protein lost during the purification process. The purity and yield 
of the GST fused gp20 Δ24-494 after the batch purification was insufficient for 
further characterisation and crystallisation.  
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The future work could be directed towards fusing maltose-binding protein (MBP, 
~42.5 kDa) as a tag, because MBP could serve as a solubility enhancer and permit 
one-step purification using amylose resin. It is also worth evaluating a potential 
use of the available GFP fused T4 portal protein constructs which are soluble in 
native buffer condition (Baumann et al, 2006).  
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8 Conclusions 
Obtaining the SPP1 portal protein gp6 in its 12-subunit biologically active state in 
vitro is considered to be extremely important for elucidating the mechanism of the 
DNA packaging molecular motor and for designing a stable molecular machine that 
can function in vitro. Two strategies involving protein engineering of fusion 
proteins and co-expression of gp6 with gp11, were designed and investigated 
using a combination of biochemical, biophysical and structural approaches.   
Several constructs of the SPP1 portal protein gp6 were fused with B. halodurans/B. 
stearothermphilus TRAP. The fusion proteins obtained with the B. 
stearothermphilus TRAP proved to be insoluble. The fusion proteins of gp6 with B. 
halodurans TRAP were successfully overexpressed in E. coli BL21 cells and 
purified, and their oligomeric states were analysed by SEC-MALLS and electron 
microscopy. The results revealed 13-fold symmetrical assemblies formed by 
construct containing gp6 truncations Δ27-466, Δ27-472 and Δ27-479, and 
mixtures of 13-mer and 14-mer assemblies for constructs containing gp6 Δ27-434. 
The oligomeric state remained 13 when the fusion protein containing gp6 Δ27-466 
was treated with the dissociation-re-association procedure. The ring 
corresponding to the TRAP assembly was detected by electron microscopy; 
however, the number of subunits contained in the TRAP ring can’t be deduced by 
EM due to the limited resolution. Because the study of the TRAP oligomer stability 
showed that B. stearothermphilus wild type and E71Stop TRAP are the most stable 
oligomers, future studies on fusion proteins could try to fuse B. stearothermphilus 
wild type and E71Stop TRAP with gp6.  
The oligomeric state of the C-terminally truncated gp6, co-expressed in E. coli with 
gp11, was characterised by SEC-MALLS, electron microscopy and crystallographic 
analysis, and the results showed that gp6 is still a 13-mer. Because the negatively 
charged C-terminus of gp6 could be important for interaction between gp6 and 
gp11, future work should be directed towards the co-expression of the full-length 
gp6 with gp11 and characterising the oligomeric state of gp6 by negative staining 
electron microscopy. Attempts to produce diffracting crystals of gp11 were 
unsuccessful; however, further solubility screening of various truncated constructs 
may prove useful. 
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The structure of the wild type gp6 Δ27-472 was solved at 2.8 Å resolution, 
revealing a 13-fold symmetrical molecule. The electron density maps 
corresponding to Asn365 are very clear. The protein’s fold is the same as for the 
N365K mutant, with most significant conformational differences observed in the 
tunnel loop and in segments of the clip and crown domains. Comparison with the 
structure of N365K mutant reveals significant differences in subunit-subunit 
interactions formed by tunnel loops, including different hydrogen bonds and van 
der Waals interactions. These differences may account for the different behaviour 
of capsids containing the mutant portal protein. 
The truncated portal protein cn3 of bacteriophage CNPH82 was successfully 
purified and crystallised. The X-ray data set from a crystal of the wild type protein 
was collected to the resolution of 4.2 Å. Self-rotation function calculation and 
SEC-MALLS experiments indicate that cn3 forms 13-subunit assemblies, like the 
SPP1 portal protein. 
The work on T4 portal protein gp20 aimed to produce soluble protein for 
structural studies. The full-length gp20 could not be purified in a soluble form; 
while a C-terminal truncated gp20 Δ1-494, as well as GST fused gp20 Δ24-494 
showed significant improvements in solubility, production of crystallisation 
quantities of pure soluble protein was not feasible. Further work could be directed 
towards exploring the effect of fusing the portal protein with a maltose-binding 
protein to improve its solubility.  
In summary, this work has focused on the study of the SPP1 portal protein gp6. In 
order to promote the formation of the dodecameric gp6, two strategies involving 
protein engineering of fusion proteins and co-expression of gp6 with gp11, were 
designed and investigated. The structure of the wild type gp6 was determined at 
2.8 Å resolution, providing structural basis for understand the effect of N365K 
substitution on the amount of packaged DNA. Finally, cloning, expression, 
purification and crystallisation studies on the SPP1 scaffolding protein gp11, 
CNPH82 portal protein cn3, and T4 portal protein gp20 were also performed. In 
the case of CNPH82 portal protein cn3, promising crystallisation conditions have 
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been identified. Further optimisation should lead to structure determination in 
future.  
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